<!DOCTYPE html SYSTEM "about:legacy-compat">
<html xmlns:ns0="http://www.w3.org/2001/XInclude" class="no-js">
  <head>
    <meta charset="utf-8"/>
    <meta http-equiv="X-UA-Compatible" content="IE=edge,chrome=1"/>
    <title>DC Code - Chapter 9. Controlled Substances Act.</title>
    <meta property="st:title" content="Chapter 9. Controlled Substances Act."/>
    <meta name="description" content="A simple, free browser for the Washington, DC Code"/>
    <meta name="viewport" content="width=device-width"/>
    <link href="https://fonts.googleapis.com/css?family=Open+Sans:400italic,700italic,400,700" rel="stylesheet" type="text/css"/>
    <link rel="stylesheet" type="text/css" href="/css/reset.css" media="screen"/>
    <link rel="stylesheet" type="text/css" href="/css/site.css" media="screen"/>
    <link rel="stylesheet" type="text/css" href="/css/body.css" media="screen"/>
    <link rel="stylesheet" type="text/css" href="/css/print.css" media="print"/>
    <link rel="stylesheet" type="text/css" href="/css/icons/style.css" media="screen"/>
    <script type="text/javascript">
            var _paq = _paq || [];
            _paq.push(['trackPageView']);
            _paq.push(['enableLinkTracking']);
            (function() {
              var u="//analytics.code.dccouncil.us/";
              _paq.push(['setTrackerUrl', u+'piwik.php']);
              _paq.push(['setSiteId', 1]);
              var d=document, g=d.createElement('script'), s=d.getElementsByTagName('script')[0];
              g.type='text/javascript'; g.async=true; g.defer=true; g.src=u+'piwik.js'; s.parentNode.insertBefore(g,s);
            })();

          window.searchHost = 'https://search.code.dccouncil.us';
          window.queryUrl = '/v1/search';
          </script>
    <noscript>
      <p>
        <img src="//analytics.code.dccouncil.us/piwik.php?idsite=1" style="border:0;" alt=""/>
      </p>
    </noscript>
  </head>
  <body>
    <header>
      <div class="container">
        <div class="right no-print search" id="search"> </div>
        <h1 id="sitename">
          <a href="/dc/council/code/">Code of the District of Columbia</a>
        </h1>
      </div>
    </header>
    <div class="main container">
      <div class="clearfix" style="width: 100%;">
        <div id="sidebar" class="col4 quiet">
          <h2>You Are Here</h2>
          <ul class="ancestors">
            <li>↪ <a href="/">D.C. Law Library</a></li>
            <li>↪ <a href="/dc/council/code/">Code of the District of Columbia</a></li>
            <li>↪ <a href="/dc/council/code/titles/48/">Title 48. Foods and Drugs.</a></li>
            <li>↪ Chapter 9. Controlled Substances Act.</li>
          </ul>
          <h2>Previous</h2>
          <p>
            <a class="internal-link" href="/dc/council/code/titles/48/">Title 48. Foods and Drugs.</a>
          </p>
          <h2>Next</h2>
          <p>
            <a class="internal-link" href="/dc/council/code/titles/48/chapters/9A/">Chapter 9A. Marijuana Consumption in Public Space.</a>
          </p>
          <h2>Publication Information</h2>
          <h3>Current through January 09, 2016</h3>
          <dl id="recency">
          <dt>Last codified D.C. Law:</dt>
          <dd>
            Law 21-46 effective January 09, 2016</dd>
          <dt>Last codified Emergency Law:</dt>
          <dd>
            Act 21-240 effective December 21, 2015</dd>
          <dt>Last codified Federal Law:</dt>
          <dd>
            Public Law 114-95 approved December 10, 2015</dd>
        </dl>
          <div class="cta">
            <p>
              <a href="mailto:code@dccouncil.us?subject=[ERROR]+/dc/council/code/titles/48/chapters/9/">Report Error</a>
            </p>
            <p>
              <a href="mailto:code@dccouncil.us?subject=[FEEDBACK]+/dc/council/code/titles/48/chapters/9/">Website Feedback</a>
            </p>
            <p>We cannot respond to questions regarding the law.</p>
          </div>
        </div>
        <div class="col8 body">
          <h1>Chapter 9. Controlled Substances Act.</h1>
          <div class="toc">
            <div class="line-group toc">
              <div class="line child-link " style="text-indent: 0em">
                <div>
                  <span class="title">
                    <a class="internal-link" href="/dc/council/code/titles/48/chapters/9/subchapters/I/">Subchapter I. Definitions.</a>
                  </span>
                </div>
                <div>
                  <span class="range">
                §§ 48-901.01 - 48-901.02</span>
                </div>
              </div>
              <div class="line child-link " style="text-indent: 0em">
                <div>
                  <span class="title">
                    <a class="internal-link" href="/dc/council/code/titles/48/chapters/9/subchapters/II/">Subchapter II. Standards and Schedules.</a>
                  </span>
                </div>
                <div>
                  <span class="range">
                §§ 48-902.01 - 48-902.14</span>
                </div>
              </div>
              <div class="line child-link " style="text-indent: 0em">
                <div>
                  <span class="title">
                    <a class="internal-link" href="/dc/council/code/titles/48/chapters/9/subchapters/III/">Subchapter III. Regulation of Manufacture, Distribution, and Dispensing.</a>
                  </span>
                </div>
                <div>
                  <span class="range">
                §§ 48-903.01 - 48-903.09</span>
                </div>
              </div>
              <div class="line child-link " style="text-indent: 0em">
                <div>
                  <span class="title">
                    <a class="internal-link" href="/dc/council/code/titles/48/chapters/9/subchapters/IV/">Subchapter IV. Offenses and Penalties.</a>
                  </span>
                </div>
                <div>
                  <span class="range">
                §§ 48-904.01 - 48-904.10</span>
                </div>
              </div>
              <div class="line child-link " style="text-indent: 0em">
                <div>
                  <span class="title">
                    <a class="internal-link" href="/dc/council/code/titles/48/chapters/9/subchapters/V/">Subchapter V. Enforcement and Administrative Provisions.</a>
                  </span>
                </div>
                <div>
                  <span class="range">
                §§ 48-905.01 - 48-905.07</span>
                </div>
              </div>
              <div class="line child-link " style="text-indent: 0em">
                <div>
                  <span class="title">
                    <a class="internal-link" href="/dc/council/code/titles/48/chapters/9/subchapters/VI/">Subchapter VI. Miscellaneous.</a>
                  </span>
                </div>
                <div>
                  <span class="range">
                §§ 48-906.01 - 48-906.03</span>
                </div>
              </div>
              <div class="line child-link " style="text-indent: 0em">
                <div>
                  <span class="title">
                    <a class="internal-link" href="/dc/council/code/titles/48/chapters/9/subchapters/VII/">Subchapter VII. Drug Interdiction and Demand Reduction Fund.</a>
                  </span>
                </div>
                <div>
                  <span class="range">
                §§ 48-907.01 - 48-907.03</span>
                </div>
              </div>
            </div>
          </div>
          <div class="content">
            <hr/>
            <div class="line heading heading-1" style="text-indent: 0em">
              <p>
                <span class="" style="">Subchapter I. Definitions.</span>
              </p>
            </div>
            <div class="line heading heading-2" style="text-indent: 0em">
              <p>
                <span class="" style="">§ 48–901.01. [Reserved].</span>
              </p>
            </div>
            <div>
                    <div class="line-group annotations">
                      <div class="line subheading">Section References</div>
                      <div class="line" style="text-indent: 1.5em">This section is referenced in § <a class="internal-link" href="/dc/council/code/sections/16-2301.html">16-2301</a>, § <a class="internal-link" href="/dc/council/code/sections/22-2603.01.html">22-2603.01</a>, § <a class="internal-link" href="/dc/council/code/sections/48-853.01.html">48-853.01</a>, and § <a class="internal-link" href="/dc/council/code/sections/50-1403.02.html">50-1403.02</a>.</div>
                    </div>
                  </div>
            <hr/>
            <div class="line heading heading-2" style="text-indent: 0em">
              <p>
                <span class="" style="">§ 48–901.02. Definitions.</span>
              </p>
            </div>
            <div>
                    <div class="line-group primary-content">
                      <div class="line" style="text-indent: 1.25em">As used in this chapter, the term:</div>
                      <div class="line" style="text-indent: 1.25em">
                        <p>
                          <span class="level-num">(1)</span>
                          <span>“Administer” means the direct application of a controlled substance, whether by injection, inhalation, ingestion, or any other means, to the body of a patient or research subject by:</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 2.5em">
                        <p>
                          <span class="level-num">(A)</span>
                          <span>A practitioner (or, in the practitioner’s presence, by the practitioner’s authorized agent); or</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 2.5em">
                        <p>
                          <span class="level-num">(B)</span>
                          <span>The patient or research subject at the direction of and in the presence of the practitioner.</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 1.25em">
                        <p>
                          <span class="level-num">(2)</span>
                          <span>“Agent” means an authorized person who acts on behalf of or at the direction of a manufacturer, distributor, or dispenser. The term “agent” does not include a common or contract carrier, a public warehouseman, or an employee of the carrier or warehouseman, when acting in the usual and lawful course of the carrier’s or warehouseman’s business.</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 1.25em">
                        <p>
                          <span class="level-num">(3)</span>
                          <span>“Cannabis” means all parts of the plant genus Cannabis, including both marijuana and hashish defined as follows:</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 2.5em">
                        <p>
                          <span class="level-num">(A)</span>
                          <span>“Marijuana” includes the leaves, stems, flowers, and seeds of all species of the plant genus Cannabis, whether growing or not. The term “marijuana” does not include the resin extracted from any part of the plant, nor any compound, manufacture, salt, derivative, mixture, or preparation from the resin, including hashish and does not include the mature stalks of the plant, fiber produced from such stalks, oil, or cake made from the seeds of the plant, any other compound, manufacture, salt, derivative, mixture or preparation of the mature stalks, fiber, oil, or cake, or the sterilized seed of the plant which is incapable of germination.</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 2.5em">
                        <p>
                          <span class="level-num">(B)</span>
                          <span>“Hashish” includes the resin extracted from any part of the plant genus Cannabis, and every compound, manufacture, salt, derivative, mixture, or preparation from such resin.</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 1.25em">
                        <p>
                          <span class="level-num">(3A)</span>
                          <span>“Contraband” means an item the mere possession of which is unlawful under District or federal law.</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 1.25em">
                        <p>
                          <span class="level-num">(4)</span>
                          <span>“Controlled substance” means a drug, substance, or immediate precursor, as set forth in Schedules I through V of subchapter II of this chapter.</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 1.25em">
                        <p>
                          <span class="level-num">(5)</span>
                          <span>“Counterfeit substance” means a controlled substance which, or the container or labeling of which, without authorization, bears the trademark, trade name, or other identifying mark, imprint, number or device, or any likeness thereof, of a manufacturer, distributor, or dispenser other than the person who in fact manufactured, distributed, or dispensed the substance.</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 1.25em">
                        <p>
                          <span class="level-num">(6)</span>
                          <span>“D.E.A.” means the Drug Enforcement Administration of the United States Department of Justice or its successor agency.</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 1.25em">
                        <p>
                          <span class="level-num">(7)</span>
                          <span>“Dispense” means to distribute a controlled substance to an ultimate user or research subject by or pursuant to the lawful order of a practitioner, including the prescribing, administering, packaging, labeling, or compounding necessary to prepare the substance for that delivery.</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 1.25em">
                        <p>
                          <span class="level-num">(8)</span>
                          <span>“Dispenser” means a practitioner who dispenses.</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 1.25em">
                        <p>
                          <span class="level-num">(9)</span>
                          <span>“Distribute” means the actual, constructive, or attempted transfer from one person to another other than by administering or dispensing of a controlled substance, whether or not there is an agency relationship.</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 1.25em">
                        <p>
                          <span class="level-num">(10)</span>
                          <span>“Distributor” means a person who distributes.</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 1.25em">
                        <p>
                          <span class="level-num">(11)</span>
                          <span>“Drug” means: (A) substances recognized as drugs in the official United States Pharmacopoeia, the official Homeopathic Pharmacopoeia of the United States, or the official National Formulary, or any supplement to any of them; (B) active substances intended for use in the diagnosis, cure, mitigation, treatment, or prevention of disease in man or animals; (C) substances (other than food) intended to affect the structure or any function of the body of man or animals; and (D) substances intended for use as a component of any article specified in clause (A), (B), or (C) of this paragraph. The term “drug” does not include devices or their components, parts, or accessories.</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 1.25em">
                        <p>
                          <span class="level-num">(12)</span>
                          <span>“Immediate precursor” means a substance which the Mayor has found to be, and by rule designates as being, the principal compound commonly used or produced primarily for use, and which is an immediate chemical intermediary used or likely to be used in the manufacture of a controlled substance, the control of which is necessary to prevent, curtail, or limit manufacture.</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 1.25em">
                        <p>
                          <span class="level-num">(13)</span>
                          <span>“Manufacture” means the production, preparation, propagation, compounding, conversion or processing of a controlled substance, either directly or indirectly by extraction from substances of natural origin, or independently by means of chemical synthesis, or by a combination of extraction and chemical synthesis, and includes any packaging or repackaging of the substance or labeling or relabeling of its container. The term “manufacture” does not include the preparation or compounding of a controlled substance by an individual for his or her own use or the preparation, compounding, packaging, or labeling of a controlled substance:</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 2.5em">
                        <p>
                          <span class="level-num">(A)</span>
                          <span>By a practitioner as an incident to administering or dispensing a controlled substance in the course of the practitioner’s professional practice; or</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 2.5em">
                        <p>
                          <span class="level-num">(B)</span>
                          <span>By a practitioner, or by his or her authorized agent under supervision, for the purpose of, or as an incident to, research, teaching, or chemical analysis and not for sale.</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 1.25em">
                        <p>
                          <span class="level-num">(14)</span>
                          <span>“Mayor” means the Mayor as provided for in § <a class="internal-link" href="/dc/council/code/sections/1-204.21.html">1-204.21</a>, or the Mayor’s designated agent.</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 1.25em">
                        <p>
                          <span class="level-num">(15)</span>
                          <span>“Narcotic drug” means any of the following substances, whether produced directly or indirectly by extraction from substances of vegetable origin, or independently by means of chemical synthesis, or by a combination of extraction and chemical synthesis:</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 2.5em">
                        <p>
                          <span class="level-num">(A)</span>
                          <span>Opium, its phenanthrene alkaloids, and their derivatives (except isoquiniline alkaloids of opium);</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 2.5em">
                        <p>
                          <span class="level-num">(B)</span>
                          <span>Any salt, compound, isomer, derivative, or preparation thereof which is chemically equivalent to or identical with any of the substances referred to in subparagraph (A) of this paragraph;</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 2.5em">
                        <p>
                          <span class="level-num">(C)</span>
                          <span>Opium poppy and poppy straw;</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 2.5em">
                        <p>
                          <span class="level-num">(D)</span>
                          <span>Cocaine, its salts, optical and geometric isomers, and salts of isomers;</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 2.5em">
                        <p>
                          <span class="level-num">(E)</span>
                          <span>Ecgonine, its derivatives, their salts, isomers, and salts of isomers; and</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 2.5em">
                        <p>
                          <span class="level-num">(F)</span>
                          <span>Any compound, mixture, or preparation that contains any of the substances referred to in this paragraph.</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 1.25em">
                        <p>
                          <span class="level-num">(16)</span>
                          <span>“Opiate” means any drug or other substance having an addiction-forming or addiction-sustaining liability similar to morphine or being capable of conversion into a drug having such addiction-forming or addiction-sustaining liability and includes its racemic and levorotatory forms. The term “opiate” does not include, unless specifically designated as controlled under § <a class="internal-link" href="/dc/council/code/sections/48-902.01.html">48-902.01</a>, the dextrorotatory isomer of 3-methoxy-n-methylmorphinan and its salts (dextromethorphan).</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 1.25em">
                        <p>
                          <span class="level-num">(17)</span>
                          <span>“Opium poppy” means the plant of the species Papaver somniferum L., except its seeds.</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 1.25em">
                        <p>
                          <span class="level-num">(18)</span>
                          <span>“Person” means an individual, corporation, government, or governmental subdivision or agency, business trust, estate, trust, partnership, or association, or unincorporated business, or any other legal entity.</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 1.25em">
                        <p>
                          <span class="level-num">(19)</span>
                          <span>“Poppy straw” means all parts, except the seeds, of the opium poppy, after mowing.</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 1.25em">
                        <p>
                          <span class="level-num">(20)</span>
                          <span>“Practitioner” means:</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 2.5em">
                        <p>
                          <span class="level-num">(A)</span>
                          <span>A physician, dentist, advanced practice registered nurse, veterinarian, scientific investigator, or other person licensed, registered, or otherwise permitted to distribute, dispense, conduct research with respect to, or to administer a controlled substance in the course of professional practice or research in the District of Columbia; or</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 2.5em">
                        <p>
                          <span class="level-num">(B)</span>
                          <span>A pharmacy, hospital, or other institution licensed, registered, or otherwise permitted to distribute, dispense, conduct research with respect to, or to administer a controlled substance in the course of its professional practice or research in the District of Columbia.</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 1.25em">
                        <p>
                          <span class="level-num">(21)</span>
                          <span>“Production” includes the manufacture, planting, cultivation, growing, or harvesting of a controlled substance.</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 1.25em">
                        <p>
                          <span class="level-num">(22)</span>
                          <span>“State” when applied to a part of the United States, includes any state, the District of Columbia, commonwealth, territory, insular possession thereof, and any area subject to the legal authority of the United States government.</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 1.25em">
                        <p>
                          <span class="level-num">(23)</span>
                          <span>“Ultimate user” means a person who lawfully possesses a controlled substance for that person’s own use or for the use of a member of that person’s household or for administering to an animal owned by him or her or by a member of that person’s household.</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 1.25em">
                        <p>
                          <span class="level-num">(24)</span>
                          <span>“Addict” means any individual who habitually uses any narcotic drug or abusive drug so as to endanger the public morals, health, safety, or welfare, or who is or has been so far addicted to the use of such narcotic drug or abusive drug as to have lost the power of self-control with reference to his addiction.</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 1.25em">
                        <p>
                          <span class="level-num">(25)</span>
                          <span>“Retail value” means the value in the market in which the substance was being distributed, manufactured or possessed, or the amount which the person possessing such controlled substance reasonably could have expected to receive upon the sale of the controlled substance at the time and place where the controlled substance was distributed, manufactured or possessed.</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 1.25em">
                        <p>
                          <span class="level-num">(26)</span>
                          <span>“Abusive drug” means any of the following substances, whether produced directly or indirectly by extraction from substances of vegetable origin, or independently by means of chemical synthesis or by a combination of extraction and chemical synthesis:</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 2.5em">
                        <p>
                          <span class="level-num">(A)</span>
                          <span>Phencyclidine or a phencyclidine immediate precursor;</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 2.5em">
                        <p>
                          <span class="level-num">(B)</span>
                          <span>Methamphetamine, its salts, isomers, and salts of its isomers; and</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 2.5em">
                        <p>
                          <span class="level-num">(C)</span>
                          <span>Phenmetrazine and its salts.</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 1.25em">
                        <p>
                          <span class="level-num">(27)</span>
                          <span>“Isomer” means the optical isomer, except as used in § <a class="internal-link" href="/dc/council/code/sections/48-902.04.html">48-902.04</a>(3) and § <a class="internal-link" href="/dc/council/code/sections/48-902.06.html">48-902.06</a>(1)(D). As used in § <a class="internal-link" href="/dc/council/code/sections/48-902.04.html">48-902.04</a>(3), “isomer” means any optical, positional, or geometric isomer. As used in § <a class="internal-link" href="/dc/council/code/sections/48-902.06.html">48-902.06</a>(1)(D), “isomer” means any optical or geometric isomer.</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 1.25em">
                        <p>
                          <span class="level-num">(28)</span>
                          <span>“Real property” means any right, title, or interest in any tract of land, or any appurtenance or improvement on a tract of land.</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 1.25em">
                        <p>
                          <span class="level-num">(29)</span>
                          <span>“Playground” means any facility intended for recreation, open to the public, and with any portion of the facility that contains one or more separate apparatus intended for the recreation of children, including, but not limited to, sliding boards, swingsets, and teeterboards.</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 1.25em">
                        <p>
                          <span class="level-num">(30)</span>
                          <span>“Video arcade” means any facility legally accessible to persons under 18 years of age, intended primarily for the use of pinball and video machines for amusement, and which contains a minimum of 10 pinball or video machines.</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 1.25em">
                        <p>
                          <span class="level-num">(31)</span>
                          <span>“Youth center” means any recreational facility or gymnasium, including any parking lot appurtenant thereto, intended primarily for use by persons under 18 years of age, which regularly provides athletic, civic, or cultural activities.</span>
                        </p>
                      </div>
                    </div>
                    <div class="line-group annotations">
                      <div class="line" style="text-indent: 1.5em">
      (<a class="internal-link" href="/dc/council/laws/4-29.html">Aug. 5, 1981, D.C. Law 4-29, § 102, 28 DCR 3081</a>; <a class="internal-link" href="/dc/council/laws/4-166.html">Mar. 9, 1983, D.C. Law 4-166, § 8, 30 DCR 1082</a>; <a class="internal-link" href="/dc/council/laws/6-201.html">Feb. 28, 1987, D.C. Law 6-201, § 2(a), (b), 34 DCR 524</a>; <a class="internal-link" href="/dc/council/laws/8-50.html">Oct. 19, 1989, D.C. Law 8-50, § 2(a), 36 DCR 5792</a>; <a class="internal-link" href="/dc/council/laws/8-138.html">June 13, 1990, D.C. Law 8-138, § 2(a), 37 DCR 2638</a>; <a class="internal-link" href="/dc/council/laws/10-229.html">Mar. 21, 1995, D.C. Law 10-229, § 2(a), 42 DCR 9</a>; <a class="internal-link" href="/dc/council/laws/10-247.html">Mar. 23, 1995, D.C. Law 10-247, § 4, 42 DCR 457</a>; <a class="internal-link" href="/dc/council/laws/11-110.html">Apr. 18, 1996, D.C. Law 11-110, § 34(a), 43 DCR 530</a>; <a class="internal-link" href="/dc/council/laws/20-278.html">June 16, 2015, D.C. Law 20-278, § 201(a), 62 DCR 1920</a>.)
    </div>
                      <div class="line subheading">Cross References</div>
                      <div class="line" style="text-indent: 1.5em">Good time credits, exceptions, see § <a class="internal-link" href="/dc/council/code/sections/24-221.06.html">24-221.06</a>.</div>
                      <div class="line subheading">Section References</div>
                      <div class="line" style="text-indent: 1.5em">This section is referenced in § <a class="internal-link" href="/dc/council/code/sections/4-751.01.html">4-751.01</a>, § <a class="internal-link" href="/dc/council/code/sections/4-1301.02.html">4-1301.02</a>, § <a class="internal-link" href="/dc/council/code/sections/7-1671.01.html">7-1671.01</a>, § <a class="internal-link" href="/dc/council/code/sections/22-811.html">22-811</a>, § <a class="internal-link" href="/dc/council/code/sections/22-4503.html">22-4503</a>, § <a class="internal-link" href="/dc/council/code/sections/23-1321.html">23-1321</a>, § <a class="internal-link" href="/dc/council/code/sections/24-221.06.html">24-221.06</a>, § <a class="internal-link" href="/dc/council/code/sections/42-3101.html">42-3101</a>, § <a class="internal-link" href="/dc/council/code/sections/42-3601.html">42-3601</a>, § <a class="internal-link" href="/dc/council/code/sections/48-853.01.html">48-853.01</a>, § <a class="internal-link" href="/dc/council/code/sections/48-1001.html">48-1001</a>, § <a class="internal-link" href="/dc/council/code/sections/48-1101.html">48-1101</a>, § <a class="internal-link" href="/dc/council/code/sections/50-1901.html">50-1901</a>, and § <a class="internal-link" href="/dc/council/code/sections/50-2206.01.html">50-2206.01</a>.</div>
                      <div class="line subheading">Prior Codifications</div>
                      <div class="line" style="text-indent: 1.5em">1981 Ed., § 33-501.</div>
                      <div class="line subheading">Effect of Amendments</div>
                      <div class="line" style="text-indent: 1.5em">The 2015 amendment by <a class="internal-link" href="/dc/council/laws/20-278.html">D.C. Law 20-278</a> added (3A).</div>
                      <div class="line subheading">Delegation of Authority</div>
                      <div class="line" style="text-indent: 1.5em">Delegation of authority pursuant to Law 4-29, see Mayor’s Order 85-171, October 18, 1985, as amended by Mayor’s Order 87-121, May 27, 1987.</div>
                      <div class="line subheading">Editor's Notes</div>
                      <div class="line" style="text-indent: 1.5em">Mayor to implement public information program: Section 5 of <a class="internal-link" href="/dc/council/laws/8-138.html">D.C. Law 8-138</a> provided that within 10 days of June 13, 1990, the Mayor shall implement an extensive public information program to detail the new penalty structure established under this act.</div>
                      <div class="line" style="text-indent: 1.5em">Drug house abatement: Section 2(a) of <a class="internal-link" href="/dc/council/laws/12-127.html">D.C. Law 12-127</a> provided that whoever shall erect, establish, continue, maintain, use, own, occupy, or release any building, erection, or place which is resorted to by persons using controlled substances in violation of § <a class="internal-link" href="/dc/council/code/sections/48-901.02.html">48-901.02</a> et seq., for the purpose of using any of these substances or for the purpose of keeping or selling any of these substances in violation of the Controlled Substances Act of 1981, is guilty of a nuisance, and the building, erection, or place, or the ground itself in or upon which such activity is conducted, permitted, or carried on, continued, or exists, and the furniture, fixtures, and contents thereof, are also declared a nuisance and disorderly house, and shall be enjoined and abated as hereinafter provided.</div>
                      <div class="line" style="text-indent: 1.5em">Uniform Law: Chapter 5, Controlled Substances, is based upon provisions contained in the Uniform Controlled Substances Act (1970, 1990, and 1994 Acts).</div>
                    </div>
                  </div>
            <hr/>
            <div class="line heading heading-1" style="text-indent: 0em">
              <p>
                <span class="" style="">Subchapter II. Standards and Schedules.</span>
              </p>
            </div>
            <div class="line heading heading-2" style="text-indent: 0em">
              <p>
                <span class="" style="">§ 48–902.01. Administration.</span>
              </p>
            </div>
            <div>
                    <div class="line-group primary-content">
                      <div class="line" style="text-indent: 1.25em">
                        <p>
                          <span class="level-num">(a)</span>
                          <span>The Mayor shall administer this chapter and, with provision for public notice and comment, may add substances to or delete or reschedule all substances enumerated in the schedules in § <a class="internal-link" href="/dc/council/code/sections/48-902.04.html">48-902.04</a>, § <a class="internal-link" href="/dc/council/code/sections/48-902.06.html">48-902.06</a>, § <a class="internal-link" href="/dc/council/code/sections/48-902.08.html">48-902.08</a>, § <a class="internal-link" href="/dc/council/code/sections/48-902.10.html">48-902.10</a> or § <a class="internal-link" href="/dc/council/code/sections/48-902.12.html">48-902.12</a> pursuant to subchapter I of Chapter 5 of Title 2 and pursuant to the procedures set forth in this chapter. In making a determination regarding a substance, the Mayor shall consider the following:</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 2.5em">
                        <p>
                          <span class="level-num">(1)</span>
                          <span>The actual or relative potential for abuse;</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 2.5em">
                        <p>
                          <span class="level-num">(2)</span>
                          <span>The scientific evidence of its pharmacological effect, if known;</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 2.5em">
                        <p>
                          <span class="level-num">(3)</span>
                          <span>The state of current scientific knowledge regarding the substance;</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 2.5em">
                        <p>
                          <span class="level-num">(4)</span>
                          <span>The history and current pattern of abuse;</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 2.5em">
                        <p>
                          <span class="level-num">(5)</span>
                          <span>The scope, duration, and significance of abuse;</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 2.5em">
                        <p>
                          <span class="level-num">(6)</span>
                          <span>The risk to the public health;</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 2.5em">
                        <p>
                          <span class="level-num">(7)</span>
                          <span>The potential of the substance to produce psychological or physiological dependence; and</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 2.5em">
                        <p>
                          <span class="level-num">(8)</span>
                          <span>Whether the substance is an immediate precursor of a substance already controlled under this subchapter.</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 1.25em">
                        <p>
                          <span class="level-num">(b)</span>
                          <span>After considering the factors enumerated in subsection (a) of this section and after complying with subchapter I of Chapter 5 of Title 2, the Mayor shall make findings with respect to the factors and issue a rule either controlling the substance if the Mayor finds that the substance has a potential for abuse or deleting the substance if the Mayor finds that the substance does not have a potential for abuse.</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 1.25em">
                        <p>
                          <span class="level-num">(c)</span>
                          <span>If the Mayor designates a substance as an immediate precursor, substances which are precursors of the controlled precursor shall not be subject to control solely because they are precursors of the controlled precursor.</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 1.25em">
                        <p>
                          <span class="level-num">(d)</span>
                          <span>If any substance is designated, rescheduled, or deleted as a controlled substance under federal law, the Mayor may similarly designate, reschedule, or delete the controlled substance under this chapter, or may otherwise designate, reschedule or delete as a controlled substance pursuant to subsections (a) and (b) of this section.</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 1.25em">
                        <p>
                          <span class="level-num">(e)</span>
                          <span>Authority to control under this section does not extend to tobacco or to distilled spirits, wine, or malt beverages, as those terms are defined or used in § <a class="internal-link" href="/dc/council/code/sections/25-103.html">25-103</a>.</span>
                        </p>
                      </div>
                    </div>
                    <div class="line-group annotations">
                      <div class="line" style="text-indent: 1.5em">
      (<a class="internal-link" href="/dc/council/laws/4-29.html">Aug. 5, 1981, D.C. Law 4-29, § 201, 28 DCR 3081</a>; <a class="internal-link" href="/dc/council/laws/6-15.html">Aug. 1, 1985, D.C. Law 6-15, § 5, 32 DCR 3570</a>; <a class="internal-link" href="/dc/council/laws/12-136.html">July 24, 1998, D.C. Law 12-136, § 2(a), 45 DCR 2942</a>; <a class="internal-link" href="/dc/council/laws/19-320.html">June 19, 2013, D.C. Law 19-320, § 301(a), 60 DCR 3390</a>.)
    </div>
                      <div class="line subheading">Section References</div>
                      <div class="line" style="text-indent: 1.5em">This section is referenced in § <a class="internal-link" href="/dc/council/code/sections/22-2603.01.html">22-2603.01</a>, § <a class="internal-link" href="/dc/council/code/sections/48-901.02.html">48-901.02</a>, § <a class="internal-link" href="/dc/council/code/sections/48-902.04.html">48-902.04</a>, § <a class="internal-link" href="/dc/council/code/sections/48-902.06.html">48-902.06</a>, § <a class="internal-link" href="/dc/council/code/sections/48-902.08.html">48-902.08</a>, § <a class="internal-link" href="/dc/council/code/sections/48-902.10.html">48-902.10</a>, and § <a class="internal-link" href="/dc/council/code/sections/48-902.12.html">48-902.12</a>.</div>
                      <div class="line subheading">Prior Codifications</div>
                      <div class="line" style="text-indent: 1.5em">1981 Ed., § 33-511.</div>
                      <div class="line subheading">Effect of Amendments</div>
                      <div class="line" style="text-indent: 1.5em">The 2013 amendment by <a class="internal-link" href="/dc/council/laws/19-320.html">D.C. Law 19-320</a>, in (d), substituted “the Mayor may similarly designate, reschedule, or delete the controlled substance” for “the Mayor may similarly propose to control or delete the substance” and added “or may otherwise designate, reschedule or delete as a controlled substance”.</div>
                      <div class="line subheading">Emergency Legislation</div>
                      <div class="line" style="text-indent: 1.5em">For temporary (90 days) amendment of this section, see § 301(a) of the Omnibus Public Safety and Justice Amendment Act of 2012 (D.C. Act 19-599, January 14, 2013, 60 DCR 1017).</div>
                      <div class="line" style="text-indent: 1.5em">For temporary (90 days) amendment of (d), see § 301(a) of the Omnibus Criminal Code Amendments Congressional Review Emergency Amendment Act of 2013 (D.C. Act 20-44, April 1, 2013,  60 DCR 5381, 20 DCSTAT 1281).</div>
                      <div class="line subheading">References in Text</div>
                      <div class="line" style="text-indent: 1.5em">Section 25-103, referred to in subsection (e) of this section, is part of Title 25, D.C. Official Code, which title was amended and enacted by <a class="internal-link" href="/dc/council/laws/13-298.html">D.C. Law 13-298</a>, effective May 3, 2001. For disposition of the subject matter of former Title 25, see the Disposition Table preceding § <a class="internal-link" href="/dc/council/code/sections/25-101.html">25-101</a>.</div>
                      <div class="line subheading">Delegation of Authority</div>
                      <div class="line" style="text-indent: 1.5em">Delegation of Authority to implement <a class="internal-link" href="/dc/council/laws/4-29.html">D.C. Law 4-29</a>, the “District of Columbia Uniformed Controlled Substances Act of 1981”, see Mayor’s Order 98-49, April 15, 1998 ( 45 DCR 2694).</div>
                      <div class="line subheading">Editor's Notes</div>
                      <div class="line" style="text-indent: 1.5em">Pursuant to subsection (b), sufentanil was added to the list of enumerated controlled substances in Schedule II, appearing in subparagraph (A) of paragraph (1) of § <a class="internal-link" href="/dc/council/code/sections/48-902.06.html">48-902.06</a>, by an order published upon adoption of the rule in  32 DCR 1097.</div>
                      <div class="line" style="text-indent: 1.5em">Pursuant to subsection (b), buprenorphine was rescheduled from Schedule II to Schedule V of enumerated controlled substances appearing in § <a class="internal-link" href="/dc/council/code/sections/48-902.12.html">48-902.12</a>(3), by an order published upon adoption of the rule in  33 DCR 6908.</div>
                      <div class="line" style="text-indent: 1.5em">Pursuant to subsection (b), loperamide was deleted from Schedule V appearing in § <a class="internal-link" href="/dc/council/code/sections/48-902.12.html">48-902.12</a>(3) by an order published upon adoption of the rule in  34 DCR 4370.</div>
                    </div>
                  </div>
            <hr/>
            <div class="line heading heading-2" style="text-indent: 0em">
              <p>
                <span class="" style="">§ 48–902.02. Nomenclature.</span>
              </p>
            </div>
            <div>
                    <div class="line-group primary-content">
                      <div class="line" style="text-indent: 1.25em">The controlled substances listed or to be listed in the schedules in §§ <a class="internal-link" href="/dc/council/code/sections/48-902.04.html">48-902.04</a>, <a class="internal-link" href="/dc/council/code/sections/48-902.06.html">48-902.06</a>, <a class="internal-link" href="/dc/council/code/sections/48-902.08.html">48-902.08</a>, <a class="internal-link" href="/dc/council/code/sections/48-902.10.html">48-902.10</a> and <a class="internal-link" href="/dc/council/code/sections/48-902.12.html">48-902.12</a> are included by whatever official, common, usual, chemical, or trade name designated.</div>
                    </div>
                    <div class="line-group annotations">
                      <div class="line" style="text-indent: 1.5em">
      (<a class="internal-link" href="/dc/council/laws/4-29.html">Aug. 5, 1981, D.C. Law 4-29, § 202, 28 DCR 3081</a>.)
    </div>
                      <div class="line subheading">Prior Codifications</div>
                      <div class="line" style="text-indent: 1.5em">1981 Ed., § 33-512.</div>
                    </div>
                  </div>
            <hr/>
            <div class="line heading heading-2" style="text-indent: 0em">
              <p>
                <span class="" style="">§ 48–902.03. Schedule I tests.</span>
              </p>
            </div>
            <div>
                    <div class="line-group primary-content">
                      <div class="line" style="text-indent: 1.25em">The Mayor shall place a substance in Schedule I if the Mayor finds that the substance:</div>
                      <div class="line" style="text-indent: 1.25em">
                        <p>
                          <span class="level-num">(1)</span>
                          <span>Has high potential for abuse; and</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 1.25em">
                        <p>
                          <span class="level-num">(2)</span>
                          <span>Has no accepted medical use in treatment in the United States or in the District of Columbia or lacks accepted safety for use in treatment under medical supervision.</span>
                        </p>
                      </div>
                    </div>
                    <div class="line-group annotations">
                      <div class="line" style="text-indent: 1.5em">
      (<a class="internal-link" href="/dc/council/laws/4-29.html">Aug. 5, 1981, D.C. Law 4-29, § 203, 28 DCR 3081</a>.)
    </div>
                      <div class="line subheading">Prior Codifications</div>
                      <div class="line" style="text-indent: 1.5em">1981 Ed., § 33-513.</div>
                    </div>
                  </div>
            <hr/>
            <div class="line heading heading-2" style="text-indent: 0em">
              <p>
                <span class="" style="">§ 48–902.04. Schedule I enumerated.</span>
              </p>
            </div>
            <div>
                    <div class="line-group primary-content">
                      <div class="line" style="text-indent: 1.25em">The controlled substances listed in this section are included in Schedule I, unless and until removed therefrom pursuant to § <a class="internal-link" href="/dc/council/code/sections/48-902.01.html">48-902.01</a>:</div>
                      <div class="line" style="text-indent: 1.25em">
                        <p>
                          <span class="level-num">(1)</span>
                          <span>Unless specifically excepted or unless listed in another schedule, any of the following opiates, including their isomers, esters, ethers, salts, and salts of isomers, esters, and ethers, whenever the existence of these isomers, esters, ethers and salts is possible within the specific chemical designation:</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 2.5em">
                        <p>
                          <span class="level-num">(A)</span>
                          <span>Acetylmethadol;</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 2.5em">
                        <p>
                          <span class="level-num">(B)</span>
                          <span>Allylprodine;</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 2.5em">
                        <p>
                          <span class="level-num">(C)</span>
                          <span>Alphacetylmethadol (except levo-alphacetylmethadol, also known as levo-alphaacetylmethadol, levomethadyl, accetate, or LAAM);</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 2.5em">
                        <p>
                          <span class="level-num">(D)</span>
                          <span>Alphameprodine;</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 2.5em">
                        <p>
                          <span class="level-num">(E)</span>
                          <span>Alphamethadol;</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 2.5em">
                        <p>
                          <span class="level-num">(F)</span>
                          <span>Benzethidine;</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 2.5em">
                        <p>
                          <span class="level-num">(G)</span>
                          <span>Betacetylmethadol;</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 2.5em">
                        <p>
                          <span class="level-num">(H)</span>
                          <span>Betameprodine;</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 2.5em">
                        <p>
                          <span class="level-num">(I)</span>
                          <span>Betamethadol;</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 2.5em">
                        <p>
                          <span class="level-num">(J)</span>
                          <span>Betaprodine;</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 2.5em">
                        <p>
                          <span class="level-num">(K)</span>
                          <span>Clonitazene;</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 2.5em">
                        <p>
                          <span class="level-num">(L)</span>
                          <span>Dextromoramide;</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 2.5em">
                        <p>
                          <span class="level-num">(M)</span>
                          <span>Diampromide;</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 2.5em">
                        <p>
                          <span class="level-num">(N)</span>
                          <span>Diethylthiambutene;</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 2.5em">
                        <p>
                          <span class="level-num">(O)</span>
                          <span>Difenoxin;</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 2.5em">
                        <p>
                          <span class="level-num">(P)</span>
                          <span>Dimenoxadol;</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 2.5em">
                        <p>
                          <span class="level-num">(Q)</span>
                          <span>Dimepheptanol;</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 2.5em">
                        <p>
                          <span class="level-num">(R)</span>
                          <span>Dimethylthiambutene;</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 2.5em">
                        <p>
                          <span class="level-num">(S)</span>
                          <span>Dioxaphetylbutyrate;</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 2.5em">
                        <p>
                          <span class="level-num">(T)</span>
                          <span>Dipipanone;</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 2.5em">
                        <p>
                          <span class="level-num">(U)</span>
                          <span>Ethylmethylthiambutene;</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 2.5em">
                        <p>
                          <span class="level-num">(V)</span>
                          <span>Etonitazene;</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 2.5em">
                        <p>
                          <span class="level-num">(W)</span>
                          <span>Etoxeridine;</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 2.5em">
                        <p>
                          <span class="level-num">(X)</span>
                          <span>Furethidine;</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 2.5em">
                        <p>
                          <span class="level-num">(Y)</span>
                          <span>Hydroxypethidine;</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 2.5em">
                        <p>
                          <span class="level-num">(Z)</span>
                          <span>Ketobemidone;</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 2.5em">
                        <p>
                          <span class="level-num">(AA)</span>
                          <span>Levomoramide;</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 2.5em">
                        <p>
                          <span class="level-num">(BB)</span>
                          <span>Levophenacylmorphan;</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 2.5em">
                        <p>
                          <span class="level-num">(CC)</span>
                          <span>Morpheridine;</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 2.5em">
                        <p>
                          <span class="level-num">(DD)</span>
                          <span>Noracymethadol;</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 2.5em">
                        <p>
                          <span class="level-num">(EE)</span>
                          <span>Norlevorphanol;</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 2.5em">
                        <p>
                          <span class="level-num">(FF)</span>
                          <span>Normethadone;</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 2.5em">
                        <p>
                          <span class="level-num">(GG)</span>
                          <span>Norpipanone;</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 2.5em">
                        <p>
                          <span class="level-num">(HH)</span>
                          <span>Phenadoxone;</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 2.5em">
                        <p>
                          <span class="level-num">(II)</span>
                          <span>Phenampromide;</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 2.5em">
                        <p>
                          <span class="level-num">(JJ)</span>
                          <span>Phenomorphan;</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 2.5em">
                        <p>
                          <span class="level-num">(KK)</span>
                          <span>Phenoperidine;</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 2.5em">
                        <p>
                          <span class="level-num">(LL)</span>
                          <span>Piritramide;</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 2.5em">
                        <p>
                          <span class="level-num">(MM)</span>
                          <span>Proheptazine;</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 2.5em">
                        <p>
                          <span class="level-num">(NN)</span>
                          <span>Properidine;</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 2.5em">
                        <p>
                          <span class="level-num">(OO)</span>
                          <span>Propiram;</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 2.5em">
                        <p>
                          <span class="level-num">(PP)</span>
                          <span>Racemoramide;</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 2.5em">
                        <p>
                          <span class="level-num">(QQ)</span>
                          <span>Thiophene;</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 2.5em">
                        <p>
                          <span class="level-num">(RR)</span>
                          <span>Trimeperidine;</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 2.5em">
                        <p>
                          <span class="level-num">(SS)</span>
                          <span>Acetyl-Alpha-Methylfentanyl;</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 2.5em">
                        <p>
                          <span class="level-num">(TT)</span>
                          <span>Alphe-methylfentanyl;</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 2.5em">
                        <p>
                          <span class="level-num">(UU)</span>
                          <span>Alpha-Methylthiofentanyl;</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 2.5em">
                        <p>
                          <span class="level-num">(VV)</span>
                          <span>Beta-hydroxyfentanyl;</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 2.5em">
                        <p>
                          <span class="level-num">(WW)</span>
                          <span>Beta-hydroxy-3-Methylfentanyl;</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 2.5em">
                        <p>
                          <span class="level-num">(XX)</span>
                          <span>3-Methylfentanyl;</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 2.5em">
                        <p>
                          <span class="level-num">(YY)</span>
                          <span>3-Methylthiofentanyl;</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 2.5em">
                        <p>
                          <span class="level-num">(ZZ)</span>
                          <span>MPPP;</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 2.5em">
                        <p>
                          <span class="level-num">(AAA)</span>
                          <span>Para-flurofentanyl;</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 2.5em">
                        <p>
                          <span class="level-num">(BBB)</span>
                          <span>PEPAP;</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 2.5em">
                        <p>
                          <span class="level-num">(CCC)</span>
                          <span>Thiofentanyl; and</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 2.5em">
                        <p>
                          <span class="level-num">(DDD)</span>
                          <span>Tilidine;</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 1.25em">
                        <p>
                          <span class="level-num">(2)</span>
                          <span>Unless specifically excepted or unless listed in another schedule, any of the following opium derivatives, its salts, isomers, and salts of isomers, whenever the existence of these salts, isomers, and salts of isomers is possible within the specific chemical designation:</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 2.5em">
                        <p>
                          <span class="level-num">(A)</span>
                          <span>Acetorphine;</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 2.5em">
                        <p>
                          <span class="level-num">(B)</span>
                          <span>Acetyldihydrocodeine;</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 2.5em">
                        <p>
                          <span class="level-num">(C)</span>
                          <span>Benzylmorphine;</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 2.5em">
                        <p>
                          <span class="level-num">(D)</span>
                          <span>Codeine methylbromide;</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 2.5em">
                        <p>
                          <span class="level-num">(E)</span>
                          <span>Codeine-N-Oxide;</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 2.5em">
                        <p>
                          <span class="level-num">(F)</span>
                          <span>Cyprenorphine;</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 2.5em">
                        <p>
                          <span class="level-num">(G)</span>
                          <span>Desomorphine;</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 2.5em">
                        <p>
                          <span class="level-num">(H)</span>
                          <span>Dihydromorphine;</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 2.5em">
                        <p>
                          <span class="level-num">(I)</span>
                          <span>Drotepanol;</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 2.5em">
                        <p>
                          <span class="level-num">(J)</span>
                          <span>Etorphine (except hydrochloride salt);</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 2.5em">
                        <p>
                          <span class="level-num">(K)</span>
                          <span>Diacetylated morphine (heroin);</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 2.5em">
                        <p>
                          <span class="level-num">(L)</span>
                          <span>Hydromorphinol;</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 2.5em">
                        <p>
                          <span class="level-num">(M)</span>
                          <span>Methyldesorphine;</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 2.5em">
                        <p>
                          <span class="level-num">(N)</span>
                          <span>Methyldihydromorphine;</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 2.5em">
                        <p>
                          <span class="level-num">(O)</span>
                          <span>Morphine methylbromide;</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 2.5em">
                        <p>
                          <span class="level-num">(P)</span>
                          <span>Morphine methylsulfonate;</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 2.5em">
                        <p>
                          <span class="level-num">(Q)</span>
                          <span>Morphine-N-Oxide;</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 2.5em">
                        <p>
                          <span class="level-num">(R)</span>
                          <span>Myrophine;</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 2.5em">
                        <p>
                          <span class="level-num">(S)</span>
                          <span>Nicocodeine;</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 2.5em">
                        <p>
                          <span class="level-num">(T)</span>
                          <span>Nicomorphine;</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 2.5em">
                        <p>
                          <span class="level-num">(U)</span>
                          <span>Normorphine;</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 2.5em">
                        <p>
                          <span class="level-num">(V)</span>
                          <span>Pholcodine; and</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 2.5em">
                        <p>
                          <span class="level-num">(W)</span>
                          <span>Thebacon;</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 1.25em">
                        <p>
                          <span class="level-num">(3)</span>
                          <span>Unless specifically excepted or unless listed in another schedule, any material, compound, mixture, or preparation which contains any quantity of the following hallucinogenic substances, its salts, isomers and salts of isomers, whenever the existence of these salts, isomers, and salts of isomers is possible within the specific chemical designation (for purposes of this paragraph only, the term “isomer” includes the optical, position, and geometric isomers):</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 2.5em">
                        <p>
                          <span class="level-num">(A)</span>
                          <span>4-bromo-2, 5-dimethoxyamphetamine;</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 2.5em">
                        <p>
                          <span class="level-num">(B)</span>
                          <span>2, 5 dimethoxyamphetamine;</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 2.5em">
                        <p>
                          <span class="level-num">(C)</span>
                          <span>4-methoxyamphetamine;</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 2.5em">
                        <p>
                          <span class="level-num">(D)</span>
                          <span>5-methoxy-3, 4-methylenedioxy amphetamine;</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 2.5em">
                        <p>
                          <span class="level-num">(E)</span>
                          <span>4-methyl-2,5-dimethoxyamphetamine;</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 2.5em">
                        <p>
                          <span class="level-num">(F)</span>
                          <span>3,4-methylenedioxyamphetamine [MDA];</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 2.5em">
                        <p>
                          <span class="level-num">(G)</span>
                          <span>3, 4, 5-trimethoxy amphetamine;</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 2.5em">
                        <p>
                          <span class="level-num">(H)</span>
                          <span>Bufotenine;</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 2.5em">
                        <p>
                          <span class="level-num">(I)</span>
                          <span>Diethyltryptamine;</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 2.5em">
                        <p>
                          <span class="level-num">(J)</span>
                          <span>Dimethyltryptamine;</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 2.5em">
                        <p>
                          <span class="level-num">(K)</span>
                          <span>Ethylamide analog of phencyclidine, PCE;</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 2.5em">
                        <p>
                          <span class="level-num">(L)</span>
                          <span>Ibogaine;</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 2.5em">
                        <p>
                          <span class="level-num">(M)</span>
                          <span>Lysergic acid diethylamide;</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 2.5em">
                        <p>
                          <span class="level-num">(N)</span>
                          <span>Mescaline;</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 2.5em">
                        <p>
                          <span class="level-num">(O)</span>
                          <span>Peyote;</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 2.5em">
                        <p>
                          <span class="level-num">(P)</span>
                          <span>N-ethyl-3-piperidyl benzilate;</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 2.5em">
                        <p>
                          <span class="level-num">(Q)</span>
                          <span>N-methyl-3-piperidyl benzilate;</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 2.5em">
                        <p>
                          <span class="level-num">(R)</span>
                          <span>Psilocybin;</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 2.5em">
                        <p>
                          <span class="level-num">(S)</span>
                          <span>Psilocyn;</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 2.5em">
                        <p>
                          <span class="level-num">(T)</span>
                          <span>Pyrrolidine analog of phencyclidine, PCPY;</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 2.5em">
                        <p>
                          <span class="level-num">(U)</span>
                          <span>Thiophene analog of phencyclidine;</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 2.5em">
                        <p>
                          <span class="level-num">(V)</span>
                          <span>Repealed;</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 2.5em">
                        <p>
                          <span class="level-num">(W)</span>
                          <span>Parahexyl;</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 2.5em">
                        <p>
                          <span class="level-num">(X)</span>
                          <span>4-bromo-2,5-dimethoxyphenethylamine;</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 2.5em">
                        <p>
                          <span class="level-num">(Y)</span>
                          <span>3,4-methylenedioxymethamphetamine [MDMA];</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 2.5em">
                        <p>
                          <span class="level-num">(Z)</span>
                          <span>Alpha-methyltryptamine (other name: AMT);</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 2.5em">
                        <p>
                          <span class="level-num">(AA)</span>
                          <span>5-methoxy-N,N-diisopropyltryptamine (other name: 5- MeO-DIPT);</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 2.5em">
                        <p>
                          <span class="level-num">(BB)</span>
                          <span>2,5-dimethoxy-4-(n)-propylthiophenethylamine (other name: 2C-T-7);</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 2.5em">
                        <p>
                          <span class="level-num">(CC)</span>
                          <span>2-(2,5-Dimethoxy-4-ethylphenyl)ethanamine (2C-E);</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 2.5em">
                        <p>
                          <span class="level-num">(DD)</span>
                          <span>2-(2,5-Dimethoxy-4-methylphenyl)ethanamine (2C-D);</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 2.5em">
                        <p>
                          <span class="level-num">(EE)</span>
                          <span>2-(4-Chloro-2,5-dimethoxyphenyl)ethanamine (2C-C);</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 2.5em">
                        <p>
                          <span class="level-num">(FF)</span>
                          <span>2-(4-Iodo-2,5-dimethoxyphenyl)ethanamine (2C-I);</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 2.5em">
                        <p>
                          <span class="level-num">(GG)</span>
                          <span>2-[4-(Ethylthio)-2,5-dimethoxyphenyl]ethanamine (2C-T-2);</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 2.5em">
                        <p>
                          <span class="level-num">(HH)</span>
                          <span>2-[4-(Isopropylthio)-2,5-dimethoxyphenyl]ethanamine (2C- T-4);</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 2.5em">
                        <p>
                          <span class="level-num">(II)</span>
                          <span>2-(2,5-Dimethoxyphenyl)ethanamine (2C-H);</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 2.5em">
                        <p>
                          <span class="level-num">(JJ)</span>
                          <span>2-(2,5-Dimethoxy-4-nitro-phenyl)ethanamine (2C-N); and</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 2.5em">
                        <p>
                          <span class="level-num">(KK)</span>
                          <span>2-(2,5-Dimethoxy-4-(n)-propylphenyl)ethanamine (2C-P);</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 1.25em">
                        <p>
                          <span class="level-num">(4)</span>
                          <span>Unless specifically excepted or unless listed in another schedule, any material, compound, or mixture, or preparation which contains any quantity of the following substances having a depressant effect on the central nervous system including its salts, isomers, and salts of isomers whenever the existence of such salts, isomers, and salts of isomers is possible within the specific chemical designation:</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 2.5em">
                        <p>
                          <span class="level-num">(A)</span>
                          <span>Mecloqualone;</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 2.5em">
                        <p>
                          <span class="level-num">(B)</span>
                          <span>Methaqualone; and</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 2.5em">
                        <p>
                          <span class="level-num">(C)</span>
                          <span>Gamma-hydroxybutyric acid (some other names include GHB; gamma-hydroxybutyrate; 4-hydroxybutyrate; 4-hydroxybutanoic acid; sodium oxybate; sodium oxybutyrate);</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 1.25em">
                        <p>
                          <span class="level-num">(5)</span>
                          <span>Unless specifically excepted or unless listed in another schedule, any material, compound, mixture, or preparation which contains any quantity of the following substances having a stimulant effect on the central nervous system, including their analogues or derivatives and its salts, isomers, and salts of isomers:</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 2.5em">
                        <p>
                          <span class="level-num">(A)</span>
                          <span>Fenethyline;</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 2.5em">
                        <p>
                          <span class="level-num">(B)</span>
                          <span>N-ethylamphetamine;</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 2.5em">
                        <p>
                          <span class="level-num">(C)</span>
                          <span>Cathinone;</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 2.5em">
                        <p>
                          <span class="level-num">(D)</span>
                          <span>N-Benzylpiperazine (some other names: BZP, 1- benzylpiperazine);</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 2.5em">
                        <p>
                          <span class="level-num">(E)</span>
                          <span>Methcathinone (Some other names: 2-(methylamino)- propiophenone; alpha-(methylamino)propiophenone; 2-(methylamino)-1-phenylpropan-1- one; alpha- -methylaminopropiophenone; monomethylpropion; ephedrone; — methylcathinone; methylcathinone; AL-464; AL-422; AL-463 and UR1432), its salts, optical isomers and salts of optical isomers, as well as synthetic substances, derivatives, and their isomers with similar chemical structure and pharmacological activity to methcathinone;</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 2.5em">
                        <p>
                          <span class="level-num">(F)</span>
                          <span>4-methyl-N-methylcathinone (other name: mephedrone);</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 2.5em">
                        <p>
                          <span class="level-num">(G)</span>
                          <span>3,4-methylenedioxypyrovalerone (other name: MDPV); and</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 2.5em">
                        <p>
                          <span class="level-num">(H)</span>
                          <span>3,4-methylenedioxy-N-methylcathinone (other name: methylone).</span>
                        </p>
                      </div>
                    </div>
                    <div class="line-group annotations">
                      <div class="line" style="text-indent: 1.5em">
      (<a class="internal-link" href="/dc/council/laws/4-29.html">Aug. 5, 1981, D.C. Law 4-29, § 204, 28 DCR 3081</a>; amended by rule, 39 DCR 1882; amended by rule, Dec. 7, 1994, 41 DCR 7967; <a class="internal-link" href="/dc/council/laws/13-99.html">May 9, 2000, D.C. Law 13-99, § 2(a), 47 DCR 791</a>; <a class="internal-link" href="/dc/council/laws/18-88.html">Dec. 10, 2009, D.C. Law 18-88, § 225, 56 DCR 7413</a>; <a class="internal-link" href="/dc/council/laws/19-320.html">June 19, 2013, D.C. Law 19-320, § 301(b), 60 DCR 3390</a>.)
    </div>
                      <div class="line subheading">Section References</div>
                      <div class="line" style="text-indent: 1.5em">This section is referenced in § <a class="internal-link" href="/dc/council/code/sections/7-3002.html">7-3002</a>, § <a class="internal-link" href="/dc/council/code/sections/44-1201.html">44-1201</a>, § <a class="internal-link" href="/dc/council/code/sections/48-901.02.html">48-901.02</a>, § <a class="internal-link" href="/dc/council/code/sections/48-902.01.html">48-902.01</a>, § <a class="internal-link" href="/dc/council/code/sections/48-902.02.html">48-902.02</a>, § <a class="internal-link" href="/dc/council/code/sections/48-1004.html">48-1004</a>, and § <a class="internal-link" href="/dc/council/code/sections/50-2206.13.html">50-2206.13</a>.</div>
                      <div class="line subheading">Prior Codifications</div>
                      <div class="line" style="text-indent: 1.5em">1981 Ed., § 33-514.</div>
                      <div class="line subheading">Effect of Amendments</div>
                      <div class="line" style="text-indent: 1.5em"><a class="internal-link" href="/dc/council/laws/13-99.html">D.C. Law 13-99</a> corrected the way in which two chemicals were stated in subsec. (3) and added provisions contained in (X) and (Y) in subsec. (3).</div>
                      <div class="line" style="text-indent: 1.5em"><a class="internal-link" href="/dc/council/laws/18-88.html">D.C. Law 18-88</a>, in par. (5), deleted “and” from the end of subpar. (A), substituted “; and” for a period at the end of subpar. (B), and added subpar. (C).</div>
                      <div class="line" style="text-indent: 1.5em">The 2013 amendment by <a class="internal-link" href="/dc/council/laws/19-320.html">D.C. Law 19-320</a> added (3)(Z) through (3)(KK); added (4)(C); inserted “their analogues or derivatives and” in the introductory language of (5); added (5)(D) through (5)(H); and made related changes.</div>
                      <div class="line subheading">Temporary Amendment of Section</div>
                      <div class="line" style="text-indent: 1.5em">For temporary (225 day) amendment of section, see § 2 of Uniform Controlled Substances Temporary Amendment Act of 1999 (<cite doc="D.C. Law 13-34">D.C. Law 13-34</cite>, October 7, 1999, law notification  47 DCR 3423).</div>
                      <div class="line subheading">Emergency Legislation</div>
                      <div class="line" style="text-indent: 1.5em">For temporary (90-day) amendment of section, see § 2 of the Uniform Controlled Substances Emergency Amendment Act of 1999 (D.C. Act 13-96, June 15, 1999,  46 DCR 5640).</div>
                      <div class="line" style="text-indent: 1.5em">For temporary (90-day) amendment of section, see § 2 of the Uniform Controlled Substances Congressional Review Emergency Amendment Act of 1999 (D.C. Act 13-144, October 18, 1999,  46 DCR 9904).</div>
                      <div class="line" style="text-indent: 1.5em">For temporary (90 day) amendment of section, see § 225 of Omnibus Public Safety and Justice Emergency Amendment Act of 2009 (D.C. Act 18-181, August 6, 2009,  56 DCR 6903).</div>
                      <div class="line" style="text-indent: 1.5em">For temporary (90 day) amendment of section, see § 225 of Omnibus Public Safety and Justice Congressional Review Emergency Amendment Act of 2009 (D.C. Act 18-227, October 21, 2009,  56 DCR 8668).</div>
                      <div class="line" style="text-indent: 1.5em">For temporary amendment of section, see § 301(b) of the Omnibus Public Safety and Justice Amendment Act of 2012 (D.C. Act 19-599, January 14, 2013,  60 DCR 1017).</div>
                      <div class="line" style="text-indent: 1.5em">For temporary (90 days) amendment of this section, see § 301(b) of the Omnibus Criminal Code Amendment Congressional Review Emergency Act of 2013 (D.C. Act 20-44, April 1, 2013,  60 DCR 5381, 20 DCSTAT 1281).</div>
                    </div>
                  </div>
            <hr/>
            <div class="line heading heading-2" style="text-indent: 0em">
              <p>
                <span class="" style="">§ 48–902.05. Schedule II tests.</span>
              </p>
            </div>
            <div>
                    <div class="line-group primary-content">
                      <div class="line" style="text-indent: 1.25em">The Mayor shall place a substance in Schedule II if the Mayor finds that:</div>
                      <div class="line" style="text-indent: 1.25em">
                        <p>
                          <span class="level-num">(1)</span>
                          <span>The substance has high potential for abuse;</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 1.25em">
                        <p>
                          <span class="level-num">(2)</span>
                          <span>The substance has currently accepted medical use in treatment in the United States or the District of Columbia, or currently accepted medical use, with severe restrictions; and</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 1.25em">
                        <p>
                          <span class="level-num">(3)</span>
                          <span>The abuse of the substance may lead to severe psychological or physical dependence.</span>
                        </p>
                      </div>
                    </div>
                    <div class="line-group annotations">
                      <div class="line" style="text-indent: 1.5em">
      (<a class="internal-link" href="/dc/council/laws/4-29.html">Aug. 5, 1981, D.C. Law 4-29, § 205, 28 DCR 3081</a>.)
    </div>
                      <div class="line subheading">Prior Codifications</div>
                      <div class="line" style="text-indent: 1.5em">1981 Ed., § 33-515.</div>
                    </div>
                  </div>
            <hr/>
            <div class="line heading heading-2" style="text-indent: 0em">
              <p>
                <span class="" style="">§ 48–902.06. Schedule II enumerated.</span>
              </p>
            </div>
            <div>
                    <div class="line-group primary-content">
                      <div class="line" style="text-indent: 1.25em">The controlled substances listed in this section are included in Schedule II unless and until removed therefrom pursuant to § <a class="internal-link" href="/dc/council/code/sections/48-902.01.html">48-902.01</a>:</div>
                      <div class="line" style="text-indent: 1.25em">
                        <p>
                          <span class="level-num">(1)</span>
                          <span>Unless specifically excepted or unless listed in another schedule, any of the following substances, whether produced directly or indirectly by extraction from substances of vegetable origin, or independently by means of chemical synthesis, or by combination of extraction and chemical synthesis:</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 2.5em">
                        <p>
                          <span class="level-num">(A)</span>
                          <span>Opium and opiate, and any salt, compound, derivative, or preparation of opium or opiate, excluding apomorphine, dextrorphan, nalbuphine, naloxone, naltrexone, and their respective salts, but including the following:</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 3.75em">
                        <p>
                          <span class="level-num">(i)</span>
                          <span>Raw opium;</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 3.75em">
                        <p>
                          <span class="level-num">(ii)</span>
                          <span>Opium extracts;</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 3.75em">
                        <p>
                          <span class="level-num">(iii)</span>
                          <span>Opium fluid extracts;</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 3.75em">
                        <p>
                          <span class="level-num">(iv)</span>
                          <span>Powdered opium;</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 3.75em">
                        <p>
                          <span class="level-num">(v)</span>
                          <span>Granulated opium;</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 3.75em">
                        <p>
                          <span class="level-num">(vi)</span>
                          <span>Tincture of opium;</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 3.75em">
                        <p>
                          <span class="level-num">(vii)</span>
                          <span>Codeine;</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 3.75em">
                        <p>
                          <span class="level-num">(viii)</span>
                          <span>Ethylmorphine;</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 3.75em">
                        <p>
                          <span class="level-num">(ix)</span>
                          <span>Etorphine Hydrochloride;</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 3.75em">
                        <p>
                          <span class="level-num">(x)</span>
                          <span>Hydrocodone;</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 3.75em">
                        <p>
                          <span class="level-num">(xi)</span>
                          <span>Metopon;</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 3.75em">
                        <p>
                          <span class="level-num">(xii)</span>
                          <span>Morphine;</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 3.75em">
                        <p>
                          <span class="level-num">(xiii)</span>
                          <span>Oxycodone;</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 3.75em">
                        <p>
                          <span class="level-num">(xiv)</span>
                          <span>Oxymorphone;</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 3.75em">
                        <p>
                          <span class="level-num">(xv)</span>
                          <span>Thebaine;</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 3.75em">
                        <p>
                          <span class="level-num">(xvi)</span>
                          <span>Hydromorphone;</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 3.75em">
                        <p>
                          <span class="level-num">(xvii)</span>
                          <span>Dihydrocodeine;</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 3.75em">
                        <p>
                          <span class="level-num">(xviii)</span>
                          <span>Sufentanil;</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 3.75em">
                        <p>
                          <span class="level-num">(xix)</span>
                          <span>Alfentanil; and</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 3.75em">
                        <p>
                          <span class="level-num">(xx)</span>
                          <span>Carfentanil;</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 2.5em">
                        <p>
                          <span class="level-num">(B)</span>
                          <span>Any salt, compound, derivative, or preparation thereof which is chemically equivalent or identical with any of the substances referred to in subparagraph (A) of this paragraph, but not including the isoquinoline alkaloids of opium;</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 2.5em">
                        <p>
                          <span class="level-num">(C)</span>
                          <span>Opium poppy and poppy straw;</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 2.5em">
                        <p>
                          <span class="level-num">(D)</span>
                          <span>Coca leaves, except coca leaves or extracts of coca leaves from which cocaine, ecgonine, or derivatives of ecgonine or their salts have been removed; cocaine, its salts, optical and geometric isomers, and salts of isomers; or any compound, mixture, or preparation that contains any substance referred to in this paragraph;</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 2.5em">
                        <p>
                          <span class="level-num">(E)</span>
                          <span>Concentrate of poppy straw (the crude extract of poppy straw in either liquid, solid, or powder form which contains the phenanthrene alkaloids of the opium poppy);</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 2.5em">
                        <p>
                          <span class="level-num">(F)</span>
                          <span>Hashish; and</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 2.5em">
                        <p>
                          <span class="level-num">(G)</span>
                          <span>Synthetic Tetrahydrocannabinols: Chemical equivalents of the substances contained in the plant, or in the resinous extractives of Cannabis, and synthetic substances, derivatives, and their isomers with similar chemical structure and pharmacological activity such as the following:</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 3.75em">
                        <p>
                          <span class="level-num">(i)</span>
                          <span>Delta 1 cis or trans tetrahydrocannabinol, and their optical isomers;</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 3.75em">
                        <p>
                          <span class="level-num">(ii)</span>
                          <span>Delta 6 cis or trans tetrahydrocannabinol, and their optical isomers; or</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 3.75em">
                        <p>
                          <span class="level-num">(iii)</span>
                          <span>Delta 3, 4 cis or trans tetrahydrocannabinol, and its optical isomers (compounds of these structures, regardless of numerical designation of atomic positions covered);</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 1.25em">
                        <p>
                          <span class="level-num">(2)</span>
                          <span>Unless specifically excepted or unless in another schedule, any of the following opiates, including their isomers, esters, ethers, salts, and salts of isomers, whenever the existence of these isomers, esters, ethers, and salts is possible within the specific chemical designation, dextrorphan excepted:</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 2.5em">
                        <p>
                          <span class="level-num">(A)</span>
                          <span>Alphaprodine;</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 2.5em">
                        <p>
                          <span class="level-num">(B)</span>
                          <span>Anileridine;</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 2.5em">
                        <p>
                          <span class="level-num">(C)</span>
                          <span>Bezitramide;</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 2.5em">
                        <p>
                          <span class="level-num">(D)</span>
                          <span>Biphetamine;</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 2.5em">
                        <p>
                          <span class="level-num">(E)</span>
                          <span>Diphenoxylate;</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 2.5em">
                        <p>
                          <span class="level-num">(F)</span>
                          <span>Eskatrol;</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 2.5em">
                        <p>
                          <span class="level-num">(G)</span>
                          <span>Fentanyl;</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 2.5em">
                        <p>
                          <span class="level-num">(H)</span>
                          <span>Fetamine;</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 2.5em">
                        <p>
                          <span class="level-num">(I)</span>
                          <span>Isomethadone;</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 2.5em">
                        <p>
                          <span class="level-num">(J)</span>
                          <span>Levo-alphacetylmethadol, also known as levo-alpha-acetylmethadol, levomethadyl acetate, or LAAM;</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 2.5em">
                        <p>
                          <span class="level-num">(K)</span>
                          <span>Levomethorphan;</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 2.5em">
                        <p>
                          <span class="level-num">(L)</span>
                          <span>Levorphanol;</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 2.5em">
                        <p>
                          <span class="level-num">(M)</span>
                          <span>Metazocine;</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 2.5em">
                        <p>
                          <span class="level-num">(N)</span>
                          <span>Methadone;</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 2.5em">
                        <p>
                          <span class="level-num">(O)</span>
                          <span>Methadone—Intermediate, 4-cyano-2-dimethylamino4, 4-diphenyl butane;</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 2.5em">
                        <p>
                          <span class="level-num">(P)</span>
                          <span>Moramide—Intermediate, 2-methyl-3-morpholino-1, 1-diphenyl- propane-carboxylic acid;</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 2.5em">
                        <p>
                          <span class="level-num">(Q)</span>
                          <span>Pethidine (meperidine);</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 2.5em">
                        <p>
                          <span class="level-num">(R)</span>
                          <span>Pethidine—Intermediate — A, 4-cyano-1-methyl-4- phenylpiperidine;</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 2.5em">
                        <p>
                          <span class="level-num">(S)</span>
                          <span>Pethidine—Intermediate — B, ethyl-4-phenylpiperidine- 4-carboxylate;</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 2.5em">
                        <p>
                          <span class="level-num">(T)</span>
                          <span>Pethidine—Intermediate — C, 1-methyl-4-phenylpiperdine- 4-carboxylic acid;</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 2.5em">
                        <p>
                          <span class="level-num">(U)</span>
                          <span>Phenazocine;</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 2.5em">
                        <p>
                          <span class="level-num">(V)</span>
                          <span>Piminodine;</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 2.5em">
                        <p>
                          <span class="level-num">(W)</span>
                          <span>Racemethorphan; and</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 2.5em">
                        <p>
                          <span class="level-num">(X)</span>
                          <span>Racemorphan;</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 1.25em">
                        <p>
                          <span class="level-num">(3)</span>
                          <span>Unless specifically excepted or unless listed in another schedule, any material, compound, mixture, or preparation which contains any quantity of the following substances having a stimulant effect on the central nervous system:</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 2.5em">
                        <p>
                          <span class="level-num">(A)</span>
                          <span>Amphetamine, its salts, optical isomers, and salts of its optical isomers;</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 2.5em">
                        <p>
                          <span class="level-num">(B)</span>
                          <span>Methamphetamine, its salts, isomers, and salts of its isomers;</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 2.5em">
                        <p>
                          <span class="level-num">(C)</span>
                          <span>Phenmetrazine and its salts;</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 2.5em">
                        <p>
                          <span class="level-num">(D)</span>
                          <span>Methylphenidate and its salts;</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 2.5em">
                        <p>
                          <span class="level-num">(E)</span>
                          <span>Repealed.</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 2.5em">
                        <p>
                          <span class="level-num">(F)</span>
                          <span>Amphetamine/methamphetamine immediate precursor: Phenyl acetone (Phenyl-2-propanone), P2P; and</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 1.25em">
                        <p>
                          <span class="level-num">(4)</span>
                          <span>Unless specifically excepted or unless listed in another schedule, any material, compound, mixture, or preparation which contains any quantity of the following substances having a depressant effect on the central nervous system, including its salts, isomers, and salts of isomers whenever the existence of such salts, isomers, and salts of isomers is possible within the specific chemical designation:</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 2.5em">
                        <p>
                          <span class="level-num">(A)</span>
                          <span>Methagualone;</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 2.5em">
                        <p>
                          <span class="level-num">(B)</span>
                          <span>Amobarbital;</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 2.5em">
                        <p>
                          <span class="level-num">(C)</span>
                          <span>Secobarbital;</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 2.5em">
                        <p>
                          <span class="level-num">(D)</span>
                          <span>Pentobarbital;</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 2.5em">
                        <p>
                          <span class="level-num">(E)</span>
                          <span>Phencyclidine;</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 2.5em">
                        <p>
                          <span class="level-num">(F)</span>
                          <span>Phencyclidine immediate precursors:</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 3.75em">
                        <p>
                          <span class="level-num">(i)</span>
                          <span>1-phenyleyclohexylamine</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 3.75em">
                        <p>
                          <span class="level-num">(ii)</span>
                          <span>1-piperidinocyclohexanecarbonitrile (PCC);</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 2.5em">
                        <p>
                          <span class="level-num">(G)</span>
                          <span>Dronabinol;</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 2.5em">
                        <p>
                          <span class="level-num">(H)</span>
                          <span>Nabilone; and</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 2.5em">
                        <p>
                          <span class="level-num">(I)</span>
                          <span>Glutethimide.</span>
                        </p>
                      </div>
                    </div>
                    <div class="line-group annotations">
                      <div class="line" style="text-indent: 1.5em">
      (<a class="internal-link" href="/dc/council/laws/4-29.html">Aug. 5, 1981, D.C. Law 4-29, § 206, 28 DCR 3081</a>; amended by rule, 32 DCR 1097; <a class="internal-link" href="/dc/council/laws/8-138.html">June 13, 1990, D.C. Law 8-138, § 2(b), 37 DCR 2638</a>; amended by rule, 39 DCR 1882; amended by rule, Dec. 7, 1994, 41 DCR 7967; <a class="internal-link" href="/dc/council/laws/19-320.html">June 19, 2013, D.C. Law 19-320, § 301(c), 60 DCR 3390</a>.)
    </div>
                      <div class="line subheading">Section References</div>
                      <div class="line" style="text-indent: 1.5em">This section is referenced in § <a class="internal-link" href="/dc/council/code/sections/7-3002.html">7-3002</a>, § <a class="internal-link" href="/dc/council/code/sections/44-1201.html">44-1201</a>, § <a class="internal-link" href="/dc/council/code/sections/48-853.01.html">48-853.01</a>, § <a class="internal-link" href="/dc/council/code/sections/48-901.02.html">48-901.02</a>, § <a class="internal-link" href="/dc/council/code/sections/48-902.01.html">48-902.01</a>, § <a class="internal-link" href="/dc/council/code/sections/48-902.02.html">48-902.02</a>, and § <a class="internal-link" href="/dc/council/code/sections/48-1004.html">48-1004</a>.</div>
                      <div class="line subheading">Prior Codifications</div>
                      <div class="line" style="text-indent: 1.5em">1981 Ed., § 33-516.</div>
                      <div class="line subheading">Effect of Amendments</div>
                      <div class="line" style="text-indent: 1.5em">The 2013 amendment by <a class="internal-link" href="/dc/council/laws/19-320.html">D.C. Law 19-320</a> substituted “Dronabinol” for “Dronabianol” in (4)(G).</div>
                      <div class="line subheading">Emergency Legislation</div>
                      <div class="line" style="text-indent: 1.5em">For temporary amendment of (4)(G), see § 301(c) of the Omnibus Criminal Code Amendments Emergency Amendment Act of 2012 (D.C. Act 19-599, January 14, 2013,  60 DCR 1017).</div>
                      <div class="line" style="text-indent: 1.5em">For temporary (90 days) amendment of this section, see § 301(c) of the Omnibus Criminal Code Amendment Congressional Review Emergency Act of 2013 (D.C. Act 20-44, April 1, 2013,  60 DCR 5381, 20 DCSTAT 1281).</div>
                      <div class="line subheading">Editor's Notes</div>
                      <div class="line" style="text-indent: 1.5em">Mayor to implement public information program: See Historical and Statutory Notes following § <a class="internal-link" href="/dc/council/code/sections/48-901.02.html">48-901.02</a>.</div>
                    </div>
                  </div>
            <hr/>
            <div class="line heading heading-2" style="text-indent: 0em">
              <p>
                <span class="" style="">§ 48–902.07. Schedule III tests.</span>
              </p>
            </div>
            <div>
                    <div class="line-group primary-content">
                      <div class="line" style="text-indent: 1.25em">The Mayor shall place a substance in Schedule III if the Mayor finds that:</div>
                      <div class="line" style="text-indent: 1.25em">
                        <p>
                          <span class="level-num">(1)</span>
                          <span>The substance has a potential for abuse less than the substances listed in Schedules I and II;</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 1.25em">
                        <p>
                          <span class="level-num">(2)</span>
                          <span>The substance has currently accepted medical use in treatment in the United States or the District of Columbia; and</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 1.25em">
                        <p>
                          <span class="level-num">(3)</span>
                          <span>The abuse of the substance may lead to moderate or low physical dependence or high psychological dependence.</span>
                        </p>
                      </div>
                    </div>
                    <div class="line-group annotations">
                      <div class="line" style="text-indent: 1.5em">
      (<a class="internal-link" href="/dc/council/laws/4-29.html">Aug. 5, 1981, D.C. Law 4-29, § 207, 28 DCR 3081</a>.)
    </div>
                      <div class="line subheading">Prior Codifications</div>
                      <div class="line" style="text-indent: 1.5em">1981 Ed., § 33-517.</div>
                    </div>
                  </div>
            <hr/>
            <div class="line heading heading-2" style="text-indent: 0em">
              <p>
                <span class="" style="">§ 48–902.08. Schedule III enumerated.</span>
              </p>
            </div>
            <div>
                    <div class="line-group primary-content">
                      <div class="line" style="text-indent: 1.25em">
                        <p>
                          <span class="level-num">(a)</span>
                          <span>The controlled substances listed in this section are included in Schedule III, unless and until removed therefrom pursuant to § <a class="internal-link" href="/dc/council/code/sections/48-902.01.html">48-902.01</a>:</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 2.5em">
                        <p>
                          <span class="level-num">(1)</span>
                          <span>Unless specifically excepted or unless listed in another schedule, any material, compound, mixture, or preparation which contains any quantity of the following substances having a stimulant effect on the central nervous system, including its salts, isomers (whether optical, position, or geometric), and salts of such isomers whenever the existence of such salts, isomers, and salts of isomers is possible within the specific chemical designation:</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 3.75em">
                        <p>
                          <span class="level-num">(A)</span>
                          <span>Those compounds, mixtures, or preparations in dosage unit form containing any stimulant substances listed in Schedule II which compounds, mixtures, or preparations were listed on August 25, 1971, as excepted compounds under § 1308.32 of the Code of Federal Regulations, and any other drug of the quantitative composition shown in that list for those drugs or which is the same except that it contains a lesser quantity of controlled substances;</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 3.75em">
                        <p>
                          <span class="level-num">(B)</span>
                          <span>Benzphetamine;</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 3.75em">
                        <p>
                          <span class="level-num">(C)</span>
                          <span>Chlorphentermine;</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 3.75em">
                        <p>
                          <span class="level-num">(D)</span>
                          <span>Chlortermine;</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 3.75em">
                        <p>
                          <span class="level-num">(E)</span>
                          <span>Mazindol; and</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 3.75em">
                        <p>
                          <span class="level-num">(F)</span>
                          <span>Phendimetrazine;</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 2.5em">
                        <p>
                          <span class="level-num">(2)</span>
                          <span>Unless listed in another schedule, any material, compound, mixture, or preparation which contains any quantity of the following substances having a potential for abuse associated with a depressant effect on the central nervous system:</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 3.75em">
                        <p>
                          <span class="level-num">(A)</span>
                          <span>Any compound, mixture, or preparation containing:</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 5em">
                        <p>
                          <span class="level-num">(i)</span>
                          <span>Amobarbital;</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 5em">
                        <p>
                          <span class="level-num">(ii)</span>
                          <span>Secobarbital; or</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 5em">
                        <p>
                          <span class="level-num">(iii)</span>
                          <span>Pentobarbital; or any salt thereof and 1 or more other active medicinal ingredients which are not listed in any schedule;</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 3.75em">
                        <p>
                          <span class="level-num">(B)</span>
                          <span>Any suppository dosage form containing:</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 5em">
                        <p>
                          <span class="level-num">(i)</span>
                          <span>Amobarbital;</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 5em">
                        <p>
                          <span class="level-num">(ii)</span>
                          <span>Secobarbital;</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 5em">
                        <p>
                          <span class="level-num">(iii)</span>
                          <span>Pentobarbital; or any salt of any of these drugs and approved by the Food and Drug Administration for marketing only as a suppository;</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 3.75em">
                        <p>
                          <span class="level-num">(C)</span>
                          <span>Any substance which contains any quantity of a derivative of barbituric acid, or any salt of a derivative of barbituric acid:</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 5em">
                        <p>
                          <span class="level-num">(i)</span>
                          <span>Chlorhexadol;</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 5em">
                        <p>
                          <span class="level-num">(ii)</span>
                          <span>Rescheduled to Schedule II;</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 5em">
                        <p>
                          <span class="level-num">(iii)</span>
                          <span>Lysergic acid;</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 5em">
                        <p>
                          <span class="level-num">(iv)</span>
                          <span>Lysergic acid amide;</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 5em">
                        <p>
                          <span class="level-num">(v)</span>
                          <span>Methyprylon;</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 5em">
                        <p>
                          <span class="level-num">(vi)</span>
                          <span>Sulfondiethylmethane;</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 5em">
                        <p>
                          <span class="level-num">(vii)</span>
                          <span>Sulfonethylmethane;</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 5em">
                        <p>
                          <span class="level-num">(viii)</span>
                          <span>Sulfonmethane;</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 5em">
                        <p>
                          <span class="level-num">(ix)</span>
                          <span>Tiletamine &amp; Zolazepam Combination Product; and</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 5em">
                        <p>
                          <span class="level-num">(x)</span>
                          <span>Vinbarbital;</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 2.5em">
                        <p>
                          <span class="level-num">(3)</span>
                          <span>Nalorphine;</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 2.5em">
                        <p>
                          <span class="level-num">(4)</span>
                          <span>Unless specifically excepted or unless listed in another schedule, any material, compound, mixture, or preparation containing limited quantities of any of the following narcotic drugs, or any salts thereof:</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 3.75em">
                        <p>
                          <span class="level-num">(A)</span>
                          <span>Not more than 1.8 grams of codeine per 100 milliliters or not more than 90 milligrams per dosage unit, with an equal or greater quantity of an isoquinoline alkaloid of opium;</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 3.75em">
                        <p>
                          <span class="level-num">(B)</span>
                          <span>Not more than 1.8 grams of codeine per 100 milliliters or not more than 90 milligrams dosage unit, with 1 or more active, nonnarcotic ingredients in recognized therapeutic amounts;</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 3.75em">
                        <p>
                          <span class="level-num">(C)</span>
                          <span>Not more than 300 milligrams of dihydrocodeinone per 100 milliliters or not more than 15 milligrams per dosage unit, with a 4-fold or greater quantity of an isoquinoline alkaloid of opium;</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 3.75em">
                        <p>
                          <span class="level-num">(D)</span>
                          <span>Not more than 300 milligrams of dihydrocodeinone per 100 milliliters or not more than 15 milligrams per dosage unit, with 1 or more active, nonnarcotic ingredients in recognized therapeutic amounts;</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 3.75em">
                        <p>
                          <span class="level-num">(E)</span>
                          <span>Not more than 1.8 grams of dihydrocodeine per 100 milliliters or not more than 90 milligrams per dosage unit, with 1 or more active, nonnarcotic ingredients in recognized therapeutic amounts;</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 3.75em">
                        <p>
                          <span class="level-num">(F)</span>
                          <span>Not more than 300 milligrams of ethylmorphine per 100 milliliters or not more than 15 milligrams per dosage unit, with 1 or more ingredients in recognized therapeutic amounts;</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 3.75em">
                        <p>
                          <span class="level-num">(G)</span>
                          <span>Not more than 500 milligrams of opium per 100 milliliters or per 100 grams or not more than 25 milligrams per dosage unit, with 1 or more active, nonnarcotic ingredients in recognized therapeutic amounts; and</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 3.75em">
                        <p>
                          <span class="level-num">(H)</span>
                          <span>Not more than 50 milligrams of morphine per 100 milliliters or per 100 grams with 1 or more active, nonnarcotic ingredients in recognized therapeutic amounts;</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 2.5em">
                        <p>
                          <span class="level-num">(5)</span>
                          <span>Unless specifically excepted or unless listed in another schedule, any material, compound, mixture, or preparation containing any quantity of the following substances, drug, or hormonal substance, chemically and pharmacologically related to testosterone (other than estrogens, progesterons, and corticorsteroids) that promotes muscle growth and includes:</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 3.75em">
                        <p>
                          <span class="level-num">(A)</span>
                          <span>Boldenone;</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 3.75em">
                        <p>
                          <span class="level-num">(B)</span>
                          <span>Chlortestosterone (4-chlortestosterone);</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 3.75em">
                        <p>
                          <span class="level-num">(C)</span>
                          <span>Clostebol;</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 3.75em">
                        <p>
                          <span class="level-num">(D)</span>
                          <span>Dehydrochlormethyltestosterone;</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 3.75em">
                        <p>
                          <span class="level-num">(E)</span>
                          <span>Dihydrotestosterone (4-dihydrotestosterone);</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 3.75em">
                        <p>
                          <span class="level-num">(F)</span>
                          <span>Drostanolone;</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 3.75em">
                        <p>
                          <span class="level-num">(G)</span>
                          <span>Ethylestrenol;</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 3.75em">
                        <p>
                          <span class="level-num">(H)</span>
                          <span>Fluoxymestorone;</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 3.75em">
                        <p>
                          <span class="level-num">(I)</span>
                          <span>Formebulone (formebolone);</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 3.75em">
                        <p>
                          <span class="level-num">(J)</span>
                          <span>Mesterolone;</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 3.75em">
                        <p>
                          <span class="level-num">(K)</span>
                          <span>Methandienone;</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 3.75em">
                        <p>
                          <span class="level-num">(L)</span>
                          <span>Methandranone;</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 3.75em">
                        <p>
                          <span class="level-num">(M)</span>
                          <span>Methandriol;</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 3.75em">
                        <p>
                          <span class="level-num">(N)</span>
                          <span>Methandrostenolone;</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 3.75em">
                        <p>
                          <span class="level-num">(O)</span>
                          <span>Methenolone;</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 3.75em">
                        <p>
                          <span class="level-num">(P)</span>
                          <span>Methyltestosterone;</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 3.75em">
                        <p>
                          <span class="level-num">(Q)</span>
                          <span>Mibolerone;</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 3.75em">
                        <p>
                          <span class="level-num">(R)</span>
                          <span>Nandrolone;</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 3.75em">
                        <p>
                          <span class="level-num">(S)</span>
                          <span>Norethandrolone;</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 3.75em">
                        <p>
                          <span class="level-num">(T)</span>
                          <span>Oxandrolone;</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 3.75em">
                        <p>
                          <span class="level-num">(U)</span>
                          <span>Oxymesterone;</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 3.75em">
                        <p>
                          <span class="level-num">(V)</span>
                          <span>Oxymetholone;</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 3.75em">
                        <p>
                          <span class="level-num">(W)</span>
                          <span>Stanolone;</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 3.75em">
                        <p>
                          <span class="level-num">(X)</span>
                          <span>Stanozolol;</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 3.75em">
                        <p>
                          <span class="level-num">(Y)</span>
                          <span>Testolactone;</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 3.75em">
                        <p>
                          <span class="level-num">(Z)</span>
                          <span>Testosterone;</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 3.75em">
                        <p>
                          <span class="level-num">(AA)</span>
                          <span>Trenbolone; and</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 3.75em">
                        <p>
                          <span class="level-num">(BB)</span>
                          <span>Any salt, ester or isomer of a drug or substance described or listed in this paragraph, if that salt, ester, or isomer promotes muscle growth. Except such term does not include an anabolic steroid which is expressly intended for administration through implants to cattle or other nonhuman species and which has been approved by Secretary of Health and Human Services for such administration. If any person prescribes, dispenses or distributes such steroid for human use such person shall be considered to have prescribed, dispensed or distributed an anabolic steroid within the meaning of this paragraph;</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 2.5em">
                        <p>
                          <span class="level-num">(6)</span>
                          <span>Cannabis; and</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 2.5em">
                        <p>
                          <span class="level-num">(7)</span>
                          <span class="level-num">(A)</span>
                          <span>Unless specifically exempted or unless listed in another schedule, any material, compound, mixture, or preparation which contains any quantity of cannabimimetic agents, or which contains their salts, isomers, and salts of isomers whenever the existence of such salts, isomers, and salts of isomers is possible within the specific chemical designation.</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 3.75em">
                        <p>
                          <span class="level-num">(B)</span>
                          <span class="level-num">(i)</span>
                          <span>For the purposes of this paragraph, the term “cannabimimetic agents” means any substance that is a cannabinoid receptor type 1 (CB1 receptor) agonist as demonstrated by binding studies and functional assays within any of the following structural classes:</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 6.25em">
                        <p>
                          <span class="level-num">(I)</span>
                          <span>2-(3-hydroxycyclohexyl)phenol with substitution at the 5-position of the phenolic ring by alkyl or alkenyl, whether or not substituted on the cyclohexyl ring to any extent.</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 6.25em">
                        <p>
                          <span class="level-num">(II)</span>
                          <span>3-(1-naphthoyl)indole or 3-(1- naphthylmethane)indole by substitution at the nitrogen atom of the indole ring, whether or not further substituted on the indole ring to any extent, whether or not substituted on the naphthoyl or naphthyl ring to any extent.</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 6.25em">
                        <p>
                          <span class="level-num">(III)</span>
                          <span>3-(1-naphthoyl)pyrrole by substitution at the nitrogen atom of the pyrrole ring, whether or not further substituted in the pyrrole ring to any extent, whether or not substituted on the naphthoyl ring to any extent.</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 6.25em">
                        <p>
                          <span class="level-num">(IV)</span>
                          <span>1-(1-naphthylmethylene)indene by substitution of the 3-position of the indene ring, whether or not further substituted in the indene ring to any extent, whether or not substituted on the naphthyl ring to any extent.</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 6.25em">
                        <p>
                          <span class="level-num">(V)</span>
                          <span>3-phenylacetylindole or 3-benzoylindole by substitution at the nitrogen atom of the indole ring, whether or not further substituted in the indole ring to any extent, whether or not substituted on the phenyl ring to any extent.</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 5em">
                        <p>
                          <span class="level-num">(ii)</span>
                          <span>The term “cannabimimetic agents” includes:</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 6.25em">
                        <p>
                          <span class="level-num">(I)</span>
                          <span>(6aR,10aR)-9-(hydroxymethyl)-6,6-dimethyl-3- (2-methyloctan-2-yl)-6a,7,10, 10a-tetrahydrobenzo[c] chromen-1-ol)(HU-210);</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 6.25em">
                        <p>
                          <span class="level-num">(II)</span>
                          <span>5-(1,1-dimethylheptyl)-2-[(1R,3S)-3- hydroxycyclohexyl]-phenol (CP 47,497);</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 6.25em">
                        <p>
                          <span class="level-num">(III)</span>
                          <span>5-(1,1-dimethyloctyl)-2-[(1R,3S)-3- hydroxycyclohexyl]-phenol (cannabicyclohexanol or CP-47,497 C8-homolog);</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 6.25em">
                        <p>
                          <span class="level-num">(IV)</span>
                          <span>1-pentyl-3-(1-naphthoyl)indole (JWH-018 and AM678);</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 6.25em">
                        <p>
                          <span class="level-num">(V)</span>
                          <span>1-butyl-3-(1-naphthoyl)indole (JWH-073);</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 6.25em">
                        <p>
                          <span class="level-num">(VI)</span>
                          <span>1-hexyl-3-(1-naphthoyl)indole (JWH- 019);</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 6.25em">
                        <p>
                          <span class="level-num">(VII)</span>
                          <span>1-[2-(4-morpholinyl)ethyl]-3-(1- naphthoyl)indole (JWH-200);</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 6.25em">
                        <p>
                          <span class="level-num">(VIII)</span>
                          <span>1-pentyl-3-(2-methoxyphenylacetyl)indole (JWH-250);</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 6.25em">
                        <p>
                          <span class="level-num">(IX)</span>
                          <span>1-pentyl-3-[1-(4-methoxynaphthoyl)]indole (JWH-081);</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 6.25em">
                        <p>
                          <span class="level-num">(X)</span>
                          <span>1-pentyl-3-(4-methyl-1-naphthoyl)indole (JWH- 122);</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 6.25em">
                        <p>
                          <span class="level-num">(XI)</span>
                          <span>1-pentyl-3-(4-chloro-1-naphthoyl)indole (JWH- 398);</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 6.25em">
                        <p>
                          <span class="level-num">(XII)</span>
                          <span>1-(5-fluoropentyl)-3-(1-naphthoyl)indole (AM2201);</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 6.25em">
                        <p>
                          <span class="level-num">(XIII)</span>
                          <span>1-(5-fluoropentyl)-3-(2-iodobenzoyl)indole (AM694);</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 6.25em">
                        <p>
                          <span class="level-num">(XIV)</span>
                          <span>1-pentyl-3-[(4-methoxy)-benzoyl]indole (SR- 19 and RCS-4);</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 6.25em">
                        <p>
                          <span class="level-num">(XV)</span>
                          <span>1-cyclohexylethyl-3-(2- methoxyphenylacetyl)indole (SR-18 and RCS-8); and</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 6.25em">
                        <p>
                          <span class="level-num">(XVI)</span>
                          <span>1-pentyl-3-(2-chlorophenylacetyl)indole (JWH-203).</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 1.25em">
                        <p>
                          <span class="level-num">(b)</span>
                          <span>The Mayor may except by rule any compound, mixture, or preparation containing any stimulant or depressant substance listed in paragraphs (1) and (2) of subsection (a) of this section from the application of all or any part of this chapter if the compound, mixture, or preparation contains 1 or more active medicinal ingredients not having a stimulant or depressant effect on the central nervous system, and if the admixtures are included therein in combinations, quantity, proportion, or concentration that vitiate the potential for abuse of the substances which have a stimulant or depressant effect on the central nervous system.</span>
                        </p>
                      </div>
                    </div>
                    <div class="line-group annotations">
                      <div class="line" style="text-indent: 1.5em">
      (<a class="internal-link" href="/dc/council/laws/4-29.html">Aug. 5, 1981, D.C. Law 4-29, § 208, 28 DCR 3081</a>; amended by rule, 39 DCR 1882; amended by rule Dec. 7, 1994, 41 DCR 7967; <a class="internal-link" href="/dc/council/laws/13-300.html">June 8, 2001, D.C. Law 13-300, § 2(a), 47 DCR 7037</a>; <a class="internal-link" href="/dc/council/laws/19-320.html">June 19, 2013, D.C. Law 19-320, § 301(d), 60 DCR 3390</a>.)
    </div>
                      <div class="line subheading">Section References</div>
                      <div class="line" style="text-indent: 1.5em">This section is referenced in § <a class="internal-link" href="/dc/council/code/sections/7-3002.html">7-3002</a>, § <a class="internal-link" href="/dc/council/code/sections/44-1201.html">44-1201</a>, § <a class="internal-link" href="/dc/council/code/sections/48-853.01.html">48-853.01</a>, § <a class="internal-link" href="/dc/council/code/sections/48-902.01.html">48-902.01</a>, § <a class="internal-link" href="/dc/council/code/sections/48-902.02.html">48-902.02</a>, and § <a class="internal-link" href="/dc/council/code/sections/48-1004.html">48-1004</a>.</div>
                      <div class="line subheading">Prior Codifications</div>
                      <div class="line" style="text-indent: 1.5em">1981 Ed., § 33-518.</div>
                      <div class="line subheading">Effect of Amendments</div>
                      <div class="line" style="text-indent: 1.5em"><a class="internal-link" href="/dc/council/laws/13-300.html">D.C. Law 13-300</a>, in subsec. (a), deleted “and” at the end of par. (4)(H), substituted “; and” for the period at the end of par. (5)(BB), and added par. (6).</div>
                      <div class="line" style="text-indent: 1.5em">The 2013 amendment by <a class="internal-link" href="/dc/council/laws/19-320.html">D.C. Law 19-320</a> added (a)(7); and made related changes.</div>
                      <div class="line subheading">Emergency Legislation</div>
                      <div class="line" style="text-indent: 1.5em">For temporary amendment of (a), see § 301(d) of the Omnibus Criminal Code Amendments Emergency Amendment Act of 2012 (D.C. Act 19-599, January 14, 2013,  60 DCR 1017).</div>
                      <div class="line" style="text-indent: 1.5em">For temporary (90 days) amendment of this section, see § 301(d) of the Omnibus Criminal Code Amendment Congressional Review Emergency Act of 2013 (D.C. Act 20-44, April 1, 2013,  60 DCR 5381, 20 DCSTAT 1281).</div>
                    </div>
                  </div>
            <hr/>
            <div class="line heading heading-2" style="text-indent: 0em">
              <p>
                <span class="" style="">§ 48–902.09. Schedule IV tests.</span>
              </p>
            </div>
            <div>
                    <div class="line-group primary-content">
                      <div class="line" style="text-indent: 1.25em">The Mayor shall place a substance in Schedule IV if the Mayor finds that:</div>
                      <div class="line" style="text-indent: 1.25em">
                        <p>
                          <span class="level-num">(1)</span>
                          <span>The substance has a low potential for abuse relative to substances in Schedule III;</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 1.25em">
                        <p>
                          <span class="level-num">(2)</span>
                          <span>The substance has currently accepted medical use in treatment in the United States or the District of Columbia; and</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 1.25em">
                        <p>
                          <span class="level-num">(3)</span>
                          <span>The abuse of the substance may lead to limited physical dependence or psychological dependence relative to the substances in Schedule III.</span>
                        </p>
                      </div>
                    </div>
                    <div class="line-group annotations">
                      <div class="line" style="text-indent: 1.5em">
      (<a class="internal-link" href="/dc/council/laws/4-29.html">Aug. 5, 1981, D.C. Law 4-29, § 209, 28 DCR 3081</a>.)
    </div>
                      <div class="line subheading">Prior Codifications</div>
                      <div class="line" style="text-indent: 1.5em">1981 Ed., § 33-519.</div>
                    </div>
                  </div>
            <hr/>
            <div class="line heading heading-2" style="text-indent: 0em">
              <p>
                <span class="" style="">§ 48–902.10. Schedule IV enumerated.</span>
              </p>
            </div>
            <div>
                    <div class="line-group primary-content">
                      <div class="line" style="text-indent: 1.25em">
                        <p>
                          <span class="level-num">(a)</span>
                          <span>The controlled substances listed in this section are included in Schedule IV, unless and until removed therefrom pursuant to § <a class="internal-link" href="/dc/council/code/sections/48-902.01.html">48-902.01</a>:</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 2.5em">
                        <p>
                          <span class="level-num">(1)</span>
                          <span>Unless specifically excepted or unless listed in another schedule, any material, compound, mixture, or preparation which contains any quantity of the following substances, including its salts, isomers, and salts of isomers whenever the existence of such salts, isomers, and salts of isomers is possible within the specific chemical designation:</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 3.75em">
                        <p>
                          <span class="level-num">(A)</span>
                          <span>Barbital;</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 3.75em">
                        <p>
                          <span class="level-num">(B)</span>
                          <span>Chloral betaine;</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 3.75em">
                        <p>
                          <span class="level-num">(C)</span>
                          <span>Chloral hydrate;</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 3.75em">
                        <p>
                          <span class="level-num">(D)</span>
                          <span>Chlordiazepoxide;</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 3.75em">
                        <p>
                          <span class="level-num">(E)</span>
                          <span>Clonazepam;</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 3.75em">
                        <p>
                          <span class="level-num">(F)</span>
                          <span>Clorazepate;</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 3.75em">
                        <p>
                          <span class="level-num">(G)</span>
                          <span>Dextropropoxyphene;</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 3.75em">
                        <p>
                          <span class="level-num">(H)</span>
                          <span>Diazepam;</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 3.75em">
                        <p>
                          <span class="level-num">(I)</span>
                          <span>Ethchlorvynol;</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 3.75em">
                        <p>
                          <span class="level-num">(J)</span>
                          <span>Ethinamate;</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 3.75em">
                        <p>
                          <span class="level-num">(K)</span>
                          <span>Flurazepam;</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 3.75em">
                        <p>
                          <span class="level-num">(L)</span>
                          <span>Lorazepam;</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 3.75em">
                        <p>
                          <span class="level-num">(M)</span>
                          <span>Mebutamate;</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 3.75em">
                        <p>
                          <span class="level-num">(N)</span>
                          <span>Meprobamate;</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 3.75em">
                        <p>
                          <span class="level-num">(O)</span>
                          <span>Methohexital;</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 3.75em">
                        <p>
                          <span class="level-num">(P)</span>
                          <span>Methylphenobarbital (mephobarbital);</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 3.75em">
                        <p>
                          <span class="level-num">(Q)</span>
                          <span>Oxazepam;</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 3.75em">
                        <p>
                          <span class="level-num">(R)</span>
                          <span>Paraldehyde;</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 3.75em">
                        <p>
                          <span class="level-num">(S)</span>
                          <span>Petrichloral;</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 3.75em">
                        <p>
                          <span class="level-num">(T)</span>
                          <span>Phenobarbital;</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 3.75em">
                        <p>
                          <span class="level-num">(U)</span>
                          <span>Prazepam;</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 3.75em">
                        <p>
                          <span class="level-num">(V)</span>
                          <span>Alprazolam;</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 3.75em">
                        <p>
                          <span class="level-num">(W)</span>
                          <span>Bromazepam;</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 3.75em">
                        <p>
                          <span class="level-num">(X)</span>
                          <span>Camazepam;</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 3.75em">
                        <p>
                          <span class="level-num">(Y)</span>
                          <span>Clobazam;</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 3.75em">
                        <p>
                          <span class="level-num">(Z)</span>
                          <span>Clotiazepam;</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 3.75em">
                        <p>
                          <span class="level-num">(AA)</span>
                          <span>Cloxazolam;</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 3.75em">
                        <p>
                          <span class="level-num">(BB)</span>
                          <span>Delorazepam;</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 3.75em">
                        <p>
                          <span class="level-num">(CC)</span>
                          <span>Estazolam;</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 3.75em">
                        <p>
                          <span class="level-num">(DD)</span>
                          <span>Ethyl loflazepate;</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 3.75em">
                        <p>
                          <span class="level-num">(EE)</span>
                          <span>Fludiazepam;</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 3.75em">
                        <p>
                          <span class="level-num">(FF)</span>
                          <span>Flunitrazepam;</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 3.75em">
                        <p>
                          <span class="level-num">(GG)</span>
                          <span>Halazepam;</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 3.75em">
                        <p>
                          <span class="level-num">(HH)</span>
                          <span>Haloxazolam;</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 3.75em">
                        <p>
                          <span class="level-num">(II)</span>
                          <span>Ketazolam;</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 3.75em">
                        <p>
                          <span class="level-num">(JJ)</span>
                          <span>Loprazolam;</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 3.75em">
                        <p>
                          <span class="level-num">(KK)</span>
                          <span>Lormetazepam;</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 3.75em">
                        <p>
                          <span class="level-num">(LL)</span>
                          <span>Medazepam;</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 3.75em">
                        <p>
                          <span class="level-num">(MM)</span>
                          <span>Midazolam;</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 3.75em">
                        <p>
                          <span class="level-num">(NN)</span>
                          <span>Nimetazepam;</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 3.75em">
                        <p>
                          <span class="level-num">(OO)</span>
                          <span>Nitrazepam;</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 3.75em">
                        <p>
                          <span class="level-num">(PP)</span>
                          <span>Oxazolam;</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 3.75em">
                        <p>
                          <span class="level-num">(QQ)</span>
                          <span>Omitted;</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 3.75em">
                        <p>
                          <span class="level-num">(RR)</span>
                          <span>Pinazepam;</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 3.75em">
                        <p>
                          <span class="level-num">(SS)</span>
                          <span>Quazepam;</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 3.75em">
                        <p>
                          <span class="level-num">(TT)</span>
                          <span>Temazepam;</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 3.75em">
                        <p>
                          <span class="level-num">(UU)</span>
                          <span>Tetrazepam;</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 3.75em">
                        <p>
                          <span class="level-num">(VV)</span>
                          <span>Triazolam; and</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 3.75em">
                        <p>
                          <span class="level-num">(WW)</span>
                          <span>Fospropofol;</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 2.5em">
                        <p>
                          <span class="level-num">(2)</span>
                          <span>Any material, compound, mixture, or preparation which contains any quantity of the following substances, including its salts, isomers (whether optical, position, or geometric), and salts of such isomers, whenever the existence of such salts, isomers, and salts of isomers is possible, such as Fenfluramine;</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 2.5em">
                        <p>
                          <span class="level-num">(3)</span>
                          <span>Unless specifically excepted or unless listed in another schedule, any material, compound, mixture, or preparation which contains any quantity of the following substances having a stimulant effect on the central nervous system, including its salts, isomers (whether optical, position, or geometric), and salts of such isomers whenever the existence of such salts, isomers, and salts of isomers is possible within the specific chemical designation:</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 3.75em">
                        <p>
                          <span class="level-num">(A)</span>
                          <span>Diethylpropion;</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 3.75em">
                        <p>
                          <span class="level-num">(B)</span>
                          <span>Phentermine;</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 3.75em">
                        <p>
                          <span class="level-num">(C)</span>
                          <span>Pemoline (including organometallic complexes and chelates thereof);</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 3.75em">
                        <p>
                          <span class="level-num">(D)</span>
                          <span>Cathine;</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 3.75em">
                        <p>
                          <span class="level-num">(E)</span>
                          <span>Fencamfimin;</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 3.75em">
                        <p>
                          <span class="level-num">(F)</span>
                          <span>Fenproporex;</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 3.75em">
                        <p>
                          <span class="level-num">(G)</span>
                          <span>Mefenorex;</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 3.75em">
                        <p>
                          <span class="level-num">(H)</span>
                          <span>Pipradrol; and</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 3.75em">
                        <p>
                          <span class="level-num">(I)</span>
                          <span>SPA;</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 2.5em">
                        <p>
                          <span class="level-num">(4)</span>
                          <span>Unless specifically excepted or unless listed in another schedule, any material, compound, mixture or preparation which contains any quantity of the following substances, including its salts:</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 3.75em">
                        <p>
                          <span class="level-num">(A)</span>
                          <span>Dextropropoxyphene (Alpha-(+)-4-dimethylamino-1), 2-diphenyl-1-3-methyl-2-propionoxybutane; and</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 3.75em">
                        <p>
                          <span class="level-num">(B)</span>
                          <span>Pentazocine; and</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 2.5em">
                        <p>
                          <span class="level-num">(5)</span>
                          <span>Unless specifically excepted or unless listed in another schedule, any material, compound, mixture, or preparation containing limited quantities of any of the following narcotic drugs, or any salts thereof of not more than 1 milligram of difenoxin and not less than 25 micrograms of atropine sulfate per dosage unit.</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 1.25em">
                        <p>
                          <span class="level-num">(b)</span>
                          <span>The Mayor may except by rule any compound, mixture, or preparation containing any depressant substance listed in paragraph (1) of subsection (a) of this section from the application of all or any part of this chapter if the compound, mixture, or preparation contains 1 or more active medicinal ingredients not having a depressant effect on the central nervous system, and if the admixtures are included therein in combinations, quantity, proportion, or concentration that vitiate the potential for abuse of the substances which have a depressant effect on the central nervous system.</span>
                        </p>
                      </div>
                    </div>
                    <div class="line-group annotations">
                      <div class="line" style="text-indent: 1.5em">
      (<a class="internal-link" href="/dc/council/laws/4-29.html">Aug. 5, 1981, D.C. Law 4-29, § 210, 28 DCR 3081</a>; amended by rule, 39 DCR 1882; <a class="internal-link" href="/dc/council/laws/19-320.html">June 19, 2013, D.C. Law 19-320, § 301(e), 60 DCR 3390</a>.)
    </div>
                      <div class="line subheading">Section References</div>
                      <div class="line" style="text-indent: 1.5em">This section is referenced in § <a class="internal-link" href="/dc/council/code/sections/7-3002.html">7-3002</a>, § <a class="internal-link" href="/dc/council/code/sections/44-1201.html">44-1201</a>, § <a class="internal-link" href="/dc/council/code/sections/48-853.01.html">48-853.01</a>, § <a class="internal-link" href="/dc/council/code/sections/48-902.01.html">48-902.01</a>, § <a class="internal-link" href="/dc/council/code/sections/48-902.02.html">48-902.02</a>, and § <a class="internal-link" href="/dc/council/code/sections/48-1004.html">48-1004</a>.</div>
                      <div class="line subheading">Prior Codifications</div>
                      <div class="line" style="text-indent: 1.5em">1981 Ed., § 33-520.</div>
                      <div class="line subheading">Effect of Amendments</div>
                      <div class="line" style="text-indent: 1.5em">The 2013 amendment by <a class="internal-link" href="/dc/council/laws/19-320.html">D.C. Law 19-320</a> added (a)(1)(WW) and made related changes; and substituted “Cathine” for “Cathine” (made no change) in (a)(3)(D).</div>
                      <div class="line subheading">Emergency Legislation</div>
                      <div class="line" style="text-indent: 1.5em">For temporary amendment of (a), see § 301(e) of the Omnibus Criminal Code Amendments Emergency Amendment Act of 2012 (D.C. Act 19-599, January 14, 2013,  60 DCR 1017).</div>
                      <div class="line" style="text-indent: 1.5em">For temporary (90 days) amendment of this section, see § 301(e) of the Omnibus Criminal Code Amendment Congressional Review Emergency Act of 2013 (D.C. Act 20-44, April 1, 2013,  60 DCR 5381, 20 DCSTAT 1281).</div>
                    </div>
                  </div>
            <hr/>
            <div class="line heading heading-2" style="text-indent: 0em">
              <p>
                <span class="" style="">§ 48–902.11. Schedule V tests.</span>
              </p>
            </div>
            <div>
                    <div class="line-group primary-content">
                      <div class="line" style="text-indent: 1.25em">The Mayor shall place a substance in Schedule V if the Mayor finds that:</div>
                      <div class="line" style="text-indent: 1.25em">
                        <p>
                          <span class="level-num">(1)</span>
                          <span>The substance has low potential for abuse relative to the controlled substances listed in Schedule IV;</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 1.25em">
                        <p>
                          <span class="level-num">(2)</span>
                          <span>The substance has currently accepted medical use in treatment in the United States or the District of Columbia; and</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 1.25em">
                        <p>
                          <span class="level-num">(3)</span>
                          <span>The substance has limited physical dependence or psychological dependence liability relative to the controlled substances listed in Schedule IV.</span>
                        </p>
                      </div>
                    </div>
                    <div class="line-group annotations">
                      <div class="line" style="text-indent: 1.5em">
      (<a class="internal-link" href="/dc/council/laws/4-29.html">Aug. 5, 1981, D.C. Law 4-29, § 211, 28 DCR 3081</a>.)
    </div>
                      <div class="line subheading">Prior Codifications</div>
                      <div class="line" style="text-indent: 1.5em">1981 Ed., § 33-521.</div>
                    </div>
                  </div>
            <hr/>
            <div class="line heading heading-2" style="text-indent: 0em">
              <p>
                <span class="" style="">§ 48–902.12. Schedule V enumerated.</span>
              </p>
            </div>
            <div>
                    <div class="line-group primary-content">
                      <div class="line" style="text-indent: 1.25em">The controlled substances listed in this section are included in Schedule V unless and until removed therefrom pursuant to § <a class="internal-link" href="/dc/council/code/sections/48-902.01.html">48-902.01</a>.</div>
                      <div class="line" style="text-indent: 1.25em">
                        <p>
                          <span class="level-num">(1)</span>
                          <span>Any compound, mixture, or preparation containing limited quantities of any of the following narcotic drugs, or salts thereof, which also contains 1 or more nonnarcotic active medicinal ingredients in sufficient proportion to confer upon the compound, mixture, or preparation valuable medicinal qualities other than those possessed by the narcotic drug alone:</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 2.5em">
                        <p>
                          <span class="level-num">(A)</span>
                          <span>Not more than 200 milligrams of codeine per 100 milliliters or per 100 grams;</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 2.5em">
                        <p>
                          <span class="level-num">(B)</span>
                          <span>Not more than 100 milligrams of opium per 100 milliliters or per 100 grams;</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 2.5em">
                        <p>
                          <span class="level-num">(C)</span>
                          <span>Not more than 100 milligrams of dihydrocodeine per 100 milliliters or per 100 grams;</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 2.5em">
                        <p>
                          <span class="level-num">(D)</span>
                          <span>Not more than 100 milligrams of ethylmorphine per 100 milliliters or per 100 grams;</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 2.5em">
                        <p>
                          <span class="level-num">(E)</span>
                          <span>Not more than 2.5 milligrams of diphenoxylate and not less than 25 micrograms of atropine sulfate per dosage unit; and</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 2.5em">
                        <p>
                          <span class="level-num">(F)</span>
                          <span>Not more than 0.5 milligrams of difenopin and not less than 25 micrograms of atropine sulfate per dosage unit;</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 1.25em">
                        <p>
                          <span class="level-num">(2)</span>
                          <span>Repealed;</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 1.25em">
                        <p>
                          <span class="level-num">(3)</span>
                          <span>Deleted upon adoption of rule in 34 DCMR 4370 on July 10, 1987;</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 1.25em">
                        <p>
                          <span class="level-num">(4)</span>
                          <span>Unless specifically excepted or unless listed in another schedule, any material, compound, mixture, or preparation containing any of the following narcotic drugs and their salts, as set forth below:Buprenorphine;</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 1.25em">Buprenorphine;</div>
                      <div class="line" style="text-indent: 1.25em">
                        <p>
                          <span class="level-num">(5)</span>
                          <span>Prophylhexedrine; and</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 1.25em">
                        <p>
                          <span class="level-num">(6)</span>
                          <span>Pyrovalerone.</span>
                        </p>
                      </div>
                    </div>
                    <div class="line-group annotations">
                      <div class="line" style="text-indent: 1.5em">
      (<a class="internal-link" href="/dc/council/laws/4-29.html">Aug. 5, 1981, D.C. Law 4-29, § 212, 28 DCR 3081</a>; amended by rule, 39 DCR 1882; <a class="internal-link" href="/dc/council/laws/13-300.html">June 8, 2001, D.C. Law 13-300, § 2(b), 47 DCR 7037</a>.)
    </div>
                      <div class="line subheading">Section References</div>
                      <div class="line" style="text-indent: 1.5em">This section is referenced in § <a class="internal-link" href="/dc/council/code/sections/7-3002.html">7-3002</a>, § <a class="internal-link" href="/dc/council/code/sections/44-1201.html">44-1201</a>, § <a class="internal-link" href="/dc/council/code/sections/48-853.01.html">48-853.01</a>, § <a class="internal-link" href="/dc/council/code/sections/48-902.01.html">48-902.01</a>, § <a class="internal-link" href="/dc/council/code/sections/48-902.02.html">48-902.02</a>, and § <a class="internal-link" href="/dc/council/code/sections/48-1004.html">48-1004</a>.</div>
                      <div class="line subheading">Prior Codifications</div>
                      <div class="line" style="text-indent: 1.5em">1981 Ed., § 33-522.</div>
                      <div class="line subheading">Effect of Amendments</div>
                      <div class="line" style="text-indent: 1.5em"><a class="internal-link" href="/dc/council/laws/13-300.html">D.C. Law 13-300</a> repealed par. (2) which had read: “(2) Cannabis;”.</div>
                    </div>
                  </div>
            <hr/>
            <div class="line heading heading-2" style="text-indent: 0em">
              <p>
                <span class="" style="">§ 48–902.13. Revising and republishing of schedules.</span>
              </p>
            </div>
            <div>
                    <div class="line-group primary-content">
                      <div class="line" style="text-indent: 1.25em">The Mayor shall revise and republish the schedules semiannually for 2 years from August 5, 1981, and thereafter annually. The published schedules may include the brand or trade names of the substances controlled.</div>
                    </div>
                    <div class="line-group annotations">
                      <div class="line" style="text-indent: 1.5em">
      (<a class="internal-link" href="/dc/council/laws/4-29.html">Aug. 5, 1981, D.C. Law 4-29, § 213, 28 DCR 3081</a>.)
    </div>
                      <div class="line subheading">Cross References</div>
                      <div class="line" style="text-indent: 1.5em">Effective date provisions, see § <a class="internal-link" href="/dc/council/code/sections/1-636.02.html">1-636.02</a>.</div>
                      <div class="line subheading">Section References</div>
                      <div class="line" style="text-indent: 1.5em">This section is referenced in § <a class="internal-link" href="/dc/council/code/sections/1-636.02.html">1-636.02</a>.</div>
                      <div class="line subheading">Prior Codifications</div>
                      <div class="line" style="text-indent: 1.5em">1981 Ed., § 33-523.</div>
                    </div>
                  </div>
            <hr/>
            <div class="line heading heading-2" style="text-indent: 0em">
              <p>
                <span class="" style="">§ 48–902.14. Treatment of controlled substance analogues.</span>
              </p>
            </div>
            <div>
                    <div class="line-group primary-content">
                      <div class="line" style="text-indent: 1.25em">
                        <p>
                          <span class="level-num">(a)</span>
                          <span>A controlled substances analogue shall, to the extent intended for human consumption, be treated for the purposes of any District of Columbia law as a controlled substance in Schedule I.</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 1.25em">
                        <p>
                          <span class="level-num">(b)</span>
                          <span>Except as provided in subsection (c) of this section, the term “controlled analogue” means:</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 2.5em">
                        <p>
                          <span class="level-num">(1)</span>
                          <span>a substance with a chemical structure that is substantially similar to the chemical structure of a controlled substance in Schedule I or II;</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 2.5em">
                        <p>
                          <span class="level-num">(2)</span>
                          <span>A substance that has a stimulant, depressant, or hallucinogenic effect on the central nervous system that is substantially similar to or greater than the stimulant, depressant, or hallucinogenic effect on the central system of a controlled substance in Schedule I or II; or</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 2.5em">
                        <p>
                          <span class="level-num">(3)</span>
                          <span>A substance that, with respect to a particular person, is represented to have or is intended to have a stimulant, depressant, or hallucinogenic effect on the central nervous system that is substantially similar to, or greater than the stimulant, depressant, or hallucinogenic effect on the central nervous system of  a controlled substance in Schedule I or II.</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 1.25em">
                        <p>
                          <span class="level-num">(c)</span>
                          <span>Such term does not include:</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 2.5em">
                        <p>
                          <span class="level-num">(1)</span>
                          <span>A controlled substance;</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 2.5em">
                        <p>
                          <span class="level-num">(2)</span>
                          <span>Any substance for which there is an approved new drug application;</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 2.5em">
                        <p>
                          <span class="level-num">(3)</span>
                          <span>With respect to a particular person any substance, if an exemption is in effect for investigational use, for that person, under § 505 of the Federal Food, Drug, and Cosmetic Act, approved June 25, 1938 (52 Stat. 1052, 21 U.S.C. § 355) to the extent conduct with respect to such substance is pursuant to such exemption; or</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 2.5em">
                        <p>
                          <span class="level-num">(4)</span>
                          <span>Any substance to the extent not intended for human consumption before such an exemption takes effect with respect to that substance.</span>
                        </p>
                      </div>
                    </div>
                    <div class="line-group annotations">
                      <div class="line" style="text-indent: 1.5em">
      (<a class="internal-link" href="/dc/council/laws/4-29.html">August 5, 1981, D.C. Law 4-29, § 214</a>; <a class="internal-link" href="/dc/council/laws/13-99.html">as added May 9, 2000, D.C. Law 13-99, § 2(b), 47 DCR 791</a>.)
    </div>
                    </div>
                  </div>
            <hr/>
            <div class="line heading heading-1" style="text-indent: 0em">
              <p>
                <span class="" style="">Subchapter III. Regulation of Manufacture, Distribution, and Dispensing.</span>
              </p>
            </div>
            <div class="line heading heading-2" style="text-indent: 0em">
              <p>
                <span class="" style="">§ 48–903.01. Rules and regulations; fees.</span>
              </p>
            </div>
            <div>
                    <div class="line-group primary-content">
                      <div class="line" style="text-indent: 1.25em">The Mayor may issue rules and regulations and may charge reasonable fees relating to the registration and control of the manufacture, distribution, and dispensing of controlled substances within the District of Columbia.</div>
                    </div>
                    <div class="line-group annotations">
                      <div class="line" style="text-indent: 1.5em">
      (<a class="internal-link" href="/dc/council/laws/4-29.html">Aug. 5, 1981, D.C. Law 4-29, § 301, 28 DCR 3081</a>.)
    </div>
                      <div class="line subheading">Prior Codifications</div>
                      <div class="line" style="text-indent: 1.5em">1981 Ed., § 33-531.</div>
                      <div class="line subheading">Delegation of Authority</div>
                      <div class="line" style="text-indent: 1.5em">Delegation of Authority to implement <a class="internal-link" href="/dc/council/laws/4-29.html">D.C. Law 4-29</a>, the “District of Columbia Uniformed Controlled Substances Act of 1981”, see Mayor’s Order 98-49, April 15, 1998 ( 45 DCR 2694).</div>
                    </div>
                  </div>
            <hr/>
            <div class="line heading heading-2" style="text-indent: 0em">
              <p>
                <span class="" style="">§ 48–903.02. Registration — Required; renewal; exceptions; waiver; inspection.</span>
              </p>
            </div>
            <div>
                    <div class="line-group primary-content">
                      <div class="line" style="text-indent: 1.25em">
                        <p>
                          <span class="level-num">(a)</span>
                          <span>Every person who manufactures, distributes, or dispenses any controlled substance within the District of Columbia, or who proposes to engage in the manufacture, distribution, or dispensing of any controlled substance within the District of Columbia, must obtain annually a registration issued by the Mayor in accordance with the rules. Applications to renew a registration must be filed in a timely manner, not less than 60 days prior to the expiration of the registration, or the registration shall abate.</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 1.25em">
                        <p>
                          <span class="level-num">(b)</span>
                          <span>Persons registered with the Mayor under this chapter to manufacture, distribute, dispense, or conduct research with controlled substances may possess, manufacture, distribute, dispense, or conduct research with those substances to the extent authorized by their registration and in conformity with the other provisions of this subchapter. Any person registered under this subchapter whose authority to possess, distribute, dispense, or conduct research with controlled substances is limited or otherwise restricted by any federal, state, or District of Columbia law, shall use such registration only to the extent authorized by said federal, state, or District of Columbia law unless otherwise specified.</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 1.25em">
                        <p>
                          <span class="level-num">(c)</span>
                          <span>The following persons need not register and may lawfully possess controlled substances under this chapter:</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 2.5em">
                        <p>
                          <span class="level-num">(1)</span>
                          <span>An agent or employee of any registered manufacturer, distributor, or dispenser of any controlled substance acting in the usual course of business or employment;</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 2.5em">
                        <p>
                          <span class="level-num">(2)</span>
                          <span>A common or contract carrier or warehouseman, or an employee thereof, whose possession of any controlled substance is in the usual course of business or employment;</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 2.5em">
                        <p>
                          <span class="level-num">(3)</span>
                          <span>An ultimate user or a person in possession of any controlled substance pursuant to a lawful order of a practitioner or in lawful possession of a Schedule V substance; and</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 2.5em">
                        <p>
                          <span class="level-num">(4)</span>
                          <span>A designated civilian employee of the Metropolitan Police Department, or a law-enforcement official or agent of the District of Columbia or the United States if he or she is on duty and is acting in the performance of officially authorized functions.</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 1.25em">
                        <p>
                          <span class="level-num">(d)</span>
                          <span>The Mayor may waive by rule the requirement for registration of certain manufacturers, distributors, or dispensers if the Mayor finds it consistent with the public health and safety.</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 1.25em">
                        <p>
                          <span class="level-num">(e)</span>
                          <span>A separate registration is required for each principal place of business or professional practice where the applicant manufactures, distributes, or dispenses controlled substances.</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 1.25em">
                        <p>
                          <span class="level-num">(f)</span>
                          <span>The Mayor may inspect the establishment of a registrant or applicant for registration in accordance with subsections (a) and (b) of this section.</span>
                        </p>
                      </div>
                    </div>
                    <div class="line-group annotations">
                      <div class="line" style="text-indent: 1.5em">
      (<a class="internal-link" href="/dc/council/laws/4-29.html">Aug. 5, 1981, D.C. Law 4-29, § 302, 28 DCR 3081</a>; <a class="internal-link" href="/dc/council/laws/12-136.html">July 24, 1998, D.C. Law 12-136, § 2(b), 45 DCR 2942</a>; <a class="internal-link" href="/dc/council/laws/12-284.html">June 12, 1999, D.C. Law 12-284, § 10(a), 46 DCR 1328</a>.)
    </div>
                      <div class="line subheading">Section References</div>
                      <div class="line" style="text-indent: 1.5em">This section is referenced in § <a class="internal-link" href="/dc/council/code/sections/48-903.03.html">48-903.03</a>.</div>
                      <div class="line subheading">Prior Codifications</div>
                      <div class="line" style="text-indent: 1.5em">1981 Ed., § 33-532.</div>
                      <div class="line subheading">Temporary Amendment of Section</div>
                      <div class="line" style="text-indent: 1.5em">For temporary (225 day) amendment of section, see § 10(a) of Metropolitan Police Department Civilianization Temporary Amendment Act of 1998 (<a class="internal-link" href="/dc/council/laws/12-282.html">D.C. Law 12-282</a>, May 28, 1999, law notification  46 DCR 5148).</div>
                      <div class="line subheading">Emergency Legislation</div>
                      <div class="line" style="text-indent: 1.5em">For temporary amendment of section, see § 10(a) of the Metropolitan Police Department Civilianization and Street Solicitation for Prostitution Emergency Amendment Act of 1998 (D.C. Act 12-428, August 6, 1998,  45 DCR 45 5884), § 10(a) of the Metropolitan Police Department Civilianization Legislative Review Emergency Amendment Act of 1998 (D.C. Act 12-506, November 10, 1998,  45 DCR 45 8139), and § 10(a) of the Metropolitan Police Department Civilianization Congressional Review Emergency Amendment Act of 1999 (D.C. Act 13-13, February 8, 1999,  46 DCR 2333).</div>
                    </div>
                  </div>
            <hr/>
            <div class="line heading heading-2" style="text-indent: 0em">
              <p>
                <span class="" style="">§ 48–903.03. Registration — Public interest; limitations.</span>
              </p>
            </div>
            <div>
                    <div class="line-group primary-content">
                      <div class="line" style="text-indent: 1.25em">
                        <p>
                          <span class="level-num">(a)</span>
                          <span>The Mayor shall register an applicant to manufacture, distribute, or dispense controlled substances included in Schedules I, II, III, IV, and V unless the Mayor determines that the issuance of that registration would be inconsistent with the public interest. In determining the public interest, the Mayor shall consider the following factors:</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 2.5em">
                        <p>
                          <span class="level-num">(1)</span>
                          <span>Maintenance of effective controls against diversion of controlled substances into other than legitimate medical, scientific, or industrial channels;</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 2.5em">
                        <p>
                          <span class="level-num">(2)</span>
                          <span>Compliance with applicable District of Columbia law;</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 2.5em">
                        <p>
                          <span class="level-num">(3)</span>
                          <span>Any convictions of the applicant under any federal, state, or District of Columbia laws relating to any controlled substance;</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 2.5em">
                        <p>
                          <span class="level-num">(4)</span>
                          <span>Past experience in the manufacture, distribution, or dispensing of controlled substances, and the existence in the applicant’s establishment of effective controls against diversion;</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 2.5em">
                        <p>
                          <span class="level-num">(5)</span>
                          <span>Furnishing by the applicant of false or fraudulent material in any application filed under this chapter;</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 2.5em">
                        <p>
                          <span class="level-num">(6)</span>
                          <span>Suspension or revocation of the applicant’s federal registration to manufacture, distribute, or dispense controlled substances as authorized by federal law; and</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 2.5em">
                        <p>
                          <span class="level-num">(7)</span>
                          <span>Any other factors relevant to and consistent with the public health and safety.</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 1.25em">
                        <p>
                          <span class="level-num">(b)</span>
                          <span>Registration under subsection (a) of this section does not entitle a registrant to:</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 2.5em">
                        <p>
                          <span class="level-num">(1)</span>
                          <span>Manufacture or distribute controlled substances in Schedule I or II other than those specified in the registration; or</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 2.5em">
                        <p>
                          <span class="level-num">(2)</span>
                          <span>Manufacture, distribute, or dispense Cannabis unless specified in the registration.</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 1.25em">
                        <p>
                          <span class="level-num">(c)</span>
                          <span>Practitioners must be registered to dispense any controlled substances or to conduct research with controlled substances in Schedules II through V if they are authorized to dispense or conduct research under the provisions of § <a class="internal-link" href="/dc/council/code/sections/48-903.02.html">48-903.02</a>. Separate registration shall be required for practitioners engaging in research with narcotic controlled substances set forth in Schedules II through V. The Mayor need not require separate registration under this subchapter for practitioners engaging in research with nonnarcotic controlled substances in Schedules II through V where the registrant is already registered under this subchapter in another capacity. Practitioners registered under federal law to conduct research with Schedule I substances may conduct research with Schedule I substances within the District of Columbia upon furnishing the Mayor evidence of that federal registration.</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 1.25em">
                        <p>
                          <span class="level-num">(d)</span>
                          <span>Compliance by manufacturers and distributors with the provisions of the federal law respecting registration entitles them to be registered under this chapter.</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 1.25em">
                        <p>
                          <span class="level-num">(e)</span>
                          <span>Any registration issued pursuant to this section shall be issued as a Public Health: Pharmacy and Pharmaceuticals endorsement to a basic business license under the basic business license system as set forth in subchapter I-A of Chapter 28 of Title 47.</span>
                        </p>
                      </div>
                    </div>
                    <div class="line-group annotations">
                      <div class="line" style="text-indent: 1.5em">
      (<a class="internal-link" href="/dc/council/laws/4-29.html">Aug. 5, 1981, D.C. Law 4-29, § 303, 28 DCR 3081</a>; <a class="internal-link" href="/dc/council/laws/12-261.html">Apr. 20, 1999, D.C. Law 12-261, § 2003(ee), 46 DCR 3142</a>; <a class="internal-link" href="/dc/council/laws/15-38.html">Oct. 28, 2003, D.C. Law 15-38, § 3(jj), 50 DCR 6913</a>.)
    </div>
                      <div class="line subheading">Section References</div>
                      <div class="line" style="text-indent: 1.5em">This section is referenced in § <a class="internal-link" href="/dc/council/code/sections/48-903.04.html">48-903.04</a>.</div>
                      <div class="line subheading">Prior Codifications</div>
                      <div class="line" style="text-indent: 1.5em">1981 Ed., § 33-533.</div>
                      <div class="line subheading">Effect of Amendments</div>
                      <div class="line" style="text-indent: 1.5em"><a class="internal-link" href="/dc/council/laws/15-38.html">D.C. Law 15-38</a>, in subsec. (e), substituted “Public Health: Pharmacy and Pharmaceuticals endorsement to a basic business license under the basic” for “Class A Public Health: Pharmacy and Pharmaceuticals endorsement to a master business license under the master”.</div>
                      <div class="line subheading">Emergency Legislation</div>
                      <div class="line" style="text-indent: 1.5em">For temporary (90 day) amendment of section, see § 3(jj) of Streamlining Regulation Emergency Act of 2003 (D.C. Act 15-145, August 11, 2003,  50 DCR 6896).</div>
                    </div>
                  </div>
            <hr/>
            <div class="line heading heading-2" style="text-indent: 0em">
              <p>
                <span class="" style="">§ 48–903.04. Registration — Suspension; revocation; forfeiture of substances.</span>
              </p>
            </div>
            <div>
                    <div class="line-group primary-content">
                      <div class="line" style="text-indent: 1.25em">
                        <p>
                          <span class="level-num">(a)</span>
                          <span>A registration issued under § <a class="internal-link" href="/dc/council/code/sections/48-903.03.html">48-903.03</a> to manufacture, distribute, or dispense a controlled substance may be suspended or revoked by the Mayor upon a finding that the registrant:</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 2.5em">
                        <p>
                          <span class="level-num">(1)</span>
                          <span>Has been convicted of a felony under any District of Columbia, state, or federal law relating to any controlled substance;</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 2.5em">
                        <p>
                          <span class="level-num">(2)</span>
                          <span>Has had his or her federal or state registration suspended or revoked to manufacture, distribute, or dispense controlled substances;</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 2.5em">
                        <p>
                          <span class="level-num">(3)</span>
                          <span>Has had his or her practitioner’s license suspended or revoked in the District of Columbia by the appropriate authority; or</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 2.5em">
                        <p>
                          <span class="level-num">(4)</span>
                          <span>has violated any provisions of this chapter.</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 1.25em">
                        <p>
                          <span class="level-num">(b)</span>
                          <span>A registration issued under § <a class="internal-link" href="/dc/council/code/sections/48-903.03.html">48-903.03</a> to manufacture, distribute, or dispense a controlled substance may be suspended by the Mayor upon a finding that the registrant has been convicted of a misdemeanor under any District of Columbia, state, or federal law relating to any controlled substance.</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 1.25em">
                        <p>
                          <span class="level-num">(c)</span>
                          <span>The Mayor may limit revocation or suspension of a registration to the particular controlled substance with respect to which grounds for revocation or suspension exist.</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 1.25em">
                        <p>
                          <span class="level-num">(d)</span>
                          <span>If the Mayor suspends or revokes a registration, all controlled substances owned or possessed by the registrant at the time of suspension or the effective date of the revocation order may be placed under seal. No disposition may be made of substances under seal until the time for taking an appeal has elapsed or until all appeals have been concluded unless a court orders the sale of perishable substances and the deposit of the proceeds of the sale with the court. Upon a revocation order becoming final, all controlled substances may be forfeited in accordance with the provisions of § <a class="internal-link" href="/dc/council/code/sections/48-905.03.html">48-905.03</a>(d).</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 1.25em">
                        <p>
                          <span class="level-num">(e)</span>
                          <span>The Mayor shall promptly notify the D.E.A. of all orders suspending or revoking registration and all forfeitures of controlled substances.</span>
                        </p>
                      </div>
                    </div>
                    <div class="line-group annotations">
                      <div class="line" style="text-indent: 1.5em">
      (<a class="internal-link" href="/dc/council/laws/4-29.html">Aug. 5, 1981, D.C. Law 4-29, § 304, 28 DCR 3081</a>; <a class="internal-link" href="/dc/council/laws/12-136.html">July 24, 1998, D.C. Law 12-136, § 2(c), 45 DCR 2942</a>.)
    </div>
                      <div class="line subheading">Section References</div>
                      <div class="line" style="text-indent: 1.5em">This section is referenced in § <a class="internal-link" href="/dc/council/code/sections/48-903.05.html">48-903.05</a>.</div>
                      <div class="line subheading">Prior Codifications</div>
                      <div class="line" style="text-indent: 1.5em">1981 Ed., § 33-534.</div>
                    </div>
                  </div>
            <hr/>
            <div class="line heading heading-2" style="text-indent: 0em">
              <p>
                <span class="" style="">§ 48–903.05. Registration — Procedural rights involving suspension or revocation.</span>
              </p>
            </div>
            <div>
                    <div class="line-group primary-content">
                      <div class="line" style="text-indent: 1.25em">
                        <p>
                          <span class="level-num">(a)</span>
                          <span>If it appears to the Mayor that an application for registration should be denied or that an existing registration should be suspended or revoked, the Mayor shall notify the applicant or registrant of the proposed denial, suspension, or revocation, briefly stating the reasons therefor. In the case of a denial of renewal of registration, notice shall be served not later than 30 days before the expiration of the registration. Service may be made by delivering a copy of the notice to the applicant or registrant personally, or by leaving a copy thereof at the place of residence identified on the application or registration with some person of suitable age and discretion then residing therein, or by mailing a copy of the notice by certified mail to the residence address identified on the application or certificate, in which case service shall be complete as of the date the return receipt was signed. In the case of an organization, service may be made upon the president, chief executive, or other officer, managing agent, or person authorized by appointment or law to receive such notice as described in the preceding sentence at the business address of the organization identified in the application or registration certificate. The person serving the notice shall make proof thereof with the Mayor in a manner prescribed by the Mayor. In the case of service by certified mail, the signed return receipt shall be filed with the Mayor together with a signed statement showing the date such notice was mailed and if the return receipt does not purport to be signed by the person named in the notice, then specific facts from which the Mayor can determine that the person who signed the receipt meets the appropriate qualifications for receipt of such notice set out in this subsection. The applicant or registrant shall have 30 days from the date the notice was served in which to request a hearing before the Mayor to contest the proposed action to be taken by the Mayor; provided, that if the applicant or registrant does not request a hearing within 30 days after the serving of the notice of the proposed action, the applicant or registrant shall be deemed to have conceded the validity of the reason or reasons stated in the notice, and the denial, suspension, or revocation shall become final. Within 30 days of the date upon which any contest is noted, the Mayor shall convene a hearing. Within 10 days of the close of the hearing, the Mayor shall notify the applicant or registrant of the decision in the case. All proceedings, including the right to judicial review of the Mayor’s decision, shall be in accordance with the District of Columbia Administrative Procedure Act. Where the application for renewal of registration has been timely filed, proceedings to refuse renewal of registration shall not abate the existing registration, which shall remain in effect pending the outcome of the administrative hearing. With regard to summary suspension of any registrant or the denial of renewal to any registration pursuant to subsection (b) of this section, a hearing shall be convened within 5 days of the institution of proceedings in this section; except, that a registrant who has been summarily suspended or denied a renewal under this section shall be entitled upon request to a postponement of such hearing.</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 1.25em">
                        <p>
                          <span class="level-num">(b)</span>
                          <span class="level-num">(1)</span>
                          <span>The Mayor may suspend, without prior notice and hearing, any registration simultaneously with the institution of proceedings under § <a class="internal-link" href="/dc/council/code/sections/48-903.04.html">48-903.04</a>, or where renewal of registration is refused, if the Mayor finds that there is an imminent danger to the public health or safety which warrants this action, including, but not limited to, the danger that would be created by the outbreak of a serious fire on the business premises of a registrant on which controlled substances are stored, resulting in heat in excess of 110 degrees fahrenheit; grossly inadequate security measures; or while proceedings under § <a class="internal-link" href="/dc/council/code/sections/48-903.04.html">48-903.04</a> are pending, continued and flagrant violations of the same sort which led to the institution of the pending proceedings.</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 2.5em">
                        <p>
                          <span class="level-num">(2)</span>
                          <span>The suspension shall continue in effect until the conclusion of the proceedings, including judicial review thereof, unless sooner withdrawn by the Mayor or dissolved by a court of competent jurisdiction.</span>
                        </p>
                      </div>
                    </div>
                    <div class="line-group annotations">
                      <div class="line" style="text-indent: 1.5em">
      (<a class="internal-link" href="/dc/council/laws/4-29.html">Aug. 5, 1981, D.C. Law 4-29, § 305, 28 DCR 3081</a>.)
    </div>
                      <div class="line subheading">Prior Codifications</div>
                      <div class="line" style="text-indent: 1.5em">1981 Ed., § 33-535.</div>
                      <div class="line subheading">References in Text</div>
                      <div class="line" style="text-indent: 1.5em">The “District of Columbia Administrative Procedure Act,” referred to in the tenth sentence of subsection (a), is codified in Chapter 5 of Title 2.</div>
                    </div>
                  </div>
            <hr/>
            <div class="line heading heading-2" style="text-indent: 0em">
              <p>
                <span class="" style="">§ 48–903.06. Records and inventories of registrants.</span>
              </p>
            </div>
            <div>
                    <div class="line-group primary-content">
                      <div class="line" style="text-indent: 1.25em">Persons registered to manufacture, distribute, or dispense controlled substances under this chapter shall keep records and maintain inventories in conformance with the record-keeping and inventory requirements of federal law, laws of the District of Columbia, and with any additional rules which the Mayor issues.</div>
                    </div>
                    <div class="line-group annotations">
                      <div class="line" style="text-indent: 1.5em">
      (<a class="internal-link" href="/dc/council/laws/4-29.html">Aug. 5, 1981, D.C. Law 4-29, § 306, 28 DCR 3081</a>.)
    </div>
                      <div class="line subheading">Section References</div>
                      <div class="line" style="text-indent: 1.5em">This section is referenced in § <a class="internal-link" href="/dc/council/code/sections/48-903.08.html">48-903.08</a>.</div>
                      <div class="line subheading">Prior Codifications</div>
                      <div class="line" style="text-indent: 1.5em">1981 Ed., § 33-536.</div>
                    </div>
                  </div>
            <hr/>
            <div class="line heading heading-2" style="text-indent: 0em">
              <p>
                <span class="" style="">§ 48–903.07. Order forms.</span>
              </p>
            </div>
            <div>
                    <div class="line-group primary-content">
                      <div class="line" style="text-indent: 1.25em">Controlled substances in Schedule I or II shall be distributed by a registrant to another registrant only pursuant to an order form. Compliance with the provisions of federal law respecting order forms shall be deemed compliance with this section.</div>
                    </div>
                    <div class="line-group annotations">
                      <div class="line" style="text-indent: 1.5em">
      (<a class="internal-link" href="/dc/council/laws/4-29.html">Aug. 5, 1981, D.C. Law 4-29, § 307, 28 DCR 3081</a>.)
    </div>
                      <div class="line subheading">Section References</div>
                      <div class="line" style="text-indent: 1.5em">This section is referenced in § <a class="internal-link" href="/dc/council/code/sections/48-904.03.html">48-904.03</a>.</div>
                      <div class="line subheading">Prior Codifications</div>
                      <div class="line" style="text-indent: 1.5em">1981 Ed., § 33-537.</div>
                    </div>
                  </div>
            <hr/>
            <div class="line heading heading-2" style="text-indent: 0em">
              <p>
                <span class="" style="">§ 48–903.08. Prescriptions.</span>
              </p>
            </div>
            <div>
                    <div class="line-group primary-content">
                      <div class="line" style="text-indent: 1.25em">
                        <p>
                          <span class="level-num">(a)</span>
                          <span>Except when dispensed directly by a practitioner, other than a pharmacy, to an ultimate user, no controlled substance in Schedule II may be dispensed without the written prescription of a practitioner.</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 1.25em">
                        <p>
                          <span class="level-num">(b)</span>
                          <span>In emergency situations, as defined by rule of the Mayor, Schedule II drugs may be dispensed upon oral prescription of a practitioner, reduced promptly to writing and filed by the pharmacy. Prescriptions shall be retained in conformity with the requirements of § <a class="internal-link" href="/dc/council/code/sections/48-903.06.html">48-903.06</a>. No prescription for a Schedule II controlled substance may be refilled.</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 1.25em">
                        <p>
                          <span class="level-num">(c)</span>
                          <span>Except when dispensed directly by a practitioner, other than a pharmacy, to an ultimate user, a controlled substance included in Schedule III or IV which is a prescription drug as determined under § 353(b) of Title 21, United States Code, shall not be dispensed without a written or oral prescription of a practitioner. The prescription shall not be filled or refilled more than 6 months after the date thereof or be refilled more than 5 times, unless renewed by the practitioner.</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 1.25em">
                        <p>
                          <span class="level-num">(d)</span>
                          <span>A controlled substance included in Schedule V shall not be distributed or dispensed other than for a medical purpose.</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 1.25em">
                        <p>
                          <span class="level-num">(e)</span>
                          <span>Whenever a practitioner dispenses any controlled substance on a written or oral prescription issued by a practitioner, the practitioner shall affix to the container in which such controlled substance is dispensed a label showing the name of the controlled substance or controlled substances contained therein unless otherwise so indicated by the prescribing practitioner; the serial number and date of initial filling; the directions for use; the practitioner’s name and registry number; the name of the ultimate user, or if the ultimate user is an animal, the name of the owner and the species of the animal; the name of the practitioner issuing the prescription; and caution statements, if any, as required by law.</span>
                        </p>
                      </div>
                    </div>
                    <div class="line-group annotations">
                      <div class="line" style="text-indent: 1.5em">
      (<a class="internal-link" href="/dc/council/laws/4-29.html">Aug. 5, 1981, D.C. Law 4-29, § 308, 28 DCR 3081</a>.)
    </div>
                      <div class="line subheading">Section References</div>
                      <div class="line" style="text-indent: 1.5em">This section is referenced in § <a class="internal-link" href="/dc/council/code/sections/48-904.02.html">48-904.02</a>.</div>
                      <div class="line subheading">Prior Codifications</div>
                      <div class="line" style="text-indent: 1.5em">1981 Ed., § 33-538.</div>
                    </div>
                  </div>
            <hr/>
            <div class="line heading heading-2" style="text-indent: 0em">
              <p>
                <span class="" style="">§ 48–903.09. Civil infractions.</span>
              </p>
            </div>
            <div>
                    <div class="line-group primary-content">
                      <div class="line" style="text-indent: 1.25em">Civil fines, penalties, and fees may be imposed as alternative sanctions for any infraction of the provisions of this subchapter, or any rules or regulations issued under the authority of this subchapter, pursuant to Chapter 18 of Title 2. Adjudication of any infraction of this subchapter shall be pursuant to Chapter 18 of Title 2.</div>
                    </div>
                    <div class="line-group annotations">
                      <div class="line" style="text-indent: 1.5em">
      (<a class="internal-link" href="/dc/council/laws/4-29.html">Aug. 5, 1981, D.C. Law 4-29, title III, § 309</a>; <a class="internal-link" href="/dc/council/laws/8-237.html">as added Mar. 8, 1991, D.C. Law 8-237, § 6, 38 DCR 314</a>.)
    </div>
                      <div class="line subheading">Cross References</div>
                      <div class="line" style="text-indent: 1.5em">Authorization or approval of interception of wire or oral communications, see § <a class="internal-link" href="/dc/council/code/sections/23-546.html">23-546</a>.</div>
                      <div class="line subheading">Prior Codifications</div>
                      <div class="line" style="text-indent: 1.5em">1981 Ed., § 33-539.</div>
                    </div>
                  </div>
            <hr/>
            <div class="line heading heading-1" style="text-indent: 0em">
              <p>
                <span class="" style="">Subchapter IV. Offenses and Penalties.</span>
              </p>
            </div>
            <div class="line heading heading-2" style="text-indent: 0em">
              <p>
                <span class="" style="">§ 48–904.01. Prohibited acts A; penalties.</span>
              </p>
            </div>
            <div>
                    <div class="line-group primary-content">
                      <div class="line" style="text-indent: 1.25em">
                        <p>
                          <span class="level-num">(a)</span>
                          <span class="level-num">(1)</span>
                          <span>Except as authorized by this chapter or Chapter 16B of Title 7 [§ <a class="internal-link" href="/dc/council/code/sections/7-1671.01.html">7-1671.01</a> et seq.], it is unlawful for any person knowingly or intentionally to manufacture, distribute, or possess, with intent to manufacture or distribute, a controlled substance. Notwithstanding any provision of this chapter to the contrary, it shall be lawful, and shall not be an offense under District of Columbia law, for any person 21 years of age or older to:</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 3.75em">
                        <p>
                          <span class="level-num">(A)</span>
                          <span>Possess, use, purchase, or transport marijuana weighing 2 ounces or less;</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 3.75em">
                        <p>
                          <span class="level-num">(B)</span>
                          <span>Transfer to another person 21 years of age or older, without remuneration, marijuana weighing one ounce or less;</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 3.75em">
                        <p>
                          <span class="level-num">(C)</span>
                          <span>Possess, grow, harvest, or process, within the interior of a house or rental unit that constitutes such person’s principal residence, no more than 6 cannabis plants, with 3 or fewer being mature, flowering plants; provided, that all persons residing within a single house or single rental unit may not possess, grow, harvest, or process, in the aggregate, more than 12 cannabis plants, with 6 or fewer being mature, flowering plants;</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 3.75em">
                        <p>
                          <span class="level-num">(D)</span>
                          <span>Possess within such house or rental unit the marijuana produced by such plants; provided that, nothing in this subsection shall make it lawful to sell, offer for sale, or make available for sale any marijuana or cannabis plants.</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 2.5em">
                        <p>
                          <span class="level-num">(1A)</span>
                          <span class="level-num">(A)</span>
                          <span>The terms “controlled substance” and “controlled substances,” as used in the District of Columbia Official Code, shall not include:</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 5em">
                        <p>
                          <span class="level-num">(i)</span>
                          <span>Marijuana that is or was in the personal possession of a person 21 years of age or older at any specific time if the total amount of marijuana that is or was in the possession of that person at that time weighs or weighed 2 ounces or less;</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 5em">
                        <p>
                          <span class="level-num">(ii)</span>
                          <span>Cannabis plants that are or were grown, possessed, harvested, or processed by a person 21 years of age or older within the interior of a house or rental unit that constitutes or at the time constituted, such person’s principal residence, if such person at that time was growing no more than 6 cannabis plants with 3 or fewer being mature flowering plants and if all persons residing within that single house or single rental unit at that time did not possess, grow, harvest, or process, in the aggregate, more than 12 cannabis plants, with 6 or fewer being mature, flowering plants; or</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 5em">
                        <p>
                          <span class="level-num">(iii)</span>
                          <span>The marijuana produced by the plants which were grown, possessed, harvested, or processed by a person who was, pursuant to sub-subparagraph (ii) of this subparagraph, permitted to grow, possess, harvest, and process such plants, if such marijuana is or was in the personal possession of that person who is growing or grew such plants, within the house or rental unit in which the plants are or were grown.</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 3.75em">
                        <p>
                          <span class="level-num">(B)</span>
                          <span>Notwithstanding the provisions of this paragraph, the terms “controlled substance” and “controlled substances,” as used in the District of Columbia Official Code, shall include any marijuana or cannabis plant sold or offered for sale or made available for sale.</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 2.5em">
                        <p>
                          <span class="level-num">(1B)</span>
                          <span>Notwithstanding any other provision of the District of Columbia Official Code, no District government agency or office shall limit or refuse to provide any facility service, program, or benefit to any person based upon or by reason of conduct that is made lawful by this subsection.</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 2.5em">
                        <p>
                          <span class="level-num">(1C)</span>
                          <span>Nothing in this subsection shall be construed to require any District government agency or office, or any employer, to permit or accommodate the use, consumption, possession, transfer, display, transportation, sale, or growing of marijuana in the workplace or to affect the ability of any such agency, office, or employer to establish and enforce policies restricting the use of marijuana by employees.</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 2.5em">
                        <p>
                          <span class="level-num">(1D)</span>
                          <span>Nothing in this subsection shall be construed to permit driving under the influence of marijuana or driving while impaired by use or ingestion of marijuana or to modify or affect the construction or application of any provision of the District of Columbia Official Code related to driving under the influence of marijuana or driving while impaired by marijuana.</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 2.5em">
                        <p>
                          <span class="level-num">(1E)</span>
                          <span>Nothing in this subsection shall be construed to prohibit any person, business, corporation, organization, or other entity, or District government agency or office, who or which occupies, owns, or controls any real property, from prohibiting or regulating the possession, consumption, use, display, transfer, distribution, sale, transportation, or growing of marijuana on or in that property.</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 2.5em">
                        <p>
                          <span class="level-num">(1F)</span>
                          <span>Nothing in this subsection shall be construed to make unlawful any conduct permitted by Chapter 16B of Title 7 [§ <a class="internal-link" href="/dc/council/code/sections/7-1671.01.html">7-1671.01</a> et seq.].</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 2.5em">
                        <p>
                          <span class="level-num">(2)</span>
                          <span>Any person who violates this subsection with respect to:</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 3.75em">
                        <p>
                          <span class="level-num">(A)</span>
                          <span>A controlled substance classified in Schedule I or II that is a narcotic or abusive drug shall be imprisoned for not more than 30 years or fined not more than the amount set forth in § <a class="internal-link" href="/dc/council/code/sections/22-3571.01.html">22-3571.01</a>, or both;</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 3.75em">
                        <p>
                          <span class="level-num">(B)</span>
                          <span>Any other controlled substance classified in Schedule I, II, or III, except for a narcotic or abusive drug, is guilty of a crime and upon conviction may be imprisoned for not more than 5 years, fined not more than the amount set forth in § <a class="internal-link" href="/dc/council/code/sections/22-3571.01.html">22-3571.01</a>, or both; except that upon conviction of manufacturing, distributing or possessing with intent to distribute ½ pound or less of marijuana, a person who has not previously been convicted of manufacturing, distributing or possessing with intent to distribute a controlled substance or attempting to manufacture, distribute, or possess with intent to distribute a controlled substance may be imprisoned for not more than 180 days or fined not more than the amount set forth in § <a class="internal-link" href="/dc/council/code/sections/22-3571.01.html">22-3571.01</a> or both;</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 3.75em">
                        <p>
                          <span class="level-num">(C)</span>
                          <span>A substance classified in Schedule IV, is guilty of a crime and upon conviction may be imprisoned for not more than 3 years, fined not more than the amount set forth in § <a class="internal-link" href="/dc/council/code/sections/22-3571.01.html">22-3571.01</a>, or both; or</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 3.75em">
                        <p>
                          <span class="level-num">(D)</span>
                          <span>A substance classified in Schedule V, is guilty of a crime and upon conviction may be imprisoned for not more than one year, fined not more than the amount set forth in § <a class="internal-link" href="/dc/council/code/sections/22-3571.01.html">22-3571.01</a>, or both.</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 1.25em">
                        <p>
                          <span class="level-num">(b)</span>
                          <span class="level-num">(1)</span>
                          <span>Except as authorized by this chapter, it is unlawful for any person to create, distribute, or possess with intent to distribute a counterfeit substance.</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 2.5em">
                        <p>
                          <span class="level-num">(2)</span>
                          <span>Any person who violates this subsection with respect to:</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 3.75em">
                        <p>
                          <span class="level-num">(A)</span>
                          <span>A counterfeit substance classified in Schedule I or II that is a narcotic or abusive drug shall be imprisoned for not more than 30 years or fined not more than the amount set forth in § <a class="internal-link" href="/dc/council/code/sections/22-3571.01.html">22-3571.01</a>, or both;</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 3.75em">
                        <p>
                          <span class="level-num">(B)</span>
                          <span>Any other counterfeit substance classified in Schedule I, II, or III, except for a narcotic or abusive drug, is guilty of a crime and upon conviction may be imprisoned for not more than 5 years, fined not more than the amount set forth in § <a class="internal-link" href="/dc/council/code/sections/22-3571.01.html">22-3571.01</a>, or both;</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 3.75em">
                        <p>
                          <span class="level-num">(C)</span>
                          <span>A counterfeit substance classified in Schedule IV, is guilty of a crime and upon conviction may be imprisoned for not more than 3 years, fined not more than the amount set forth in § <a class="internal-link" href="/dc/council/code/sections/22-3571.01.html">22-3571.01</a>, or both; or</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 3.75em">
                        <p>
                          <span class="level-num">(D)</span>
                          <span>A counterfeit substance classified in Schedule V, is guilty of a crime and upon conviction may be imprisoned for not more than 1 year, fined not more than the amount set forth in § <a class="internal-link" href="/dc/council/code/sections/22-3571.01.html">22-3571.01</a>, or both.</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 1.25em">
                        <p>
                          <span class="level-num">(c)</span>
                          <span>Repealed.</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 1.25em">
                        <p>
                          <span class="level-num">(d)</span>
                          <span class="level-num">(1)</span>
                          <span>It is unlawful for any person knowingly or intentionally to possess a controlled substance unless the substance was obtained directly from, or pursuant to, a valid prescription or order of a practitioner while acting in the course of his or her professional practice, or except as otherwise authorized by this chapter or Chapter 16B of Title 7 [§ <a class="internal-link" href="/dc/council/code/sections/7-1671.01.html">7-1671.01</a> et seq.], and provided in § <a class="internal-link" href="/dc/council/code/sections/48-1201.html">48-1201</a>. Except as provided in paragraph (2) of this subsection, any person who violates this subsection is guilty of a misdemeanor and upon conviction may be imprisoned for not more than 180 days, fined not more than the amount set forth in § <a class="internal-link" href="/dc/council/code/sections/22-3571.01.html">22-3571.01</a>, or both.</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 2.5em">
                        <p>
                          <span class="level-num">(2)</span>
                          <span>Any person who violates this subsection by knowingly or intentionally possessing the abusive drug phencyclidine in liquid form is guilty of a felony and, upon conviction, may be imprisoned for not more than 3 years, fined not more than the amount set forth in § <a class="internal-link" href="/dc/council/code/sections/22-3571.01.html">22-3571.01</a>, or both.</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 1.25em">
                        <p>
                          <span class="level-num">(e)</span>
                          <span class="level-num">(1)</span>
                          <span>If any person who has not previously been convicted of violating any provision of this chapter, or any other law of the United States or any state relating to narcotic or abusive drugs or depressant or stimulant substances is found guilty of a violation of subsection (d) of this section and has not previously been discharged and had the proceedings dismissed pursuant to this subsection, the court may, without entering a judgment of guilty and with the consent of such person, defer further proceedings and place him or her on probation upon such reasonable conditions as it may require and for such period, not to exceed one year, as the court may prescribe. Upon violation of a condition of the probation, the court may enter an adjudication of guilt and proceed as otherwise provided. The court may, in its discretion, dismiss the proceedings against such person and discharge him or her from probation before the expiration of the maximum period prescribed for such person’s probation. If during the period of probation such person does not violate any of the conditions of the probation, then upon expiration of such period the court shall discharge such person and dismiss the proceedings against him or her. Discharge and dismissal under this subsection shall be without court adjudication of guilt, but a nonpublic record thereof shall be retained solely for the purpose of use by the courts in determining whether or not, in subsequent proceedings, such person qualifies under this subsection. Such discharge or dismissal shall not be deemed a conviction for purposes of disqualifications or disabilities imposed by law upon conviction of a crime (including the penalties prescribed under § <a class="internal-link" href="/dc/council/code/sections/48-904.08.html">48-904.08</a> for second or subsequent convictions) or for any other purpose.</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 2.5em">
                        <p>
                          <span class="level-num">(2)</span>
                          <span>Upon the dismissal of such person and discharge of the proceedings against him under paragraph (1) of this subsection, such person may apply to the court for an order to expunge from all official records (other than the nonpublic records to be retained under paragraph (1) of this subsection) all recordation relating to his or her arrest, indictment or information, trial, finding of guilty, and dismissal and discharge pursuant to this subsection. If the court determines, after hearing, that such person was dismissed and the proceedings against him or her discharged, it shall enter such order. The effect of such order shall be to restore such person, in the contemplation of this law, to the status he or she occupied before such arrest or indictment or information. No person as to whom such order has been entered shall be held thereafter under any provision of any law to be guilty of perjury or otherwise giving a false statement by reason of failure to recite or acknowledge such arrest, or indictment, or trial in response to any inquiry made of him or her for any purpose.</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 2.5em">
                        <p>
                          <span class="level-num">(3)</span>
                          <span>A person who was discharged from probation and whose case was dismissed pursuant to paragraph (1) of this subsection shall be entitled to a copy of the nonpublic record retained under paragraph (1) of this subsection but only to the extent that such record would have been available to the person before an order of expungement was entered pursuant to paragraph (2) of this subsection. A request for a copy of the nonpublic record may be made ex parte and under seal by the person or by an authorized representative of the person.</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 1.25em">
                        <p>
                          <span class="level-num">(f)</span>
                          <span>The prosecutor may charge any person who violates the provisions of subsection (a) or (b) of this section relating to the distribution of or possession with intent to distribute a controlled or counterfeit substance with a violation of subsection (d) of this section if the interests of justice so dictate.</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 1.25em">
                        <p>
                          <span class="level-num">(g)</span>
                          <span>For the purposes of this section, “offense” means a prior conviction for a violation of this section or a felony that relates to narcotic or abusive drugs, marijuana, or depressant or stimulant drugs, that is rendered by a court of competent jurisdiction in the United States.</span>
                        </p>
                      </div>
                    </div>
                    <div class="line-group annotations">
                      <div class="line" style="text-indent: 1.5em">
      (<a class="internal-link" href="/dc/council/laws/4-29.html">Aug. 5, 1981, D.C. Law 4-29, § 401, 28 DCR 3081</a>; <a class="internal-link" href="/dc/council/laws/4-52.html">Nov. 17, 1981, D.C. Law 4-52, § 3(c)(1), 28 DCR 4348</a>; <a class="internal-link" href="/dc/council/laws/4-166.html">Mar. 9, 1983, D.C. Law 4-166, §§ 9, 10, 30 DCR 1082</a>; <a class="internal-link" href="/dc/council/laws/5-121.html">Sept. 26, 1984, D.C. Law 5-121, § 2(a), 31 DCR 4046</a>; <a class="internal-link" href="/dc/council/laws/5-171.html">Mar. 15, 1985, D.C. Law 5-171, § 2(a), 32 DCR 730</a>; <a class="internal-link" href="/dc/council/laws/6-201.html">Feb. 28, 1987, D.C. Law 6-201, § 2(c), 34 DCR 524</a>; <a class="internal-link" href="/dc/council/laws/8-138.html">June 13, 1990, D.C. Law 8-138, § 2(c), 37 DCR 2638</a>; <a class="internal-link" href="/dc/council/laws/10-151.html">Aug. 20, 1994, D.C. Law 10-151, § 112(a), 41 DCR 2608</a>; <a class="internal-link" href="/dc/council/laws/10-258.html">May 25, 1995, D.C. Law 10-258,§ 3, 42 DCR 238</a>; <a class="internal-link" href="/dc/council/laws/11-110.html">Apr. 18, 1996, D.C. Law 11-110, § 34(b), 43 DCR 530</a>; <a class="internal-link" href="/dc/council/laws/13-300.html">June 8, 2001, D.C. Law 13-300, § 2(c), 47 DCR 7037</a>; <a class="internal-link" href="/dc/council/laws/18-196.html">July 23, 2010, D.C. Law 18-196, § 2, 57 DCR 4522</a>; <a class="internal-link" href="/dc/council/laws/18-210.html">July 27, 2010, D.C. Law 18-210, § 3(c), 57 DCR 4798</a>; <a class="internal-link" href="/dc/council/laws/19-317.html">June 11, 2013, D.C. Law 19-317, § 252(a), 60 DCR 2064</a>; <a class="internal-link" href="/dc/council/laws/19-319.html">June 15, 2013, D.C. Law 19-319, § 5, 60 DCR 2333</a>; <a class="internal-link" href="/dc/council/laws/20-126.html">July 17, 2014, D.C. Law 20-126, § 408, 61 DCR 3482</a>; <a class="internal-link" href="/dc/council/laws/20-153.html">Feb. 26, 2015, D.C. Law 20-153, § 2, 62 DCR 880</a>.)
    </div>
                      <div class="line subheading">Cross References</div>
                      <div class="line" style="text-indent: 1.5em">Duties, powers, and goals of Prison Commission, see § <a class="internal-link" href="/dc/council/code/sections/24-112.html">24-112</a>.</div>
                      <div class="line" style="text-indent: 1.5em">Good time credits, exceptions, see § <a class="internal-link" href="/dc/council/code/sections/24-221.06.html">24-221.06</a>.</div>
                      <div class="line subheading">Section References</div>
                      <div class="line" style="text-indent: 1.5em">This section is referenced in § <a class="internal-link" href="/dc/council/code/sections/7-403.html">7-403</a>, § <a class="internal-link" href="/dc/council/code/sections/23-546.html">23-546</a>, § <a class="internal-link" href="/dc/council/code/sections/24-112.html">24-112</a>, § <a class="internal-link" href="/dc/council/code/sections/24-221.06.html">24-221.06</a>, § <a class="internal-link" href="/dc/council/code/sections/24-906.html">24-906</a>, § <a class="internal-link" href="/dc/council/code/sections/48-904.06.html">48-904.06</a>, § <a class="internal-link" href="/dc/council/code/sections/48-904.07.html">48-904.07</a>, § <a class="internal-link" href="/dc/council/code/sections/48-904.07a.html">48-904.07a</a>, and § <a class="internal-link" href="/dc/council/code/sections/48-905.02.html">48-905.02</a>.</div>
                      <div class="line subheading">Prior Codifications</div>
                      <div class="line" style="text-indent: 1.5em">1981 Ed., § 33-541.</div>
                      <div class="line subheading">Effect of Amendments</div>
                      <div class="line" style="text-indent: 1.5em"><a class="internal-link" href="/dc/council/laws/13-300.html">D.C. Law 13-300</a>, in subsec. (a), par. (2)(A), substituted “both; except that upon conviction of manufacturing, distributing or possessing with intent to distribute ½ pound or less of marijuana, a person who has not previously been convicted of manufacturing, distributing or possessing with intent to distribute a controlled substance or attempting to manufacture, distribute, or possess with intent to distribute a controlled substance may be imprisoned for not more than 180 days or fined not more than $1000 or both” for “both”.</div>
                      <div class="line" style="text-indent: 1.5em"><a class="internal-link" href="/dc/council/laws/18-196.html">D.C. Law 18-196</a> rewrote subsec. (d), which had read as follows: “(d) It is unlawful for any person knowingly or intentionally to possess a controlled substance unless the substance was obtained directly from, or pursuant to, a valid prescription or order of a practitioner while acting in the course of his or her professional practice, or except as otherwise authorized by this chapter. Any person who violates this subsection is guilty of a misdemeanor and upon conviction may be imprisoned for not more than 180 days, fined not more than $1,000, or both.”</div>
                      <div class="line" style="text-indent: 1.5em"><a class="internal-link" href="/dc/council/laws/18-210.html">D.C. Law 18-210</a>, in subsec. (a)(1), substituted “Except as authorized by this chapter or Chapter 16B of Title 7,” for “Except as authorized by this chapter”; and, in subsec. (d), substituted “except as otherwise authorized by this chapter or Chapter 16B of Title 7” for “except as otherwise authorized by this chapter”.</div>
                      <div class="line" style="text-indent: 1.5em">The 2013 amendment by <a class="internal-link" href="/dc/council/laws/19-317.html">D.C. Law 19-317</a> substituted “not more than the amount set forth in § <a class="internal-link" href="/dc/council/code/sections/22-3571.01.html">22-3571.01</a>” for “not more than $500,000” in (a)(2)(A); in (a)(2)(B), substituted the first occurrence of “not more than the amount set forth in § <a class="internal-link" href="/dc/council/code/sections/22-3571.01.html">22-3571.01</a>” for “not more than $50,000” and the second occurrence for “not more than $1,000”; substituted “not more than the amount set forth in § <a class="internal-link" href="/dc/council/code/sections/22-3571.01.html">22-3571.01</a>” for “not more than $25,000” in (a)(2)(C) and for “not more than $10,000” in (a)(2)(D); in (b)(2), substituted “not more than the amount set forth in § <a class="internal-link" href="/dc/council/code/sections/22-3571.01.html">22-3571.01</a>” for “not more than $500,000” in (b)(2)(A), for “not more than $50,000” in (b)(2)(B), for “not more than $25,000” in (b)(2)(C), and for “not more than $10,000” in (b)(2)(D); and in (d), substituted “not more than the amount set forth in § <a class="internal-link" href="/dc/council/code/sections/22-3571.01.html">22-3571.01</a>” for “not more than $1,000” in (d)(1), and for “not more than $3,000” in (d)(2).</div>
                      <div class="line" style="text-indent: 1.5em">The 2013 amendment by <a class="internal-link" href="/dc/council/laws/19-319.html">D.C. Law 19-319</a> added (e)(3).</div>
                      <div class="line" style="text-indent: 1.5em">The 2015 amendment by <a class="internal-link" href="/dc/council/laws/20-153.html">D.C. Law 20-153</a> rewrote (a).</div>
                      <div class="line subheading">Emergency Legislation</div>
                      <div class="line" style="text-indent: 1.5em">For temporary (90 days) amendment of this section, see § 252(a) of the Criminal Fine Proportionality Emergency Act of 2013 (D.C. Act 20-45, April 1, 2013,  60 DCR 5400, 20 DCSTAT 1300).</div>
                      <div class="line subheading">Editor's Notes</div>
                      <div class="line" style="text-indent: 1.5em">Mayor to implement public information program: See Historical and Statutory Notes following § <a class="internal-link" href="/dc/council/code/sections/48-901.02.html">48-901.02</a>.</div>
                      <div class="line" style="text-indent: 1.5em">Applicability of <a class="internal-link" href="/dc/council/laws/19-317.html">D.C. Law 19-317</a>: Section 401 of <a class="internal-link" href="/dc/council/laws/19-317.html">D.C. Law 19-317</a> provided that the act shall apply only to offenses committed on or after June 11, 2013.</div>
                      <div class="line" style="text-indent: 1.5em">Section 4 of <a class="internal-link" href="/dc/council/laws/20-153.html">D.C. Law 20-153</a> provided that the amounts of the fines set forth in § <a class="internal-link" href="/dc/council/code/sections/22-3571.01.html">22-3571.01</a> and § <a class="internal-link" href="/dc/council/code/sections/48-1103.html">48-1103</a> shall be adjusted through implementing or amending legislation enacted by the Council of the District of Columbia to the extent necessary to ensure that the act does not negate or limit any act of the Council of the District of Columbia pursuant to § <a class="internal-link" href="/dc/council/code/sections/1-204.46.html">1-204.46</a>.</div>
                      <div class="line" style="text-indent: 1.5em">Section 809 of through 113 P.L. 235 provided:</div>
                      <div class="line" style="text-indent: 1.5em">“(a) None of the Federal funds contained in this Act may be used to enact or carry out any law, rule, or regulation to legalize or otherwise reduce penalties associated with the possession, use, or distribution of any schedule I substance under the Controlled Substances Act ( 21 U.S.C. 801 et seq.) or any tetrahydrocannabinols derivative.</div>
                      <div class="line" style="text-indent: 1.5em">“(b) None of the funds contained in this Act may be used to enact any law, rule, or regulation to legalize or otherwise reduce penalties associated with the possession, use, or distribution of any schedule I substance under the Controlled Substances Act ( 21 U.S.C. 801 et seq.) or any tetrahydrocannabinols derivative for recreational purposes.”</div>
                    </div>
                  </div>
            <hr/>
            <div class="line heading heading-2" style="text-indent: 0em">
              <p>
                <span class="" style="">§ 48–904.02. Prohibited acts B; penalties.</span>
              </p>
            </div>
            <div>
                    <div class="line-group primary-content">
                      <div class="line" style="text-indent: 1.25em">
                        <p>
                          <span class="level-num">(a)</span>
                          <span>It is unlawful for any person:</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 2.5em">
                        <p>
                          <span class="level-num">(1)</span>
                          <span>Who is subject to subchapter III of this chapter to distribute or dispense a controlled substance in violation of § <a class="internal-link" href="/dc/council/code/sections/48-903.08.html">48-903.08</a>;</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 2.5em">
                        <p>
                          <span class="level-num">(2)</span>
                          <span>Who is a registrant, to manufacture a controlled substance not authorized by registration, or to distribute or dispense a controlled substance not authorized by registration to another registrant or other authorized person;</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 2.5em">
                        <p>
                          <span class="level-num">(3)</span>
                          <span>To refuse or fail to make, keep or furnish any record, notification, order form, statement, invoice, or information required under this chapter;</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 2.5em">
                        <p>
                          <span class="level-num">(4)</span>
                          <span>To refuse an entry into any premises for any inspection authorized by this chapter;</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 2.5em">
                        <p>
                          <span class="level-num">(5)</span>
                          <span>Knowingly to keep or maintain any store, shop, warehouse, dwelling, building, vehicle, boat, aircraft, or other structure or place, which is resorted to by persons using controlled substances in violation of this chapter for the purpose of using these substances or which is used for keeping or selling them in violation of this chapter;</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 2.5em">
                        <p>
                          <span class="level-num">(6)</span>
                          <span>Who is a law-enforcement official, as designated by the Mayor, or a designated civilian employee of the Metropolitan Police Department, to divulge any knowledge relating to the records, order forms, or prescriptions of registrants which he or she received by virtue of his or her office, except in connection with officially authorized duties or in connection with a prosecution or proceeding in court or before a licensing or registration board or officer, to which prosecution or proceeding the registrant to whom such records, order forms, or prescriptions relate is a party; or</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 2.5em">
                        <p>
                          <span class="level-num">(7)</span>
                          <span>To use to his or her own advantage or to reveal, other than to duly authorized officers or employees of the District of Columbia or the United States, or to the courts when relevant in any judicial proceeding under this subchapter or subchapter III of this chapter, any information acquired in the course of an authorized inspection concerning any method or process which as a trade secret is entitled to protection.</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 1.25em">
                        <p>
                          <span class="level-num">(b)</span>
                          <span>Except as provided for in subsection (c) of this section, any person who violates this section shall, with respect to any violation, be subject to a civil penalty of not more than $50,000.</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 1.25em">
                        <p>
                          <span class="level-num">(c)</span>
                          <span>If a violation of this section is prosecuted by an information or indictment which alleges that the violation was committed knowingly and the trier of fact specifically finds that the violation was so committed, such person shall be guilty of a crime and upon conviction may be imprisoned for not more than one year, fined not more than the amount set forth in § <a class="internal-link" href="/dc/council/code/sections/22-3571.01.html">22-3571.01</a>, or both.</span>
                        </p>
                      </div>
                    </div>
                    <div class="line-group annotations">
                      <div class="line" style="text-indent: 1.5em">
      (<a class="internal-link" href="/dc/council/laws/4-29.html">Aug. 5, 1981, D.C. Law 4-29, § 402, 28 DCR 3081</a>; <a class="internal-link" href="/dc/council/laws/12-284.html">June 12, 1999, D.C. Law 12-284, § 10(b), 46 DCR 1328</a>; <a class="internal-link" href="/dc/council/laws/19-317.html">June 11, 2013, D.C. Law 19-317, § 252(b), 60 DCR 2064</a>.)
    </div>
                      <div class="line subheading">Prior Codifications</div>
                      <div class="line" style="text-indent: 1.5em">1981 Ed., § 33-542.</div>
                      <div class="line" style="text-indent: 1.5em">1981 Ed., § 33-542.</div>
                      <div class="line subheading">Effect of Amendments</div>
                      <div class="line" style="text-indent: 1.5em">The 2013 amendment by <a class="internal-link" href="/dc/council/laws/19-317.html">D.C. Law 19-317</a> substituted “not more than the amount set forth in § <a class="internal-link" href="/dc/council/code/sections/22-3571.01.html">22-3571.01</a>” for “not more than $50,000” in (c).</div>
                      <div class="line subheading">Temporary Amendment of Section</div>
                      <div class="line" style="text-indent: 1.5em">For temporary (225 day) amendment of section, see § 10(b) of Metropolitan Police Department Civilianization Temporary Amendment Act of 1998 (<a class="internal-link" href="/dc/council/laws/12-282.html">D.C. Law 12-282</a>, May 28, 1999, law notification  46 DCR 5148).</div>
                      <div class="line subheading">Emergency Legislation</div>
                      <div class="line" style="text-indent: 1.5em">For temporary amendment of section, see § 10(b) of the Metropolitan Police Department Civilianization and Street Solicitation for Prostitution Emergency Amendment Act of 1998 (D.C. Act 12-428, August 6, 1998,  45 DCR 5884), § 10(b) of the Metropolitan Police Department Civilianization Legislative Review Emergency Amendment Act of 1998 (D.C. Act 12-506, November 10, 1998,  45 DCR 8139), and § 10(b) of the Metropolitan Police Department Civilianization Congressional Review Emergency Amendment Act of 1999 (D.C. Act 13-13, February 8, 1999,  46 DCR 2333).</div>
                      <div class="line" style="text-indent: 1.5em">For temporary (90 days) amendment of this section, see § 252(b) of the Criminal Fine Proportionality Emergency Act of 2013 (D.C. Act 20-45, April 1, 2013,  60 DCR 5400, 20 DCSTAT 1300).</div>
                      <div class="line subheading">Editor's Notes</div>
                      <div class="line" style="text-indent: 1.5em">Applicability of <a class="internal-link" href="/dc/council/laws/19-317.html">D.C. Law 19-317</a>: Section 401 of <a class="internal-link" href="/dc/council/laws/19-317.html">D.C. Law 19-317</a> provided that the act shall apply only to offenses committed on or after June 11, 2013.</div>
                    </div>
                  </div>
            <hr/>
            <div class="line heading heading-2" style="text-indent: 0em">
              <p>
                <span class="" style="">§ 48–904.03. Prohibited acts C; penalties.</span>
              </p>
            </div>
            <div>
                    <div class="line-group primary-content">
                      <div class="line" style="text-indent: 1.25em">
                        <p>
                          <span class="level-num">(a)</span>
                          <span>It is unlawful for any person knowingly or intentionally:</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 2.5em">
                        <p>
                          <span class="level-num">(1)</span>
                          <span>To distribute as a registrant a controlled substance classified in Schedule I or II, except pursuant to an order form as required by § <a class="internal-link" href="/dc/council/code/sections/48-903.07.html">48-903.07</a>;</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 2.5em">
                        <p>
                          <span class="level-num">(2)</span>
                          <span>To use in the course of the manufacture or distribution of a controlled substance a registration number which is fictitious, revoked, suspended, or issued to another person;</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 2.5em">
                        <p>
                          <span class="level-num">(3)</span>
                          <span>To acquire or obtain possession of a controlled substance by misrepresentation, fraud, forgery, deception, or subterfuge;</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 2.5em">
                        <p>
                          <span class="level-num">(4)</span>
                          <span>To furnish false or fraudulent material information in, or omit any material information from, any application, report, or other document required to be kept or filed under this chapter, or any record required to be kept by this chapter; or</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 2.5em">
                        <p>
                          <span class="level-num">(5)</span>
                          <span>To make, distribute, or possess any punch, die, plate, stone, or other thing designed to print, imprint, or reproduce the trademark, trade name, or other identifying mark, imprint, or device of another or any likeness of any of the foregoing upon any drug or container or labeling thereof so as to render the drug a counterfeit substance.</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 1.25em">
                        <p>
                          <span class="level-num">(b)</span>
                          <span>Any person who violates this section is guilty of a crime and upon conviction may be imprisoned for not more than 4 years, fined not more than the amount set forth in § <a class="internal-link" href="/dc/council/code/sections/22-3571.01.html">22-3571.01</a>, or both.</span>
                        </p>
                      </div>
                    </div>
                    <div class="line-group annotations">
                      <div class="line" style="text-indent: 1.5em">
      (<a class="internal-link" href="/dc/council/laws/4-29.html">Aug. 5, 1981, D.C. Law 4-29, § 403, 28 DCR 3081</a>; <a class="internal-link" href="/dc/council/laws/19-317.html">June 11, 2013, D.C. Law 19-317, § 252(c), 60 DCR 2064</a>.)
    </div>
                      <div class="line subheading">Prior Codifications</div>
                      <div class="line" style="text-indent: 1.5em">1981 Ed., § 33-543.</div>
                      <div class="line subheading">Effect of Amendments</div>
                      <div class="line" style="text-indent: 1.5em">The 2013 amendment by <a class="internal-link" href="/dc/council/laws/19-317.html">D.C. Law 19-317</a> substituted “not more than the amount set forth in § <a class="internal-link" href="/dc/council/code/sections/22-3571.01.html">22-3571.01</a>” for “not more than $50,000” in (b).</div>
                      <div class="line subheading">Emergency Legislation</div>
                      <div class="line" style="text-indent: 1.5em">For temporary (90 days) amendment of this section, see § 252(c) of the Criminal Fine Proportionality Emergency Act of 2013 (D.C. Act 20-45, April 1, 2013,  60 DCR 5400, 20 DCSTAT 1300).</div>
                      <div class="line subheading">Editor's Notes</div>
                      <div class="line" style="text-indent: 1.5em">Applicability of <a class="internal-link" href="/dc/council/laws/19-317.html">D.C. Law 19-317</a>: Section 401 of <a class="internal-link" href="/dc/council/laws/19-317.html">D.C. Law 19-317</a> provided that the act shall apply only to offenses committed on or after June 11, 2013.</div>
                    </div>
                  </div>
            <hr/>
            <div class="line heading heading-2" style="text-indent: 0em">
              <p>
                <span class="" style="">§ 48–904.03a. Prohibited acts D; penalties.</span>
              </p>
            </div>
            <div>
                    <div class="line-group primary-content">
                      <div class="line" style="text-indent: 1.25em">
                        <p>
                          <span class="level-num">(a)</span>
                          <span>It shall be unlawful for any person to knowingly open or maintain any place to manufacture, distribute, or store for the purpose of manufacture or distribution a narcotic or abusive drug.</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 1.25em">
                        <p>
                          <span class="level-num">(b)</span>
                          <span>Any person who violates this section shall be imprisoned for not less than 5 years nor more than 25 years, fined not more than the amount set forth in § <a class="internal-link" href="/dc/council/code/sections/22-3571.01.html">22-3571.01</a>, or both.</span>
                        </p>
                      </div>
                    </div>
                    <div class="line-group annotations">
                      <div class="line" style="text-indent: 1.5em">
      (<a class="internal-link" href="/dc/council/laws/4-29.html">Aug. 5, 1981, D.C. Law 4-29, § 411</a>; <a class="internal-link" href="/dc/council/laws/8-138.html">as added June 13, 1990, D.C. Law 8-138, § 2(e), 37 DCR 2638</a>; <a class="internal-link" href="/dc/council/laws/19-317.html">June 11, 2013, D.C. Law 19-317, § 252(f), 60 DCR 2064</a>.)
    </div>
                      <div class="line subheading">Prior Codifications</div>
                      <div class="line" style="text-indent: 1.5em">1981 Ed., § 33-543a.</div>
                      <div class="line subheading">Effect of Amendments</div>
                      <div class="line" style="text-indent: 1.5em">The 2013 amendment by <a class="internal-link" href="/dc/council/laws/19-317.html">D.C. Law 19-317</a> substituted “not more than the amount set forth in § <a class="internal-link" href="/dc/council/code/sections/22-3571.01.html">22-3571.01</a>” for “not more than $500,000” in (b).</div>
                      <div class="line subheading">Emergency Legislation</div>
                      <div class="line" style="text-indent: 1.5em">For temporary (90 days) amendment of this section, see § 252(f) of the Criminal Fine Proportionality Emergency Act of 2013 (D.C. Act 20-45, April 1, 2013,  60 DCR 5400, 20 DCSTAT 1300).</div>
                      <div class="line subheading">Editor's Notes</div>
                      <div class="line" style="text-indent: 1.5em">Mayor to implement public information program: See Historical and Statutory Notes following § <a class="internal-link" href="/dc/council/code/sections/48-901.02.html">48-901.02</a>.</div>
                      <div class="line" style="text-indent: 1.5em">Applicability of <a class="internal-link" href="/dc/council/laws/19-317.html">D.C. Law 19-317</a>: Section 401 of <a class="internal-link" href="/dc/council/laws/19-317.html">D.C. Law 19-317</a> provided that the act shall apply only to offenses committed on or after June 11, 2013.</div>
                    </div>
                  </div>
            <hr/>
            <div class="line heading heading-2" style="text-indent: 0em">
              <p>
                <span class="" style="">§ 48–904.04. Penalties under other laws.</span>
              </p>
            </div>
            <div>
                    <div class="line-group primary-content">
                      <div class="line" style="text-indent: 1.25em">Any penalty imposed for violation of this chapter is in addition to, and not in lieu of, any civil or administrative penalty or sanction otherwise authorized by law.</div>
                    </div>
                    <div class="line-group annotations">
                      <div class="line" style="text-indent: 1.5em">
      (<a class="internal-link" href="/dc/council/laws/4-29.html">Aug. 5, 1981, D.C. Law 4-29, § 404, 28 DCR 3081</a>.)
    </div>
                      <div class="line subheading">Prior Codifications</div>
                      <div class="line" style="text-indent: 1.5em">1981 Ed., § 33-544.</div>
                    </div>
                  </div>
            <hr/>
            <div class="line heading heading-2" style="text-indent: 0em">
              <p>
                <span class="" style="">§ 48–904.05. Effect of acquittal or conviction under federal law.</span>
              </p>
            </div>
            <div>
                    <div class="line-group primary-content">
                      <div class="line" style="text-indent: 1.25em">No person shall be prosecuted for a violation of any provision of this chapter if such person has been acquitted or convicted under any United States statute governing the sale or distribution of controlled substances of the same act or omission which is alleged to constitute a violation of this chapter.</div>
                    </div>
                    <div class="line-group annotations">
                      <div class="line" style="text-indent: 1.5em">
      (<a class="internal-link" href="/dc/council/laws/4-29.html">Aug. 5, 1981, D.C. Law 4-29, § 405, 28 DCR 3081</a>.)
    </div>
                      <div class="line subheading">Prior Codifications</div>
                      <div class="line" style="text-indent: 1.5em">1981 Ed., § 33-545.</div>
                    </div>
                  </div>
            <hr/>
            <div class="line heading heading-2" style="text-indent: 0em">
              <p>
                <span class="" style="">§ 48–904.06. Distribution to minors.</span>
              </p>
            </div>
            <div>
                    <div class="line-group primary-content">
                      <div class="line" style="text-indent: 1.25em">
                        <p>
                          <span class="level-num">(a)</span>
                          <span>Any person who is 21 years of age or over and who violates § <a class="internal-link" href="/dc/council/code/sections/48-904.01.html">48-904.01</a>(a) by distributing a controlled substance which is listed in Schedule I or II and which is a narcotic drug, phencyclidine, or a phencyclidine immediate precursor to a person who is under 18 years of age may be punished by the fine authorized by § <a class="internal-link" href="/dc/council/code/sections/48-904.01.html">48-904.01</a>(a)(2)(A), by a term of imprisonment of up to twice that authorized by § <a class="internal-link" href="/dc/council/code/sections/48-904.01.html">48-904.01</a>(a)(2)(A), or by both.</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 1.25em">
                        <p>
                          <span class="level-num">(b)</span>
                          <span>Any person who is 21 years of age or over and who violates § <a class="internal-link" href="/dc/council/code/sections/48-904.01.html">48-904.01</a>(a) by distributing for remuneration any other controlled substance which is listed in Schedule I, II, III, IV, or V, except for phencyclidine or a phencyclidine immediate precursor, to a person who is under 18 years of age may be punished by the fine authorized by § <a class="internal-link" href="/dc/council/code/sections/48-904.01.html">48-904.01</a>(a)(2)(B), (C), or (D), respectively, by a term of imprisonment up to twice that authorized by § <a class="internal-link" href="/dc/council/code/sections/48-904.01.html">48-904.01</a>(a)(2)(B), (C), or (D), respectively, or both.</span>
                        </p>
                      </div>
                    </div>
                    <div class="line-group annotations">
                      <div class="line" style="text-indent: 1.5em">
      (<a class="internal-link" href="/dc/council/laws/4-29.html">Aug. 5, 1981, D.C. Law 4-29, § 406, 28 DCR 3081</a>; <a class="internal-link" href="/dc/council/laws/5-171.html">Mar. 15, 1985, D.C. Law 5-171, § 2(b), 32 DCR 730</a>.)
    </div>
                      <div class="line subheading">Section References</div>
                      <div class="line" style="text-indent: 1.5em">This section is referenced in § <a class="internal-link" href="/dc/council/code/sections/48-904.08.html">48-904.08</a>.</div>
                      <div class="line subheading">Prior Codifications</div>
                      <div class="line" style="text-indent: 1.5em">1981 Ed., § 33-546.</div>
                    </div>
                  </div>
            <hr/>
            <div class="line heading heading-2" style="text-indent: 0em">
              <p>
                <span class="" style="">§ 48–904.07. Enlistment of minors to distribute.</span>
              </p>
            </div>
            <div>
                    <div class="line-group primary-content">
                      <div class="line" style="text-indent: 1.25em">
                        <p>
                          <span class="level-num">(a)</span>
                          <span>Any person who is 21 years of age or over and who enlists, hires, contracts, or encourages any person under 18 years of age to sell or distribute any controlled substance, in violation of § <a class="internal-link" href="/dc/council/code/sections/48-904.01.html">48-904.01</a>(a), for the profit or benefit of such person who enlists, hires, contracts, or encourages this criminal activity shall be punished for sale or distribution in the same manner as if that person directly sold or distributed the controlled substance.</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 1.25em">
                        <p>
                          <span class="level-num">(b)</span>
                          <span>Anyone found guilty of subsection (a) of this section shall be subject to the following additional penalties:</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 2.5em">
                        <p>
                          <span class="level-num">(1)</span>
                          <span>Upon a first conviction the party may be imprisoned for not more than 10 years, fined not more than the amount set forth in § <a class="internal-link" href="/dc/council/code/sections/22-3571.01.html">22-3571.01</a>, or both;</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 2.5em">
                        <p>
                          <span class="level-num">(2)</span>
                          <span>Upon a second or subsequent conviction, the party may be imprisoned for not more than 20 years, fined not more than the amount set forth in § <a class="internal-link" href="/dc/council/code/sections/22-3571.01.html">22-3571.01</a>, or both.</span>
                        </p>
                      </div>
                    </div>
                    <div class="line-group annotations">
                      <div class="line" style="text-indent: 1.5em">
      (<a class="internal-link" href="/dc/council/laws/4-29.html">Aug. 5, 1981, D.C. Law 4-29, § 407, 28 DCR 3081</a>; <a class="internal-link" href="/dc/council/laws/19-317.html">June 11, 2013, D.C. Law 19-317, § 252(d), 60 DCR 2064</a>.)
    </div>
                      <div class="line subheading">Prior Codifications</div>
                      <div class="line" style="text-indent: 1.5em">1981 Ed., § 33-547.</div>
                      <div class="line subheading">Effect of Amendments</div>
                      <div class="line" style="text-indent: 1.5em">The 2013 amendment by <a class="internal-link" href="/dc/council/laws/19-317.html">D.C. Law 19-317</a> substituted “not more than the amount set forth in § <a class="internal-link" href="/dc/council/code/sections/22-3571.01.html">22-3571.01</a>” for “not more than $10,000” in (b)(1), and for “not more than $20,000” in (b)(2).</div>
                      <div class="line subheading">Emergency Legislation</div>
                      <div class="line" style="text-indent: 1.5em">For temporary (90 days) amendment of this section, see § 252(d) of the Criminal Fine Proportionality Emergency Act of 2013 (D.C. Act 20-45, April 1, 2013,  60 DCR 5400, 20 DCSTAT 1300).</div>
                      <div class="line subheading">Editor's Notes</div>
                      <div class="line" style="text-indent: 1.5em">Applicability of <a class="internal-link" href="/dc/council/laws/19-317.html">D.C. Law 19-317</a>: Section 401 of <a class="internal-link" href="/dc/council/laws/19-317.html">D.C. Law 19-317</a> provided that the act shall apply only to offenses committed on or after June 11, 2013.</div>
                    </div>
                  </div>
            <hr/>
            <div class="line heading heading-2" style="text-indent: 0em">
              <p>
                <span class="" style="">§ 48–904.07a. Drug free zones.</span>
              </p>
            </div>
            <div>
                    <div class="line-group primary-content">
                      <div class="line" style="text-indent: 1.25em">
                        <p>
                          <span class="level-num">(a)</span>
                          <span>All areas within 1000 feet of an appropriately identified public or private day care center, elementary school, vocational school, secondary school, junior college, college, or university, or any public swimming pool, playground, video arcade, youth center, or public library, or in and around public housing, as defined in section 3(1) of the United States Housing Act of 1937, approved August 22, 1974 (88 Stat. 654; 42 U.S.C. § 1437a(b)), the development or administration of which is assisted by Department of Housing and Urban Development, or in or around housing that is owned, operated, or financially assisted by the District of Columbia Housing Authority, or an event sponsored by any of the above entities shall be declared a drug free zone. For the purposes of this subsection, the term “appropriately identified” means that there is a sign that identifies the building or area as a drug free zone.</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 1.25em">
                        <p>
                          <span class="level-num">(b)</span>
                          <span>Any person who violates § <a class="internal-link" href="/dc/council/code/sections/48-904.01.html">48-904.01</a>(a) by distributing or possessing with the intent to distribute a controlled substance which is listed in Schedule I, II, III, IV, or V within a drug free zone shall be punished by a fine up to twice that otherwise authorized by this chapter to be imposed, by a term of imprisonment up to twice that otherwise imposed, or both.</span>
                        </p>
                      </div>
                    </div>
                    <div class="line-group annotations">
                      <div class="line" style="text-indent: 1.5em">
      (<a class="internal-link" href="/dc/council/laws/4-29.html">Aug. 5, 1981, D.C. Law 4-29, § 407a</a>; <a class="internal-link" href="/dc/council/laws/10-229.html">as added Mar. 21, 1995, D.C. Law 10-229, § 2(b), 42 DCR 9</a>; <a class="internal-link" href="/dc/council/laws/12-146.html">Sept. 18, 1998, D.C. Law 12-146, § 2, 45 DCR 3851</a>; <a class="internal-link" href="/dc/council/laws/15-353.html">Apr. 13, 2005, D.C. Law 15-353, § 702, 52 DCR 2331</a>; <a class="internal-link" href="/dc/council/laws/16-306.html">Apr. 24, 2007, D.C. Law 16-306, § 225, 53 DCR 8610</a>.)
    </div>
                      <div class="line subheading">Prior Codifications</div>
                      <div class="line" style="text-indent: 1.5em">1981 Ed., § 33-547.1.</div>
                      <div class="line subheading">Effect of Amendments</div>
                      <div class="line" style="text-indent: 1.5em"><a class="internal-link" href="/dc/council/laws/15-353.html">D.C. Law 15-353</a>, in subsec. (a), inserted “public charter school,” following “secondary school,”.</div>
                      <div class="line" style="text-indent: 1.5em"><a class="internal-link" href="/dc/council/laws/16-306.html">D.C. Law 16-306</a> rewrote subsec. (a), which had read as follows: “(a) All areas within 1000 feet of a public or private day care center, elementary school, vocational school, secondary school, public charter school, junior college, college, or university, or any public swimming pool, playground, video arcade, youth center, public library, or in and around public housing, as defined in section 3(1) of the United States Housing Act of 1937, approved August 22, 1974 (88 Stat. 654;  42 U.S.C. § 1437a(b)), the development or administration of which is assisted by the United States Department of Housing and Urban Development, or an event sponsored by any of the above entities shall be declared a drug free zone.”</div>
                      <div class="line subheading">Temporary Amendment of Section</div>
                      <div class="line" style="text-indent: 1.5em">For temporary (225 day) amendment of section, see § 702 of the Child and Youth, Safety and Health Omnibus Temporary Amendment Act of 2002 (<a class="internal-link" href="/dc/council/laws/14-164.html">D.C. Law 14-164</a>, June 25, 2002, law notification  49 DCR 6500).</div>
                      <div class="line" style="text-indent: 1.5em">For temporary (225 day) amendment of section, see § 702 of the Child and Youth, Safety and Health Omnibus Temporary Amendment Act of 2003 (<a class="internal-link" href="/dc/council/laws/15-2.html">D.C. Law 15-2</a>, May 3, 2003, law notification  50 DCR 3782).</div>
                      <div class="line" style="text-indent: 1.5em">For temporary (225 day) addition of section, see § 702 of the Child and Youth, Safety and Health Omnibus Temporary Amendment Act of 2004 (<a class="internal-link" href="/dc/council/laws/15-117.html">D.C. Law 15-117</a>, March 30, 2004, law notification  51 DCR 3804).</div>
                      <div class="line" style="text-indent: 1.5em">For temporary (225 day) addition of section, see § 702 of the Child and Youth, Safety and Health Omnibus Second Temporary Amendment Act of 2004 (<a class="internal-link" href="/dc/council/laws/15-319.html">D.C. Law 15-319</a>, on April 8, 2005, law notification  52 DCR 4708).</div>
                      <div class="line subheading">Emergency Legislation</div>
                      <div class="line" style="text-indent: 1.5em">For temporary (90 day) amendment of section, see § 702 of Child and Youth, Safety And Health Omnibus Emergency Amendment Act of 2002 (D.C. Act 14-310, March 26, 2002,  49 DCR 3420).</div>
                      <div class="line" style="text-indent: 1.5em">For temporary (90 day) amendment of section, see § 702 of Child and Youth, Safety and Health Omnibus Emergency Amendment Act of 2003 (D.C. Act 15-3, January 22, 2003,  50 DCR 1426).</div>
                      <div class="line" style="text-indent: 1.5em">For temporary (90 day) amendment of section, see § 702 of Child and Youth, Safety and Health Omnibus Congressional Review Emergency Amendment Act of 2003 (D.C. Act 15-71, April 16, 2003,  50 DCR 3593).</div>
                      <div class="line" style="text-indent: 1.5em">For temporary (90 day) amendment of section, see § 702 of Child and Youth, Safety and Health Omnibus Second Emergency Amendment Act of 2003 (D.C. Act 15-279, December 18, 2003,  51 DCR 60).</div>
                      <div class="line" style="text-indent: 1.5em">For temporary (90 day) amendment of section, see § 702 of Child and Youth, Safety and Health Omnibus Congressional Review Emergency Amendment Act of 2004 (D.C. Act 15-407, March 18, 2004,  51 DCR 3659).</div>
                      <div class="line" style="text-indent: 1.5em">For temporary (90 day) amendment of section, see § 702 of Child and Youth, Safety and Health Omnibus Emergency Amendment Act of 2004 (D.C. Act 15-630, November 30, 2004,  52 DCR 1143).</div>
                      <div class="line" style="text-indent: 1.5em">For temporary (90 day) amendment of section, see § 702 of Child and Youth, Safety and Health Omnibus Congressional Review Emergency Amendment Act of 2005 (D.C. Act 16-30, February 17, 2005,  52 DCR 2993).</div>
                      <div class="line" style="text-indent: 1.5em">For temporary (90 day) amendment of section, see § 225 of Omnibus Public Safety Emergency Amendment Act of 2006 (D.C. Act 16-445, July 19, 2006,  53 DCR 6443).</div>
                      <div class="line" style="text-indent: 1.5em">For temporary (90 day) amendment of section, see § 225 of Omnibus Public Safety Congressional Review Emergency Amendment Act of 2006 (D.C. Act 16-490, October 18, 2006,  53 DCR 8686).</div>
                      <div class="line" style="text-indent: 1.5em">For temporary (90 day) amendment of section, see § 225 of Omnibus Public Safety Congressional Review Emergency Amendment Act of 2007 (D.C. Act 17-10, January 16, 2007,  54 DCR 1479).</div>
                      <div class="line" style="text-indent: 1.5em">For temporary (90 day) amendment of section, see § 225 of Omnibus Public Safety Second Congressional Review Emergency Amendment Act of 2007 (D.C. Act 17-25, April 19, 2007,  54 DCR 4036).</div>
                    </div>
                  </div>
            <hr/>
            <div class="line heading heading-2" style="text-indent: 0em">
              <p>
                <span class="" style="">§ 48–904.08. Second or subsequent offenses.</span>
              </p>
            </div>
            <div>
                    <div class="line-group primary-content">
                      <div class="line" style="text-indent: 1.25em">
                        <p>
                          <span class="level-num">(a)</span>
                          <span>Any person convicted under this chapter of a second or subsequent offense may be imprisoned for a term up to twice the term otherwise authorized, fined an amount up to twice that otherwise authorized, or both.</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 1.25em">
                        <p>
                          <span class="level-num">(b)</span>
                          <span>For purposes of this section, an offense is considered a second or subsequent offense if, prior to commission of the offense, the offender has at any time been convicted under this chapter or under any statute of the United States or of any state relating to a controlled substance.</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 1.25em">
                        <p>
                          <span class="level-num">(c)</span>
                          <span>A person who is convicted of violating § <a class="internal-link" href="/dc/council/code/sections/48-904.06.html">48-904.06</a> may be sentenced according to the provisions of § <a class="internal-link" href="/dc/council/code/sections/48-904.06.html">48-904.06</a> or according to the provisions of this section, but not both.</span>
                        </p>
                      </div>
                    </div>
                    <div class="line-group annotations">
                      <div class="line" style="text-indent: 1.5em">
      (<a class="internal-link" href="/dc/council/laws/4-29.html">Aug. 5, 1981, D.C. Law 4-29, § 408, 28 DCR 3081</a>; <a class="internal-link" href="/dc/council/laws/19-320.html">June 19, 2013, D.C. Law 19-320, § 301(f), 60 DCR 3390</a>.)
    </div>
                      <div class="line subheading">Section References</div>
                      <div class="line" style="text-indent: 1.5em">This section is referenced in § <a class="internal-link" href="/dc/council/code/sections/48-904.01.html">48-904.01</a>.</div>
                      <div class="line subheading">Prior Codifications</div>
                      <div class="line" style="text-indent: 1.5em">1981 Ed., § 33-548.</div>
                      <div class="line subheading">Effect of Amendments</div>
                      <div class="line" style="text-indent: 1.5em">The 2013 amendment by <a class="internal-link" href="/dc/council/laws/19-320.html">D.C. Law 19-320</a> substituted “convicted under this chapter of a second or subsequent offense” for “convicted of a second or subsequent offense under this chapter” in (a); and substituted “a controlled substance” for “narcotic drugs, depressants, stimulants, or hallucinogenic drugs” in (b).</div>
                      <div class="line subheading">Emergency Legislation</div>
                      <div class="line" style="text-indent: 1.5em">For temporary amendment of section, see § 301(f) of the Omnibus Criminal Code Amendments Emergency Amendment Act of 2012 (D.C. Act 19-599, January 14, 2013,  60 DCR 1017).</div>
                      <div class="line" style="text-indent: 1.5em">For temporary (90 days) amendment of this section, see § 301(f) of the Omnibus Criminal Code Amendment Congressional Review Emergency Act of 2013 (D.C. Act 20-44, April 1, 2013,  60 DCR 5381, 20 DCSTAT 1281).</div>
                    </div>
                  </div>
            <hr/>
            <div class="line heading heading-2" style="text-indent: 0em">
              <p>
                <span class="" style="">§ 48–904.09. Attempt; conspiracy.</span>
              </p>
            </div>
            <div>
                    <div class="line-group primary-content">
                      <div class="line" style="text-indent: 1.25em">Any person who attempts or conspires to commit any offense defined in this subchapter is punishable by imprisonment or fine or both which may not exceed the maximum punishment prescribed for the offense, the commission of which was the object of the attempt or conspiracy.</div>
                    </div>
                    <div class="line-group annotations">
                      <div class="line" style="text-indent: 1.5em">
      (<a class="internal-link" href="/dc/council/laws/4-29.html">Aug. 5, 1981, D.C. Law 4-29, § 409, 28 DCR 3081</a>.)
    </div>
                      <div class="line subheading">Prior Codifications</div>
                      <div class="line" style="text-indent: 1.5em">1981 Ed., § 33-549.</div>
                    </div>
                  </div>
            <hr/>
            <div class="line heading heading-2" style="text-indent: 0em">
              <p>
                <span class="" style="">§ 48–904.10. Possession of drug paraphernalia.</span>
              </p>
            </div>
            <div>
                    <div class="line-group primary-content">
                      <div class="line" style="text-indent: 1.25em">Whoever, except for a physician, dentist, chiropodist, or veterinarian licensed in the District of Columbia or a state, registered nurse, registered embalmer, manufacturer or dealer in embalming supplies, wholesale druggist, industrial user, official of any government having possession of the proscribed articles by reason of his or her official duties, nurse or medical laboratory technician acting under the direction of a physician or dentist, employees of a hospital or medical facility acting under the direction of its superintendent or officer in immediate charge, person engaged in chemical, clinical, pharmaceutical or other scientific research, acting in the course of their professional duties, has in his or her possession a hypodermic needle, hypodermic syringe, or other instrument that has on or in it any quantity (including a trace) of a controlled substance with intent to use it for administration of a controlled substance by subcutaneous injection in a human being shall be fined not more than the amount set forth in § <a class="internal-link" href="/dc/council/code/sections/22-3571.01.html">22-3571.01</a> or imprisoned for not more than 180 days, or both.</div>
                    </div>
                    <div class="line-group annotations">
                      <div class="line" style="text-indent: 1.5em">
      (<a class="internal-link" href="/dc/council/laws/4-29.html">Aug. 5, 1981, D.C. Law 4-29, § 410, 28 DCR 3081</a>; <a class="internal-link" href="/dc/council/laws/10-151.html">Aug. 20, 1994, D.C. Law 10-151, § 112(b), 41 DCR 2608</a>; <a class="internal-link" href="/dc/council/laws/19-317.html">June 11, 2013, D.C. Law 19-317, § 252(e), 60 DCR 2064</a>.)
    </div>
                      <div class="line subheading">Cross References</div>
                      <div class="line" style="text-indent: 1.5em">Needle exchange program, privileges and immunities, see § <a class="internal-link" href="/dc/council/code/sections/48-1103.01.html">48-1103.01</a>.</div>
                      <div class="line subheading">Section References</div>
                      <div class="line" style="text-indent: 1.5em">This section is referenced in § <a class="internal-link" href="/dc/council/code/sections/7-403.html">7-403</a> and § <a class="internal-link" href="/dc/council/code/sections/48-1103.01.html">48-1103.01</a>.</div>
                      <div class="line subheading">Prior Codifications</div>
                      <div class="line" style="text-indent: 1.5em">1981 Ed., § 33-550.</div>
                      <div class="line subheading">Effect of Amendments</div>
                      <div class="line" style="text-indent: 1.5em">The 2013 amendment by <a class="internal-link" href="/dc/council/laws/19-317.html">D.C. Law 19-317</a> substituted “not more than the amount set forth in § <a class="internal-link" href="/dc/council/code/sections/22-3571.01.html">22-3571.01</a>” for “not more than $1,000”.</div>
                      <div class="line subheading">Emergency Legislation</div>
                      <div class="line" style="text-indent: 1.5em">For temporary (90 days) amendment of this section, see § 252(e) of the Criminal Fine Proportionality Emergency Act of 2013 (D.C. Act 20-45, April 1, 2013,  60 DCR 5400, 20 DCSTAT 1300).</div>
                      <div class="line subheading">Editor's Notes</div>
                      <div class="line" style="text-indent: 1.5em">Applicability of <a class="internal-link" href="/dc/council/laws/19-317.html">D.C. Law 19-317</a>: Section 401 of <a class="internal-link" href="/dc/council/laws/19-317.html">D.C. Law 19-317</a> provided that the act shall apply only to offenses committed on or after June 11, 2013.</div>
                    </div>
                  </div>
            <hr/>
            <div class="line heading heading-1" style="text-indent: 0em">
              <p>
                <span class="" style="">Subchapter V. Enforcement and Administrative Provisions.</span>
              </p>
            </div>
            <div class="line heading heading-2" style="text-indent: 0em">
              <p>
                <span class="" style="">§ 48–905.01. Cooperative arrangements; confidentiality.</span>
              </p>
            </div>
            <div>
                    <div class="line-group primary-content">
                      <div class="line" style="text-indent: 1.25em">
                        <p>
                          <span class="level-num">(a)</span>
                          <span>The Mayor shall cooperate with the Board of Education, federal agencies, and other state agencies in discharging the Mayor’s responsibilities concerning traffic in controlled substances and in suppressing the abuse of controlled substances. To this end, the Mayor may:</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 2.5em">
                        <p>
                          <span class="level-num">(1)</span>
                          <span>Arrange for the exchange of general information among governmental officials concerning the general use and abuse of controlled substances; and</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 2.5em">
                        <p>
                          <span class="level-num">(2)</span>
                          <span>Coordinate and cooperate in training programs concerning controlled substance law enforcement within the District of Columbia.</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 1.25em">
                        <p>
                          <span class="level-num">(b)</span>
                          <span>Results, information, and evidence received from the D.E.A. relating to the regulatory functions of this chapter, including results of inspections conducted by it, may be relied and acted upon by the Mayor in the exercise of the Mayor’s regulatory functions under this chapter.</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 1.25em">
                        <p>
                          <span class="level-num">(c)</span>
                          <span class="level-num">(1)</span>
                          <span>A practitioner engaged in medical practice or research shall not nor shall be compelled to:</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 3.75em">
                        <p>
                          <span class="level-num">(A)</span>
                          <span>Furnish to the Mayor the name or identity of a patient or research subject without the prior consent of the patient or research subject; or</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 3.75em">
                        <p>
                          <span class="level-num">(B)</span>
                          <span>Furnish the name or identity of an individual that the practitioner is obligated to keep confidential in any civil, criminal, administrative, legislative, or other proceedings in the District of Columbia without prior consent of such individual.</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 2.5em">
                        <p>
                          <span class="level-num">(2)</span>
                          <span>This section per se shall not limit, in a criminal investigation or prosecution or in an administrative proceeding by the Commission on Licensure to Practice the Healing Art in the District of Columbia, the authority to subpoena dispensing logs or other records of a practitioner containing information concerning the sale, prescription, or distribution of controlled substances under this chapter. The court may order sealed any information furnished without consent, pursuant to the provisions of this subsection.</span>
                        </p>
                      </div>
                    </div>
                    <div class="line-group annotations">
                      <div class="line" style="text-indent: 1.5em">
      (<a class="internal-link" href="/dc/council/laws/4-29.html">Aug. 5, 1981, D.C. Law 4-29, § 501, 28 DCR 3081</a>.)
    </div>
                      <div class="line subheading">Prior Codifications</div>
                      <div class="line" style="text-indent: 1.5em">1981 Ed., § 33-551.</div>
                      <div class="line subheading">Delegation of Authority</div>
                      <div class="line" style="text-indent: 1.5em">Delegation of Authority to implement <a class="internal-link" href="/dc/council/laws/4-29.html">D.C. Law 4-29</a>, the “District of Columbia Uniformed Controlled Substances Act of 1981”, see Mayor’s Order 98-49, April 15, 1998 ( 45 DCR 2694).</div>
                    </div>
                  </div>
            <hr/>
            <div class="line heading heading-2" style="text-indent: 0em">
              <p>
                <span class="" style="">§ 48–905.02. Forfeitures.</span>
              </p>
            </div>
            <div>
                    <div class="line-group primary-content">
                      <div class="line" style="text-indent: 1.25em">
                        <p>
                          <span class="level-num">(a)</span>
                          <span>The following property is subject to forfeiture if determined to be used in furtherance of or as proceeds of the manufacture or distribution of a controlled substance as prohibited by §  48-904.01(a): containers, conveyances, equipment, raw materials, real property, money, currency, securities, negotiable instruments, instrumentalities, books, records, and research products, including formulas and data.</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 1.25em">
                        <p>
                          <span class="level-num">(b)</span>
                          <span>Contraband is not subject to forfeiture under this section, but may be seized and disposed of in accordance with applicable law; provided, that controlled substances shall be retained until the prosecutorial authority responsible for prosecuting a violation under this chapter certifies that such controlled substances are no longer needed as evidence.</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 1.25em">
                        <p>
                          <span class="level-num">(c)</span>
                          <span>No property shall be subject to forfeiture for conduct involving only a violation of § <a class="internal-link" href="/dc/council/code/sections/48-904.01.html">48-904.01</a>(d).</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 1.25em">
                        <p>
                          <span class="level-num">(d)</span>
                          <span>All seizures and forfeitures under this section shall follow the standards and procedures set forth in <a class="internal-link" href="/dc/council/laws/20-278.html">D.C. Law 20-278</a>.</span>
                        </p>
                      </div>
                    </div>
                    <div class="line-group annotations">
                      <div class="line" style="text-indent: 1.5em">
      (<a class="internal-link" href="/dc/council/laws/4-29.html">Aug. 5, 1981, D.C. Law 4-29, § 502, 28 DCR 3081</a>; <a class="internal-link" href="/dc/council/laws/4-96.html">Apr. 3, 1982, D.C. Law 4-96, § 2, 29 DCR 762</a>; <a class="internal-link" href="/dc/council/laws/7-162.html">Sept. 29, 1988, D.C. Law 7-162, § 2, 35 DCR 5733</a>; Dec. 12, 1989, 103 Stat. 1901, Pub. L. 101-223, § 6; <a class="internal-link" href="/dc/council/laws/8-138.html">June 13, 1990, D.C. Law 8-138, § 2(d), 37 DCR 2638</a>; <a class="internal-link" href="/dc/council/laws/9-155.html">Sept. 26, 1992, D.C. Law 9-155, § 2(a), 39 DCR 5679</a>; <a class="internal-link" href="/dc/council/laws/9-253.html">Mar. 25, 1993, D.C. Law 9-253, § 3, 40 DCR 790</a>; <a class="internal-link" href="/dc/council/laws/10-255.html">May 16, 1995, D.C. Law 10-255, § 25, 41 DCR 5193</a>; <a class="internal-link" href="/dc/council/laws/12-284.html">June 12, 1999, D.C. Law 12-284, § 10(c), 46 DCR 1328</a>; <a class="internal-link" href="/dc/council/laws/13-160.html">October 4, 2000, D.C. Law 13-160, § 403(b), 47 DCR 4619</a>; <a class="internal-link" href="/dc/council/laws/19-21.html">Sept. 14, 2011, D.C. Law 19-21, § 9067(a), 58 DCR 6226</a>; <a class="internal-link" href="/dc/council/laws/19-171.html">Sept. 26, 2012, D.C. Law 19-171, § 98(d), 59 DCR 6190</a>; <a class="internal-link" href="/dc/council/laws/20-278.html">June 16, 2015, D.C. Law 20-278, § 201(b), 62 DCR 1920</a>.)
    </div>
                      <div class="line subheading">Section References</div>
                      <div class="line" style="text-indent: 1.5em">This section is referenced in § <a class="internal-link" href="/dc/council/code/sections/7-2507.06a.html">7-2507.06a</a>, § <a class="internal-link" href="/dc/council/code/sections/22-902.html">22-902</a>, and § <a class="internal-link" href="/dc/council/code/sections/22-2723.html">22-2723</a>.</div>
                      <div class="line subheading">Prior Codifications</div>
                      <div class="line" style="text-indent: 1.5em">1981 Ed., § 33-552.</div>
                      <div class="line subheading">Effect of Amendments</div>
                      <div class="line" style="text-indent: 1.5em"><a class="internal-link" href="/dc/council/laws/13-160.html">D.C. Law 13-160</a> rewrote subsec. (b) which formerly provided: “(b) Property subject to forfeiture under this chapter may be seized by law enforcement officials, as designated by the Mayor, or designated civilian employees of the Metropolitan Police Department, upon process issued by the Superior Court of the District of Columbia having jurisdiction over the property, or without process if authorized by other law.”</div>
                      <div class="line" style="text-indent: 1.5em"><a class="internal-link" href="/dc/council/laws/19-21.html">D.C. Law 19-21</a> rewrote subsec. (d)(3)(B), which formerly read:</div>
                      <div class="line" style="text-indent: 1.5em">“(B) Any person claiming the property may, at any time within 30 days from the date of receipt of notice of seizure, file with the Mayor a claim stating his or her interest in the property. Upon the filing of a claim, the claimant shall give a bond to the District government in the penal sum of $2,500 or 10% of the fair market value of the claimed property (as appraised by the Chief of the Metropolitan Police Department), whichever is lower, but not less than $250, with sureties to be approved by the Mayor. In case of forfeiture of the claimed property, the costs and expenses of the forfeiture proceedings shall be deducted from the bonds. Any costs that exceed the amount of the bond shall be paid by the claimant. In determining the fair market value of the property seized, the Chief of the Metropolitan Police Department shall consider any verifiable and reasonable evidence of value that the claimant may present. The balance of the proceeds shall be transferred to the Drug Interdiction and Demand Reduction Fund (’Fund’) created by subchapter VII of this chapter. The Fund shall remain available until expended regardless of the expiration of the fiscal year in which the proceeds were collected. The Fund shall be distributed in the following descending order of priority:</div>
                      <div class="line" style="text-indent: 1.5em">“ (i) To fund law enforcement activities of the Metropolitan Police Department of the District of Columbia, except that, beginning October 1, 1990, not more than 49% of the total amount deposited to the Fund in the immediately preceding quarter-year period shall be used for this purpose in the next succeeding quarter-year period; and</div>
                      <div class="line" style="text-indent: 1.5em">“(ii) To provide grants to fund community-based drug education, prevention, and demand reduction programs;”</div>
                      <div class="line" style="text-indent: 1.5em">The 2012 amendment by <a class="internal-link" href="/dc/council/laws/19-171.html">D.C. Law 19-171</a> validated a previously made technical correction.</div>
                      <div class="line" style="text-indent: 1.5em">The 2015 amendment by <a class="internal-link" href="/dc/council/laws/20-278.html">D.C. Law 20-278</a> rewrote the section.</div>
                      <div class="line subheading">Temporary Legislation</div>
                      <div class="line" style="text-indent: 1.5em">For temporary (225 day) amendment of section, see § 10(c) of Metropolitan Police Department Civilianization Temporary Amendment Act of 1998 (<a class="internal-link" href="/dc/council/laws/12-282.html">D.C. Law 12-282</a>, May 28, 1999, law notification  46 DCR 5148).</div>
                      <div class="line subheading">Emergency Legislation</div>
                      <div class="line" style="text-indent: 1.5em">For temporary amendment of section, see § 10(c) of the Metropolitan Police Department Civilianization and Street Solicitation for Prostitution Emergency Amendment Act of 1998 (D.C. Act 12-428, August 6, 1998,  45 DCR 5884), § 10(c) of the Metropolitan Police Department Civilianization Legislative Review Emergency Amendment Act of 1998 (D.C. Act 12-506, November 10, 1998,  45 DCR 45 8139), and § 10(c) of the Metropolitan Police Department Civilianization Congressional Review Emergency Amendment Act of 1999 (D.C. Act 13-13, February 8, 1999,  46 DCR 2333).</div>
                      <div class="line subheading">References in Text</div>
                      <div class="line" style="text-indent: 1.5em">Section 23-527, referred to in subsec. (a-1), did not exist in the 1981 Edition at the time of the recodification into the 2001 Edition.</div>
                      <div class="line subheading">Editor's Notes</div>
                      <div class="line" style="text-indent: 1.5em">Mayor to implement public information program: See Historical and Statutory Notes following § <a class="internal-link" href="/dc/council/code/sections/48-901.02.html">48-901.02</a>.</div>
                      <div class="line" style="text-indent: 1.5em"><a class="internal-link" href="/dc/council/laws/20-278.html">D.C. Law 20-278</a>, referred to in (d), enacted Chapter 3 of Title 41 (§ <a class="internal-link" href="/dc/council/code/sections/41-301.html">41-301</a> et seq.), made amendments to the criminal offenses in §§ <a class="internal-link" href="/dc/council/code/sections/48-901.02.html">48-901.02</a> and <a class="internal-link" href="/dc/council/code/sections/48-905.02.html">48-905.02</a>, and made conforming amendments to §§ <a class="internal-link" href="/dc/council/code/sections/7-2507.06a.html">7-2507.06a</a>, <a class="internal-link" href="/dc/council/code/sections/8-905.html">8-905</a>, <a class="internal-link" href="/dc/council/code/sections/22-902.html">22-902</a>, <a class="internal-link" href="/dc/council/code/sections/22-1705.html">22-1705</a>, <a class="internal-link" href="/dc/council/code/sections/22-2723.html">22-2723</a>, <a class="internal-link" href="/dc/council/code/sections/32-1343.html">32-1343</a>, <a class="internal-link" href="/dc/council/code/sections/48-905.03.html">48-905.03</a>, and <a class="internal-link" href="/dc/council/code/sections/50-1501.04.html">50-1501.04</a>.</div>
                    </div>
                  </div>
            <hr/>
            <div class="line heading heading-2" style="text-indent: 0em">
              <p>
                <span class="" style="">§ 48–905.03. Burden of proof.</span>
              </p>
            </div>
            <div>
                    <div class="line-group primary-content">
                      <div class="line" style="text-indent: 1.25em">
                        <p>
                          <span class="level-num">(a)</span>
                          <span>It is not necessary for the prosecution to negate any exemption or exception in this chapter in any complaint, information, indictment, or other pleading or in any trial, hearing, or other proceeding under this chapter. The burden of proof of any exemption or exception is upon the person claiming it.</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 1.25em">
                        <p>
                          <span class="level-num">(b)</span>
                          <span>In the absence of proof that a person is the duly authorized holder of an appropriate registration or order form issued under this chapter, he or she is presumed not to be the holder of the registration or form. The burden of proof is upon him or her to rebut the presumption.</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 1.25em">
                        <p>
                          <span class="level-num">(c)</span>
                          <span>Subsections (a) and (b) of this section shall not apply to <a class="internal-link" href="/dc/council/laws/20-278.html">D.C. Law 20-278</a>.</span>
                        </p>
                      </div>
                    </div>
                    <div class="line-group annotations">
                      <div class="line" style="text-indent: 1.5em">
      (<a class="internal-link" href="/dc/council/laws/4-29.html">Aug. 5, 1981, D.C. Law 4-29, § 503, 28 DCR 3081</a>; <a class="internal-link" href="/dc/council/laws/20-278.html">June 16, 2015, D.C. Law 20-278, § 301, 62 DCR 1920</a>.)
    </div>
                      <div class="line subheading">Section References</div>
                      <div class="line" style="text-indent: 1.5em">This section is referenced in § <a class="internal-link" href="/dc/council/code/sections/48-903.04.html">48-903.04</a>.</div>
                      <div class="line subheading">Prior Codifications</div>
                      <div class="line" style="text-indent: 1.5em">1981 Ed., § 33-553.</div>
                      <div class="line subheading">Effect of Amendments</div>
                      <div class="line" style="text-indent: 1.5em">The 2015 amendment by <a class="internal-link" href="/dc/council/laws/20-278.html">D.C. Law 20-278</a> added (c).</div>
                      <div class="line subheading">Editor's Notes</div>
                      <div class="line" style="text-indent: 1.5em"><a class="internal-link" href="/dc/council/laws/20-278.html">D.C. Law 20-278</a>, referred to in (c), enacted Chapter 3 of Title 41 (§ <a class="internal-link" href="/dc/council/code/sections/41-301.html">41-301</a> et seq.), made amendments to the criminal offenses in §§ <a class="internal-link" href="/dc/council/code/sections/48-901.02.html">48-901.02</a> and <a class="internal-link" href="/dc/council/code/sections/48-905.02.html">48-905.02</a>, and made conforming amendments to §§ <a class="internal-link" href="/dc/council/code/sections/7-2507.06a.html">7-2507.06a</a>, <a class="internal-link" href="/dc/council/code/sections/8-905.html">8-905</a>, <a class="internal-link" href="/dc/council/code/sections/22-902.html">22-902</a>, <a class="internal-link" href="/dc/council/code/sections/22-1705.html">22-1705</a>, <a class="internal-link" href="/dc/council/code/sections/22-2723.html">22-2723</a>, <a class="internal-link" href="/dc/council/code/sections/32-1343.html">32-1343</a>, <a class="internal-link" href="/dc/council/code/sections/48-905.03.html">48-905.03</a>, and <a class="internal-link" href="/dc/council/code/sections/50-1501.04.html">50-1501.04</a>.</div>
                    </div>
                  </div>
            <hr/>
            <div class="line heading heading-2" style="text-indent: 0em">
              <p>
                <span class="" style="">§ 48–905.04. Educational programs; research purposes.</span>
              </p>
            </div>
            <div>
                    <div class="line-group primary-content">
                      <div class="line" style="text-indent: 1.25em">
                        <p>
                          <span class="level-num">(a)</span>
                          <span>The Mayor shall establish and operate an educational program consisting of films, lectures, panel discussions, or whatever other educational device the Mayor deems necessary and appropriate to enlighten persons on the habitual use of controlled substances in general and to instill in persons participating in such a program a respect for the law and legal institutions.</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 1.25em">
                        <p>
                          <span class="level-num">(b)</span>
                          <span>The Mayor shall cooperate with the Board of Education in preparing similar programs for school children with the purpose of preventing their abuse of controlled substances.</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 1.25em">
                        <p>
                          <span class="level-num">(c)</span>
                          <span>The Mayor shall prepare and operate similar and appropriate programs for children found to be delinquent for violation of the provisions of this chapter.</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 1.25em">
                        <p>
                          <span class="level-num">(d)</span>
                          <span>The Mayor may authorize the possession and distribution of controlled substances by persons engaged in research. Possession and distribution of controlled substances by such persons, in the course of their research and to the extent of the authorization, does not violate the provisions of this chapter.</span>
                        </p>
                      </div>
                    </div>
                    <div class="line-group annotations">
                      <div class="line" style="text-indent: 1.5em">
      (<a class="internal-link" href="/dc/council/laws/4-29.html">Aug. 5, 1981, D.C. Law 4-29, § 504, 28 DCR 3081</a>.)
    </div>
                      <div class="line subheading">Section References</div>
                      <div class="line" style="text-indent: 1.5em">This section is referenced in § <a class="internal-link" href="/dc/council/code/sections/16-2320.html">16-2320</a>.</div>
                      <div class="line subheading">Prior Codifications</div>
                      <div class="line" style="text-indent: 1.5em">1981 Ed., § 33-554.</div>
                    </div>
                  </div>
            <hr/>
            <div class="line heading heading-2" style="text-indent: 0em">
              <p>
                <span class="" style="">§ 48–905.05. Administrative inspections.</span>
              </p>
            </div>
            <div>
                    <div class="line-group primary-content">
                      <div class="line" style="text-indent: 1.25em">
                        <p>
                          <span class="level-num">(a)</span>
                          <span>The Mayor may make administrative inspections of controlled premises in accordance with the following provisions:</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 2.5em">
                        <p>
                          <span class="level-num">(1)</span>
                          <span>For purposes of this section only, the term “controlled premises” means:</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 3.75em">
                        <p>
                          <span class="level-num">(A)</span>
                          <span>Places where persons registered or exempted from registration requirements under this chapter are required to keep records; and</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 3.75em">
                        <p>
                          <span class="level-num">(B)</span>
                          <span>Places including factories, warehouses, establishments, and conveyances in which persons registered or exempted from registration requirements under this chapter are permitted to hold, manufacture, compound, process, sell, deliver, or otherwise dispose of any controlled substance.</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 2.5em">
                        <p>
                          <span class="level-num">(2)</span>
                          <span>When authorized by an administrative inspection warrant issued pursuant to subsection (b) of this section, an officer, an employee designated by the Mayor, or a designated civilian employee of the Metropolitan Police Department, upon presenting the warrant and appropriate credentials to the owner, operator, or agent in charge, may enter controlled premises for the purpose of conducting an administrative inspection.</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 2.5em">
                        <p>
                          <span class="level-num">(3)</span>
                          <span>When authorized by an administrative inspection warrant, an officer or employee designated by the Mayor may:</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 3.75em">
                        <p>
                          <span class="level-num">(A)</span>
                          <span>Inspect and copy records required by this chapter to be kept;</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 3.75em">
                        <p>
                          <span class="level-num">(B)</span>
                          <span>Inspect, within reasonable limits and in a reasonable manner, controlled premises and all pertinent equipment, finished and unfinished material, containers and labeling found therein, and, except as provided in paragraph (5) of this subsection, all other things therein, including records, files, papers, processes, controls, and facilities bearing on violation of this chapter; and</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 3.75em">
                        <p>
                          <span class="level-num">(C)</span>
                          <span>Inventory any stock of any controlled substance therein and obtain samples thereof.</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 2.5em">
                        <p>
                          <span class="level-num">(4)</span>
                          <span>This section does not prevent the inspection without a warrant of books and records pursuant to an administrative subpoena issued in accordance with § <a class="internal-link" href="/dc/council/code/sections/48-905.07.html">48-905.07</a> nor does it prevent entries and administrative inspections, including seizures of property, without a warrant:</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 3.75em">
                        <p>
                          <span class="level-num">(A)</span>
                          <span>If the owner, operator, or agent in charge of the controlled premises consents;</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 3.75em">
                        <p>
                          <span class="level-num">(B)</span>
                          <span>In situations presenting imminent danger to health or safety;</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 3.75em">
                        <p>
                          <span class="level-num">(C)</span>
                          <span>In situations involving inspection of conveyances if there is reasonable cause to believe that the mobility of the conveyance makes it impracticable to obtain a warrant;</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 3.75em">
                        <p>
                          <span class="level-num">(D)</span>
                          <span>In any other exceptional or emergency circumstance where time or opportunity to apply for a warrant is lacking; or</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 3.75em">
                        <p>
                          <span class="level-num">(E)</span>
                          <span>In all other situations in which a warrant is not constitutionally required.</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 2.5em">
                        <p>
                          <span class="level-num">(5)</span>
                          <span>An inspection authorized by this section shall not extend to financial data, sales data, other than shipment data, or pricing data unless the owner, operator, or agent in charge of the controlled premises consents in writing.</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 1.25em">
                        <p>
                          <span class="level-num">(b)</span>
                          <span>Issuance and execution of administrative inspection warrants shall be as follows:</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 2.5em">
                        <p>
                          <span class="level-num">(1)</span>
                          <span>A judge of the Superior Court of the District of Columbia, upon proper oath or affirmation showing probable cause, may issue warrants for the purpose of conducting administrative inspections authorized by this chapter or rules hereunder, and seizures of property appropriate to the inspections. For purposes of the issuance of administrative inspection warrants, probable cause exists upon showing a valid public interest in the effective enforcement of this chapter or rules hereunder, sufficient to justify administrative inspection of the area, premises, building, or conveyance in the circumstances specified in the application for the warrant.</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 2.5em">
                        <p>
                          <span class="level-num">(2)</span>
                          <span>A warrant shall issue only upon an affidavit of a designated officer or employee having knowledge of the facts alleged, sworn to before the judge and establishing the grounds for issuing the warrant. If the judge is satisfied that grounds for the issuance of the warrant exist or that there is probable cause to believe they exist, a warrant shall be issued identifying the area, premises, building, or conveyance to be inspected, the purpose of the inspection, and, if appropriate, the type of property to be inspected, if any. The warrant shall:</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 3.75em">
                        <p>
                          <span class="level-num">(A)</span>
                          <span>State the grounds for its issuance and the name of each person whose affidavit has been taken in support thereof;</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 3.75em">
                        <p>
                          <span class="level-num">(B)</span>
                          <span>Be directed to a person authorized and designated by the Mayor to execute it;</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 3.75em">
                        <p>
                          <span class="level-num">(C)</span>
                          <span>Command the person to whom it is directed to inspect the area, premises, building, or conveyance identified for the purpose specified and, if appropriate, direct the seizure of the property specified;</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 3.75em">
                        <p>
                          <span class="level-num">(D)</span>
                          <span>Identify the item or types of property to be seized, if any; and</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 3.75em">
                        <p>
                          <span class="level-num">(E)</span>
                          <span>Direct that it be served during normal business hours and designate the judge to whom it shall be returned.</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 2.5em">
                        <p>
                          <span class="level-num">(3)</span>
                          <span>A warrant issued pursuant to this section must be executed and returned within 10 days of its date unless, upon a showing of a need for additional time, the Court orders otherwise. If property is seized pursuant to a warrant, a copy shall be given to the person from whom or from whose premises the property is taken, together with a receipt for the property taken. The return of the warrant shall be made promptly, accompanied by a written inventory of any property taken. The inventory shall be made in the presence of the person executing the warrant and of the person from whose possession or premises the property was taken, if present, or in the presence of at least one person other than the person executing the warrant. A copy of the inventory shall be delivered to the person from whom or from whose premises the property was taken and to the applicant for the warrant.</span>
                        </p>
                      </div>
                    </div>
                    <div class="line-group annotations">
                      <div class="line" style="text-indent: 1.5em">
      (<a class="internal-link" href="/dc/council/laws/4-29.html">Aug. 5, 1981, D.C. Law 4-29, § 505, 28 DCR 3081</a>; <a class="internal-link" href="/dc/council/laws/12-284.html">June 12, 1999, D.C. Law 12-284, § 10(d), 46 DCR 1328</a>.)
    </div>
                      <div class="line subheading">Prior Codifications</div>
                      <div class="line" style="text-indent: 1.5em">1981 Ed., § 33-555.</div>
                      <div class="line subheading">Temporary Amendment of Section</div>
                      <div class="line" style="text-indent: 1.5em">For temporary (225 day) amendment of section, see § 10(d) of Metropolitan Police Department Civilianization Temporary Amendment Act of 1998 (<a class="internal-link" href="/dc/council/laws/12-282.html">D.C. Law 12-282</a>, May 28, 1999, law notification  46 DCR 5148).</div>
                      <div class="line subheading">Emergency Legislation</div>
                      <div class="line" style="text-indent: 1.5em">For temporary amendment of section, see § 10(d) of the Metropolitan Police Department Civilianization and Street Solicitation for Prostitution Emergency Amendment Act of 1998 (D.C. Act 12-428, August 6, 1998,  45 DCR 5884), § 10(d) of the Metropolitan Police Department Civilianization Legislative Review Emergency Amendment Act of 1998 (D.C. Act 12-506, November 10, 1998,  45 DCR 8139), and § 10(d) of the Metropolitan Police Department Civilianization Congressional Review Emergency Amendment Act of 1999 (D.C. Act 13-13, February 8, 1999,  46 DCR 2333).</div>
                    </div>
                  </div>
            <hr/>
            <div class="line heading heading-2" style="text-indent: 0em">
              <p>
                <span class="" style="">§ 48–905.06. Chemist reports.</span>
              </p>
            </div>
            <div>
                    <div class="line-group primary-content">
                      <div class="line" style="text-indent: 1.25em">In a proceeding for a violation of this chapter, the official report of chain of custody and of analysis of a controlled substance performed by a chemist charged with an official duty to perform such analysis, when attested to by that chemist and by the officer having legal custody of the report and accompanied by a certificate under seal that the officer has legal custody, shall be admissible in evidence as evidence of the facts stated therein and the results of that analysis. A copy of the certificate must be furnished upon demand by the defendant or his or her attorney in accordance with the rules of the Superior Court of the District of Columbia or, if no demand is made, no later than 5 days prior to trial. In the event that the defendant or his or her attorney subpoenas the chemist for examination, the subpoena shall be without fee or cost and the examination shall be as on cross-examination.</div>
                    </div>
                    <div class="line-group annotations">
                      <div class="line" style="text-indent: 1.5em">
      (<a class="internal-link" href="/dc/council/laws/4-29.html">Aug. 5, 1981, D.C. Law 4-29, § 506, 28 DCR 3081</a>.)
    </div>
                      <div class="line subheading">Prior Codifications</div>
                      <div class="line" style="text-indent: 1.5em">1981 Ed., § 33-556.</div>
                    </div>
                  </div>
            <hr/>
            <div class="line heading heading-2" style="text-indent: 0em">
              <p>
                <span class="" style="">§ 48–905.07. Mayoral subpoenas.</span>
              </p>
            </div>
            <div>
                    <div class="line-group primary-content">
                      <div class="line" style="text-indent: 1.25em">
                        <p>
                          <span class="level-num">(a)</span>
                          <span>In any investigation relating to the Mayor’s functions under this subchapter with respect to controlled substances, the Mayor may subpoena witnesses, compel the attendance and testimony of witnesses, and require the production of any records (including books, papers, documents, and other tangible things which constitute or contain evidence) which the Mayor finds relevant or material to the investigation. The attendance of witnesses and the production of records may be required from any place in the District of Columbia. Witnesses summoned under this section shall be paid the same fees and mileage that are paid witnesses in the Superior Court of the District of Columbia.</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 1.25em">
                        <p>
                          <span class="level-num">(b)</span>
                          <span>A subpoena issued under this section may be served by any person designated in the subpoena to serve it. Service upon a natural person may be made by personal delivery of the subpoena to that person. Service may be made upon a domestic or foreign corporation or upon a partnership or other unincorporated association which is subject to suit under a common name, by delivering the subpoena to an officer, to a managing or general agent, or to any other agent authorized by appointment or by law to receive service of process. The affidavit of the person serving the subpoena entered on a true copy thereof by the person serving it shall be proof of service.</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 1.25em">
                        <p>
                          <span class="level-num">(c)</span>
                          <span>In the case of contumacy by or refusal to obey a subpoena issued to any person, the Mayor may invoke the aid of any District of Columbia court within the jurisdiction of which the investigation is carried on or of which the subpoenaed person is an inhabitant, or in which the subpoenaed person carries on business or may be found, to compel compliance with the subpoena. The court may issue an order requiring the subpoenaed person to appear before the Mayor to produce records, if so ordered, or to give testimony touching the matter under investigation. Any failure to obey the order of the court may be punished by the court as a contempt thereof.</span>
                        </p>
                      </div>
                    </div>
                    <div class="line-group annotations">
                      <div class="line" style="text-indent: 1.5em">
      (<a class="internal-link" href="/dc/council/laws/4-29.html">Aug. 5, 1981, D.C. Law 4-29, § 507, 28 DCR 3081</a>; <a class="internal-link" href="/dc/council/laws/7-231.html">May 10, 1989, D.C. Law 7-231, § 41, 36 DCR 492</a>.)
    </div>
                      <div class="line subheading">Section References</div>
                      <div class="line" style="text-indent: 1.5em">This section is referenced in § <a class="internal-link" href="/dc/council/code/sections/48-905.05.html">48-905.05</a>.</div>
                      <div class="line subheading">Prior Codifications</div>
                      <div class="line" style="text-indent: 1.5em">1981 Ed., § 33-557.</div>
                    </div>
                  </div>
            <hr/>
            <div class="line heading heading-1" style="text-indent: 0em">
              <p>
                <span class="" style="">Subchapter VI. Miscellaneous.</span>
              </p>
            </div>
            <div class="line heading heading-2" style="text-indent: 0em">
              <p>
                <span class="" style="">§ 48–906.01. Pending proceedings.</span>
              </p>
            </div>
            <div>
                    <div class="line-group primary-content">
                      <div class="line" style="text-indent: 1.25em">
                        <p>
                          <span class="level-num">(a)</span>
                          <span>Prosecution for any violation of the laws repealed by <a class="internal-link" href="/dc/council/laws/4-29.html">D.C. Law 4-29</a>, pursuant to § 604, which were initiated prior to August 5, 1981, is not affected or abated by this chapter. If the offense being prosecuted is similar to an offense set out in subchapter IV of this chapter, then the penalties under subchapter IV of this chapter apply if they are less than those under prior law.</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 1.25em">
                        <p>
                          <span class="level-num">(b)</span>
                          <span>Civil seizures or forfeitures commenced prior to August 5, 1981, are not affected by this chapter.</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 1.25em">
                        <p>
                          <span class="level-num">(c)</span>
                          <span>All administrative proceedings pending under prior laws which are superseded by this chapter shall be continued and brought to a final determination in accord with the laws and rules in effect prior to August 5, 1981.</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 1.25em">
                        <p>
                          <span class="level-num">(d)</span>
                          <span>The Mayor shall initially permit persons to register who own or operate any establishment engaged in the manufacture, distribution, or dispensing of any controlled substance prior to August 5, 1981, and who are registered or licensed by the District of Columbia on August 5, 1981, pursuant to laws and rules in effect immediately prior thereto.</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 1.25em">
                        <p>
                          <span class="level-num">(e)</span>
                          <span>This chapter applies to violations of law, seizures and forfeiture, administrative proceedings, and investigations which occur following its effective date.</span>
                        </p>
                      </div>
                    </div>
                    <div class="line-group annotations">
                      <div class="line" style="text-indent: 1.5em">
      (<a class="internal-link" href="/dc/council/laws/4-29.html">Aug. 5, 1981, D.C. Law 4-29, § 601, 28 DCR 3081</a>.)
    </div>
                      <div class="line subheading">Prior Codifications</div>
                      <div class="line" style="text-indent: 1.5em">1981 Ed., § 33-561.</div>
                    </div>
                  </div>
            <hr/>
            <div class="line heading heading-2" style="text-indent: 0em">
              <p>
                <span class="" style="">§ 48–906.02. Continuation of orders and rules.</span>
              </p>
            </div>
            <div>
                    <div class="line-group primary-content">
                      <div class="line" style="text-indent: 1.25em">Any orders and rules issued under any law affected by this chapter and in effect on August 5, 1981, and not in conflict with it, continue in effect until modified, superseded, or repealed.</div>
                    </div>
                    <div class="line-group annotations">
                      <div class="line" style="text-indent: 1.5em">
      (<a class="internal-link" href="/dc/council/laws/4-29.html">Aug. 5, 1981, D.C. Law 4-29, § 602, 28 DCR 3081</a>.)
    </div>
                      <div class="line subheading">Prior Codifications</div>
                      <div class="line" style="text-indent: 1.5em">1981 Ed., § 33-562.</div>
                    </div>
                  </div>
            <hr/>
            <div class="line heading heading-2" style="text-indent: 0em">
              <p>
                <span class="" style="">§ 48–906.03. Severability.</span>
              </p>
            </div>
            <div>
                    <div class="line-group primary-content">
                      <div class="line" style="text-indent: 1.25em">If any provision of this chapter or the application thereof to any person or circumstance is held invalid, the invalidity does not affect other provisions or applications of the chapter which can be given effect without the invalid provision or application, and to this end the provisions of this chapter are severable.</div>
                    </div>
                    <div class="line-group annotations">
                      <div class="line" style="text-indent: 1.5em">
      (<a class="internal-link" href="/dc/council/laws/4-29.html">Aug. 5, 1981, D.C. Law 4-29, § 603, 28 DCR 3081</a>.)
    </div>
                      <div class="line subheading">Cross References</div>
                      <div class="line" style="text-indent: 1.5em">Controlled substances, forfeitures, proceeds transferred to Fund, see § <a class="internal-link" href="/dc/council/code/sections/48-905.02.html">48-905.02</a>.</div>
                      <div class="line subheading">Prior Codifications</div>
                      <div class="line" style="text-indent: 1.5em">1981 Ed., § 33-563.</div>
                    </div>
                  </div>
            <hr/>
            <div class="line heading heading-1" style="text-indent: 0em">
              <p>
                <span class="" style="">Subchapter VII. Drug Interdiction and Demand Reduction Fund.</span>
              </p>
            </div>
            <div class="line heading heading-2" style="text-indent: 0em">
              <p>
                <span class="" style="">§ 48–907.01. Establishment of Fund. [Repealed]</span>
              </p>
            </div>
            <div>
                    <div class="line-group primary-content">
                      <div class="line" style="text-indent: 1.25em">Repealed.</div>
                    </div>
                    <div class="line-group annotations">
                      <div class="line" style="text-indent: 1.5em">
      (<a class="internal-link" href="/dc/council/laws/4-29.html">Aug. 5, 1981, D.C. Law 4-29, § 701</a>; <a class="internal-link" href="/dc/council/laws/8-138.html">as added June 13, 1990, D.C. Law 8-138, § 2(f), 37 DCR 2638</a>; <a class="internal-link" href="/dc/council/laws/19-21.html">Sept. 14, 2011, D.C. Law 19-21, § 9067(b), 58 DCR 6226</a>.)
    </div>
                      <div class="line subheading">Prior Codifications</div>
                      <div class="line" style="text-indent: 1.5em">1981 Ed., § 33-571.</div>
                      <div class="line subheading">Editor's Notes</div>
                      <div class="line" style="text-indent: 1.5em">Mayor to implement public information program: See Historical and Statutory Notes following § <a class="internal-link" href="/dc/council/code/sections/48-901.02.html">48-901.02</a>.</div>
                    </div>
                  </div>
            <hr/>
            <div class="line heading heading-2" style="text-indent: 0em">
              <p>
                <span class="" style="">§ 48–907.02. Funding and disbursements. [Repealed]</span>
              </p>
            </div>
            <div>
                    <div class="line-group primary-content">
                      <div class="line" style="text-indent: 1.25em">Repealed.</div>
                    </div>
                    <div class="line-group annotations">
                      <div class="line" style="text-indent: 1.5em">
      (<a class="internal-link" href="/dc/council/laws/4-29.html">Aug. 5, 1981, D.C. Law 4-29, § 702</a>; <a class="internal-link" href="/dc/council/laws/8-138.html">as added June 13, 1990, D.C. Law 8-138, § 2(f), 37 DCR 2638</a>; <a class="internal-link" href="/dc/council/laws/9-155.html">Sept. 26, 1992, D.C. Law 9-155, § 2(b), 39 DCR 5679</a>; <a class="internal-link" href="/dc/council/laws/11-52.html">Sept. 26, 1995, D.C. Law 11-52, § 809(a), 42 DCR 3684</a>; <a class="internal-link" href="/dc/council/laws/19-168.html">Sept. 20, 2012, D.C. Law 19-168, § 8004, 59 DCR 8025</a>.)
    </div>
                      <div class="line subheading">Section References</div>
                      <div class="line" style="text-indent: 1.5em">This section is referenced in § <a class="internal-link" href="/dc/council/code/sections/23-532.html">23-532</a>.</div>
                      <div class="line subheading">Prior Codifications</div>
                      <div class="line" style="text-indent: 1.5em">1981 Ed., § 33-572.</div>
                      <div class="line subheading">Temporary Legislation</div>
                      <div class="line" style="text-indent: 1.5em">For temporary (225 day) amendment of section, see § 804(a) of Multiyear Budget Spending Reduction and Support Temporary Act of 1995 (<a class="internal-link" href="/dc/council/laws/10-253.html">D.C. Law 10-253</a>, March 23, 1995, law notification  42 DCR 1652).</div>
                      <div class="line subheading">Emergency Legislation</div>
                      <div class="line" style="text-indent: 1.5em">For temporary (90 day) repeal of section, see § 8004 of Fiscal Year 2013 Budget Support  Emergency Act of 2012 (D.C. Act 19-383, June 19, 2012,  59 DCR 7764).</div>
                      <div class="line" style="text-indent: 1.5em">For temporary (90 day) repeal of section, see § 8004 of Fiscal Year 2013 Budget Support Congressional Review Emergency Act of 2012 (D.C. Act 19-413, July 25, 2012,  59 DCR 9290).</div>
                      <div class="line subheading">Editor's Notes</div>
                      <div class="line" style="text-indent: 1.5em">Section 8010 of <a class="internal-link" href="/dc/council/laws/19-168.html">D.C. Law 19-168</a> provided that §§ 8002, 8003, 8004, 8005, 8006, and 8007 of the act shall apply as of September 14, 2011.</div>
                    </div>
                  </div>
            <hr/>
            <div class="line heading heading-2" style="text-indent: 0em">
              <p>
                <span class="" style="">§ 48–907.03. Grant Award Committee. [Repealed]</span>
              </p>
            </div>
            <div>
                    <div class="line-group primary-content">
                      <div class="line" style="text-indent: 1.25em">Repealed.</div>
                    </div>
                    <div class="line-group annotations">
                      <div class="line" style="text-indent: 1.5em">
      (<a class="internal-link" href="/dc/council/laws/4-29.html">Aug. 5, 1981, D.C. Law 4-29, § 703</a>; <a class="internal-link" href="/dc/council/laws/9-123.html">as added June 11, 1992, D.C. Law 9-123, § 2(c), 39 DCR 3202</a>; <a class="internal-link" href="/dc/council/laws/9-155.html">Sept. 26, 1992, D.C. Law 9-155, § 2(c), 39 DCR 5679</a>; <a class="internal-link" href="/dc/council/laws/11-52.html">Sept. 26, 1995, D.C. Law 11-52, § 809(b), 42 DCR 3684</a>.)
    </div>
                      <div class="line subheading">Prior Codifications</div>
                      <div class="line" style="text-indent: 1.5em">1981 Ed., § 33-573.</div>
                      <div class="line subheading">Temporary Amendment of Section</div>
                      <div class="line" style="text-indent: 1.5em">For temporary (225 day) amendment of section, see § 804(b) of Multiyear Budget Spending Reduction and Support Temporary Act of 1995 (<a class="internal-link" href="/dc/council/laws/10-253.html">D.C. Law 10-253</a>, March 23, 1995, law notification  42 DCR 1652).</div>
                      <div class="line subheading">Editor's Notes</div>
                      <div class="line" style="text-indent: 1.5em"><a class="internal-link" href="/dc/council/laws/10-253.html">D.C. Law 10-253</a>, title VIII, § 804(b) ( 42 DCR 721), eff. March 23, 1995, provided for the temporary repeal of this section. Title XIII, § 1301(b) of <a class="internal-link" href="/dc/council/laws/10-253.html">D.C. Law 10-253</a> provided for expiration “on the 225th day of its having taken effect or upon the effective date of the Multiyear Budget Spending Reduction and Support Act of 1995, whichever occurs first.”</div>
                    </div>
                  </div>
            <hr/>
          </div>
        </div>
      </div>
    </div>
    <footer>
      <div class="container center">
        <p>The codes and laws on this website are in the public domain.</p>
        <p>
              Please do not scrape. Instead, bulk download the <a href="https://github.com/dccouncil/dc-law-html">HTML</a> or <a href="https://github.com/dccouncil/dc-law-xml">XML</a>.
            </p>
      </div>
    </footer>
    <script type="text/javascript" src="/js/search.js"> </script>
  </body>
</html>
